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Abstract of Thesis. 
This thesis has focussed on the regulation of the gene encoding the 
essential DNA replication protein Proliferating Cell Nuclear Antigen 
(PCNA). PCNA expression in Plasmodium falciparum had earlier been 
shown to be stage specific during development in the intraerythrocytic 
cycle. Here its expression was examined in more detail. In addition, a 
preliminary analysis of the regulation of the gene encoding DNA 
polymerase 8, of which PCNA is an auxiliary factor, was made. 
Antisera raised against P.falciparum PCNA (PfPCNA) and DNA 
polymerase ö (PfPol) have been used against extracts from synchronised 
parasites to show that both proteins accumulate in trophozoites and 
persist in schizonts. The steady-state transcripts from both PfPCNA and 
PfPol8 also accumulate at the trophozoite stage. However, nuclear run on 
analysis shows that; whereas PfPol8 promoter activity is absent in rings 
- but present in trophozoites and schizonts, the PfPCNA promoter is active 
throughout the intraerythrocytic cycle. This suggests that mechanisms 
regulating the expression of these two genes may be different although 
their coordinated activity is required for DNA replication. 
A major transcription start site 960bp upstream of the translational start of 
the PfPCNA coding sequence was identified. A second, minor, site is 
situated a further 40bp upstream. These results were developed from a 
number of methods to reduce the possibility of ambiguities which may 
arise due to the extreme AT-richness of P.falciparum non-coding DNA. 
Consensus TATA boxes and an OCT-i box were identified upstream of the 
putative transcription start sites. Analysis of cDNA clones identified a 
putative transcription stop site 250bp downstream of the stop codon. 
An attempt was made to develop a transient transfection system using 5' 
and 3' flanking sequences from PfPCNA with the novel reporter gene 
encoding the green fluorescent protein (GFP) of Aquorea victoria. No GFP 
fluorescence was observed although analysis indicated the construct 
reached the cytoplasm of the parasite after electroporation. In contrast the 
intraerythrocytic stages were successfully transfected with constructs 
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containing a firefly luciferase reporter gene under the transcriptional 
control of variously modified elements of the PfPCNA 5' flanking 
sequence to test the effect on promoter activity. The analysis identified an 
essential region for promoter activity which contains the physically 
mapped transcription start sites. In addition, a region approximately 400bp 
upstream of the transcription start sites is required for efficient promoter 
activity. 
Work from this thesis has been published elsewhere; 
Horrocks, P., Jackson, M., Cheesman, S., White, J.H. and Kilbey, B.J. (1996) 
Stage specific expression of Proliferating Cell Nuclear Antigen and DNA 
Polymerase ö from Plasmodium falciparum. Molecular and Biochemical 
Parasitology (in press) 
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Malaria is the disease caused by the parasites of the genus Plasmodium. 
Human malaria is found in the tropics and sub-tropics, and is endemic in 
over 90 countries. Almost one half of the world's population is at risk of 
contracting malaria. The exact figures regarding the number of people 
who develop malaria, and its subsequent mortality, are difficult to assess. 
Estimates of over 280 million infections, with 110 millions developing 
disease symptoms leading to 2 million deaths have been made (Brown, 
1992, Miller et a!, 1994). In Africa alone, around 1 million people, mainly 
infants and children under 5 years of age, die annually from malaria. 
References to the symptoms of malaria have been recorded in ancient 
Egyptian and Chinese writings. From early times malaria has been 
associated with marshes; plaudism is from the French word for swamps 
or marsh. Initially the "airs" (ma!: bad, aria: air) associated with swamps 
or evil spirits were blamed for causing the disease. It was not until 1880 
that Laveran identified parasites in the blood of . patients suffering from 
malaria (Bruce-Chwatt, 1985, Phillips, 1993). 
The protozoan parasites responsible for the disease, of which over 120 
species have been identified, are found in a wide range of distinct 
vertebrate hosts including; birds, man, primates, reptiles and rodents. 4 
species of Plasmodium infect man, P.malariae, P.ovale, P.vivax and the 
more severe P.falciparum (Phillips, 1983). 
In 1955 the 8th World Assembly adopted a global programme for the 
eradication of malaria. This programme was taken over two years later by 
the World Health Organisation. As part of an 8 year programme 
insecticides and anti-malarial drugs were used to eradicate the mosquito 
vector and treat human reservoirs of the disease. After some initial 
promising progress the disease appeared to returning to many regions 
from which had been eradicated. In the 1970's malaria was once again 
endemic in tropical and sub-tropical regions, although malaria had 
receded from some more temperate regions (Bruce-Chwatt, 1985). 
Mosquitoes resistant to the insecticide DDT and drug resistant parasites 
were identified during this period as being responsible for the resurgence. 
Human Plasmodium, with multiple drug resistance, presents an ever 
increasing world health problem. 
The governments in regions where malaria is endemic have, over the 
last 10-15 years, faced increasing financial restrictions. The falling levels of 
income per capita have led to a reduced health expenditure during 1980-
90s. The financial burden of malaria has been estimated, during 1985 for 
example, to have accounted for a substantial proportion of the gross 
domestic product of these developing regions (Evans and Jamison, 1994). 
This figure was based upon the costs of prevention programmes, clinical 
treatment and loss of production of goods from people incapacitated by 
malaria. The burden of the disease at the village and family level is even 
more disastrous. These governments have had to face choices of how to 
control malaria and realistically justify the costs to the don brnations of 
the developed world. Currently, control programmes throughout the 
world are concentrating on preventative measures such as education, 
impregnated bed nets and health clinics in the community (Kolberg, 
1994). 
1.2 P.falciparum life cycle. 
The life cycle of P.falciparum (Phillips, 1983, Bruce-Chwatt, 1985) takes 
place in two hosts; the asexual phase in the human vertebrate host and a 
sexual phase in the female Anopholes mosquito (Figure 1). 
Infection in the human host starts when sporozoites from the saliva of an 
infected mosquito are introduced into the blood stream during a blood 
meal. The motile sporozoites move through the skins capillary beds into 
the main blood stream. When the sporozoites reach the liver they attach 
to, and invade parenchymal cells. The entire process takes approximately 
30 minutes, during which time many of the sporozoites are destroyed by 
phagocytes. In the parenchymal cells the remaining sporozoites undergo 
many mitotic divisions, in a process known as exoerythrocytic 
schizogony, which produces many thousands of merozoites. On 
completion of schizogony the parenchymal cells rupture releasing the 
merozoites into the blood stream. The merozoites rapidly recognise, 
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attach to and invade erythrocytes, a process that takes approximately 20 
seconds. 
Within the erythrocytes the parasite undergoes intraerythrocytic 
schizogony, a process that takes 48 hours. The merozoite initially 
develops into a small circular form known as the ring stage. The ring 
stage grows and become irregular in shape as it develops into a 
trophozoite. The trophozoite stage, sometimes referred to as the "feeding 
form", uses the erythrocyte haemoglobin as a nutrient source. DNA 
synthesis starts in the mid-trophozoite stage and the nucleus undergoes 
up to 4 rounds of division. As the trophozoites develop into schizonts the 
cytoplasm is divided. The nuclei and cytoplasm separate to give up to 16 
merozoites which are released when the erythrocyte bursts. The rupture 
of the infected erythrocytes is synchronised and coincides with a peak in 
the fever symptoms. The falciparum malaria is particularly severe due to 
the ability of infected erythrocytes to attach to one another, in a process 
known as rosetting, as well as to the epithelium of capillaries. Attachment 
to the epithelia of capillaries in the brain, resulting in their subsequent 
blockage, is thought to be responsible for the fatal coma found in either 
the young or non-immune victims of falciparum malaria (Miller et al., 
1994). 
The released merozoites may re-invade erythrocytes undergoing a further 
cycle of intraerythrocytic schizogony or they may become committed to 
sexual differentiation as gametocytes. The factors that control the switch 
from the asexual to sexual stages are not completely understood. 
However, body temperature, host immunity and nutrient levels are all 
thought to be involved. 
A male microgametocyte or a female macrogametocyte are formed, and 
both types of gametocyte are taken up into the mosquito mid-gut in a 
subsequent blood meal. The erythrocyte membrane is shed and the 
parasites complete gametogenesis. The microgametocyte undergoes 
exflagellation, a process that gives rise to 8 microgametes. A microgamete 
fertilises a macrogamete to give a zygote. The zygote is the only 
developmental stage to be diploid as meiosis follows rapidly. Over the 
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Figure 1. 
Plasmodium falciparum life cycle (Bruce-Chwatt, 1985) 
through the mid-gut epithelium to rest between the basement cell 
membrane and the basel lamina of the mid-gut wall. The ookinete 
undergoes many rounds of mitotic division, over the following 10-12 
days, developing into an oocyst in which thousands of sporozoites are 
formed. When the sporozoites are released from a ruptured oocyst they 
travel through the haemocoel to the salivary glands. The sporozoites are 
then introduced into the human host when the next blood meal is taken. 
1.3 P.falciparum genome. 
1.3.1 Genome size and DNA composition. 
The P.falciparum genome is haploid throughout most of the life-cycle, 
with zygote formation and meiosis occurring only during the mosquito 
phase of development (Walliker et al., 1987). Early attempts to study the 
genome using microscopy did not reveal any information as P.falciparum 
chromosomes do not condense during development. However, the 
advent of pulsed field gel electrophoresis (PFGE) techniques during the 
mid-1980s allowed 14 chromosomes, ranging in size between 800kb and 
3500kb, to be identified in P.falciparum (van der Ploeg et al., 1985, Kemp et 
al., 1985). Initial estimates of the P.falciparum genome size of the order of 
1-3X10 7bp were based on the analysis of P.falciparum genomic libraries 
(Goman et al., 1982, Pollack et at, 1982, Wellems et al., 1987). More recent 
genome mapping work has indicated that 3X10 7bp is a more accurate 
estimation of the size of the genome (Walker-Jonah et al., 1992). The 
P.falciparum genome has an A+T content that averages 69% in coding 
regions but increases to 90-95% in non-coding regions (Pollack et al., 1982, 
Weber, 1987). 
1.3.2 Molecular karyotype and chromosome plasticity. 
The observation from PFGE that P.falciparum has 14 chromosomes agrees 
well with the 14 kinetochores observed using electron microscopy 
(Sinden and Strong, 1987). A complete genome map is in preparation 
using the information from mapping of genes and other markers to their 
respective chromosomes and the subcloning of large regions of these 
chromosomes using yeast artificial chromosome technology (Lanzer et al., 
1993b, Triglia and Kemp, 1991, Wanatabe and Inselburg, 1994). When gene 
markers from chromosome 2 were mapped to a complete set of 
overlapping yeast artificial chromosome clones it appeared that the 
chromosome was compartmentalised. Gene encoding "housekeeping" 
proteins were located towards the centre of the chromosome and antigen 
encoding genes map to positions just within the subtelomeric repeats 
(Lanzer et al., 1993b, Scherf, 1996). 
Variations of up to 20% in chromosome sizes have been observed 
between isolates and even between clones from the same isolate (Kemp et 
al., 1985, Sinnis and Wellems, 1988, van der Ploeg et al., 1985). Analysis of 
the progeny from a genetic cross revealed the presence of size 
polymorphisms that were not present within the parental clones. 
Walliker et al. (1987) suggested that the size polymorphisms arose during 
meiosis. However, chromosome size polymorphisms have also been 
shown to arise during mitotic division when subtelomeric deletions were 
found in P. berghei cultures passaged between murine hosts by syringe 
rather than through a mosquito host (Janse, 1992). 
The molecular mechanisms that result in chromosome size 
polymorphisms may include reciprocal exchange between heterologous 
chromosomes, deletions or DNA amplification (Ravetch, 1989, Frontali, 
1994). Analysis of shortened chromosomes reveal that the predominant 
mechanism of shortening was through homologous recombination and 
deletions. The mechanisms which gave rise to these size polymorphisms 
were associated with sequences in the subtelomeric regions (Corcoran et 
al., 1988). The subtelomeric region of all chromosomes appears to contain 
a series of transcriptionally silent ordered repetitive sequence elements 
(de Bruin et al., 1994, Lanzer et al., 1993b). The common sequence 
elements in the subtelomeric regions were proposed to be the preferred 
sites for chromosomal pairing during the formation of the synaptonemal 
complex. Cross-overs and gene conversions within the subtelomeric 
region could give rise to genetically distinct parasites, some possibly with 
novel antigens (Vernick et a!, 1988). 
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1.3.3 Chromatin structure. 
Initial evidence suggesting that genomic DNA was packaged in chromatin 
was obtained from electron microscopy of P.knowlesi (Wunderlich et al., 
1980). The DNA appeared to have a beaded appearance which suggested 
that nucleosomes, the first level of chromatin structure, were formed. 
P.falciparum DNA was demonstrated to be organised into nucleosomes 
when genomic DNA, partially digested with micrococcal nuclease, gave a 
series of laddered DNA fragments in multiples of 180bp (Cary et al., 1994). 
The multiples of 180bp represent DNA which is protected from 
micrococcal nuclease by its association with the nucleosome. The highly 
conserved histone H2A gene has been cloned from P.falciparum (Creedon 
et al., 1992) and a group of proteins with histone-like properties have been 
extracted from the nucleus (Cary et al., 1994). 
1.3.4 Extrachromosomal DNA. 
P.falciparum, along with all other apicomplexan parasites, have 2 
extrachromosomal DNAs; multiple tandem repeats of a 6kb element and 
a single copy of a 35kb circle (Feagin, 1994). 
The 6kb element contains 3 open reading frames which encode 
- cytochrome b and the cytocrome c oxidase subunits I and III. Fragments of 
several genes with extensive homology to ribosomal RNA genes have 
also been identified (Feagin et al., 1992). Using subcellular fractionation 
techniques, the 6kb element was shown to probably reside in the 
mitochondria (Wilson et al., 1992). Uniparental inheritance of the 6kb 
element provided further evidence to support its mitochondrial origin 
(Creasey et al., 1993). 
The 35kb circle was originally thought to be a second mitochondrial DNA 
due to its size and circular nature (Feagin, 1994). Recent evidence, 
however, suggests that the 35kb circle may reside in a plastid rather than a 
mitochondrion (Palmer, 1992). The 35kb circle encodes rRNA subunits, 
various tRNAs and several subunits of a RNA polymerase (Feagin, 1994). 
Mitochondrial genomes, however, do not generally contain RNA 
polymerase genes. This, and phylogenetical studies of the rRNAs and 
tRNAs suggest a plastid origin (Feagin et al., 1992, 1994). A gene encoding 
a protein with homology to a protein found only in the plastids of a red 
algae appears to reinforce the idea that there was an early symbiotic 
relationship between algae and Plasmodia (Williamson et al., 1994). 
"Spherical bodies", which resemble plastid structures, have been found to 
be closely associated with the mitochondria of P.gallinaceum (Wilson, 
1991). No function has yet been assigned to this structure. Plastids in some 
plants contain a porphyrin biosynthetic pathway, this has led to the 
proposal that "spherical bodies" may play some role in removing the toxic 
haem, released during haemoglobin digestion, from the parasite's 
cytoplasm (Wilson et al., 1991). 
1.4 Plasmodium chromosomal DNA replication. 
1.4.1 DNA replication during the Plasmodium life cycle. 
Chromosomal DNA replication appears to take place at 5 points during 
the life cycle: (i) exoerythrocytic schizogony, (ii) intraerythrocytic 
schizogony, (iii) gametogenesis, (iv) during meiosis in the zygote and (v) 
sporogony in the oocysts (reviewed in White and Kilbey, 1996). 
Experimental evidence for DNA replication has not been obtained for the 
sporogony and exoerythrocytic schizogony stages of development. 
The measurement of incorporation of radiolabelled adenosine or 
hypoxanthine during the intraerythrocytic schizogony determined that 
DNA synthesis, in P.falciparum, starts approximately 30 hours after 
erythrocyte invasion (Gritzmacher and Reese, 1984, Inselburg and Banyal, 
1984). DNA synthesis was found to start in mid-trophozoites and to 
continue throughout schizont development, stopping only when 
schizogony is complete (Inselburg and Banyal, 1984). Their observation 
that DNA synthesis occurs during the latter stages of the intraerythrocytic 
cycle of P.falciparu m was similar to the findings from other Plasmodium 
species (Janse et al., 1986a, Conklin et al., 1973, Newbold et al., 1982). 
Experiments using microfluorimetry indicates that the DNA contents of 
both the male and female gametocytes increased during gametogenesis 
(Janse et al., 1986a, 1988). The DNA content of both P.berghei and 
P.falciparum macrogametes almost doubles. The increase in DNA content 
is more likely, however, to be the result of DNA amplification rather than 
DNA replication as Fuelgen staining indicates that no nuclear segregation 
takes place. Selective amplification of genes encoding ribosomal RNA has 
been proposed to occur in both macro- and microgametocytes but, as yet, 
no evidence to support this theory has been found. Microgametocytes are 
activated in the midgut and undergo exflagellation which leads to an 
approximate 8-fold increase in the DNA content (Janse et al., 1988, Janse et 
al., 1986a). In P.berghei the 8-fold increase in DNA takes place in 10 
minutes; a feat that has been calculated to require at least 1300 origins of 
replication. 
After fertilisation of the macrogamete in P.berghei the DNA content of 
the zygote was observed to double within 3 hours (Janse et a!, 1986b). This 
increase is consistent with the duplication of paired chromosomes in the 
first stage of meiosis. Electron microscopy has shown that synaptonemal 
complexes are associated with paired chromosomes at this developmental 
stage. (Sinden et al., 1985). 
Various concentrations of the DNA polymerase inhibitor aphidocolin 
have been shown to inhibit DNA synthesis, in both P.falciparum and 
P. berghei, throughout all the developmental stages described (Inselburg 
and Banyal, 1984, Janse et al., 1986a, 1986b, 1988). The three chromosomal 
DNA polymerases ((x,B and E) are all sensitive to aphidocolin (Kornberg 
and Baker, 1992), indicating that at least one of these polymerases must 
also replicate Plasmodium chromosomal DNA. 
Attempts to purify these polymerase activities have been made by 
separating cell extracts by SDS-PAGE. A stage specific DNA polymerase 
activity, sensitive to aphidocolin, has been isolated from P.falciparum 
(Abu-Elheiga et a!, 1990, Choi and Mikkelsen, 1991). Antibodies raised 
against DNA polymerase a precipitated a 180kDa protein, from the cell 
extracts, along with several smaller proteins thought to be degradation 
products. Further analysis indicated that two proteins, of 105kDa and 
72kDa, had DNA polymerase activity which were sensitive to aphidocolin 
but were not precipitated by the antibodies raised against DNA 
polymerase a. These proteins were tentatively assigned as either full 
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length and degraded DNA Polymerase 8 or degraded DNA Polymerase e . 
1.4.2 Cloning of P.falciparum DNA replication protein genes. 
The study of chromosomal DNA polymerase activities is complicated by 
the large numbers of parasites that are required and the presence of 
contaminating DNA polymerase activities from organelles. A different 
approach to the study of chromosomal DNA polymerase activity has been 
taken in Edinburgh, where genes encoding the chromosomal DNA 
replication proteins are being cloned, heterologously expressed and 
purified. Chromosomal DNA synthesis may be reconstituted and studied 
in vitro using purified replication proteins. To date, a number of genes 
have been cloned, including; DNA polymerases cx -and 8, proliferating cell 
nuclear antigen (PCNA), topoisomerases I and II (Figure 2). These were 
identified by screening genomic and cDNA libraries with either 
oligonucleotides designed to conserved regions or heterologous probing 
with S.cerevisiae gene fragments. 
DNA polymerase 8. 
DNA polymerase 8 is required for the elongation of both the leading and 
lagging strands (Tsurimoto et al., 1990, Waga and Stillman, 1994). The core 
enzyme consists of two subunits; a catalytic subunit of 125kDa with 
polymerase and 3'-5' exonuclease activity and a second subunit of 50kDa 
with an unknown function (Syruoja et al., 1990). 
The catalytic subunit of DNA polymerase 5 has been cloned from 
P.falciparum (Fox and Bzik, 1991, Ridley et al., 1991). A single copy of the 
gene, of 3282bp, is found on chromosome 10. A transcript of 
approximately 5.2kb encodes a polypeptide of 1094 amino acids with a 
predicted molecular mass of approximately 120kDa (Figure 2). 
The amino acid sequence contains 6 motifs which characterise the 
polypeptide as a DNA polymerase (1-VI). These motifs, I being the most 
conserved to VI which is the least conserved, are present in the same 
order as all other polymerases. Motif I has been implicated in polymerase 
activity (Dorsky and Crumpacker, 1990) and motif II and ifi are thought to 
be required for binding dNTPs (Blasco et al., 1992). A seventh highly 
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conserved motif (VII) is present in both P.falciparum DNA polymerase a 
and S (Ridley et al., 1991, White et al., 1993). Although this motif is 
conserved in other DNA polymerases the literature does not usually 
describe this motif. One or more of 4 conserved regions (exol, I', II and III) 
of DNA polymerase S are thought to be required for proof reading activity 
(Bernard et al., 1989, Simon et al., 1991). All four motifs are present in the 
P.falciparum DNA polymerase S polypeptide. The C terminus contains 
two putative zinc finger domains (ZnF1 and 2). ZnF2 is more conserved 
between species than ZnF1 although all the cysteine residues required are 
still present. Zinc fingers are required for both protein-protein and DNA-
protein interactions (Harrison, 1991), of which both types of interaction 
are required by DNA polymeràse & The DNA polymerase S from human ; 
mouse, calf thymus and S.pombe (Chung et al., 1990, Cullman et al., 1993, 
Zhang et al., 1991, Pignede et al., 1991) all contain a pair of conserved 
motifs towards the N terminus which are thought to be required for 
either interaction with PCNA or are nuclear targeting signals (Culiman et 
al., 1993). These motifs, however, are missing from the DNA polymerase 
S of P.falciparum. 
Proliferating Cell Nuclear Antigen. 
PCNA was first identified as a human auto-antigen in patients with 
systematic lupus erythematosus (Miyachi et al., 1978). PCNA was 
subsequently identified as a protein which accumulated during the S 
phase (Bravo and Cellis, 1980) and was therefore thought to be a cyclin. 
PCNA was later shown to be an auxiliary protein required for DNA 
polymerase S activity (Tan etal., 1986), where PCNA binds to DNA as a 
trimer and acts as a toroidal clamp for DNA polymerase S (Krishna et al., 
1994, Kong et al., 1992). 
The PCNA gene has been cloned from P.falciparum (Kilbey et al., 1993) 
and found to be present as a single copy on chromosome 13. The gene, of 
825bp, encodes a polypeptide of 275 amino acids which has a predicted 
molecular mass of approximately 30.5kDa (Figure 2). Two transcripts have 
been reported, a major transcript of approximately 1.6kb and a minor 
12 
transcript of approximately 2.2kb. Indirect immunofluorescence assays 
indicate that the protein accumulates in trophozoites and persists in 
schizonts (Kilbey et al., 1993). 
The polypeptide contains several conserved dispersed amino acids which 
confirm that it is PCNA, yet the overall identity is weak with the strongest 
homology to human PCNA (approximately 60%). A conserved region 
towards the N terminus, between amino acids 61-80, contains an a helix- 
turn-cc helix motif which is a putative DNA binding domain, although 
no evidence of this interaction has been found. PfPCNA contains 15 more 
amino acids than other PCNAs, of which 9-10 charged amino acids are 
present as an insert close to the carboxy terminus. Mutational analysis of 
human PCNA identified a number of conserved -amino acids, found on 
the surface of the protein, which are presumably required for interactions 
with DNA polymerase ö, other PCNA subunits and replication factor C 
(Fukuda et al., 1995, Jonsson et al., 1995). PCNA is discussed in more detail 
in section 1.7. 
DNA polymerase a. 
DNA polymerase a is responsible for the initiation of DNA synthesis on 
both the leading and lagging strand (Stillman, 1989, Waga and Stillman, 
1994). The DNA polymerase a catalytic subunit is comprised of a subunit 
containing the polymerase activity (205kDa), 2 subunits with primase 
activity (55-6OkDa and 48-5OkDa) and a 70kDa subunit with an unknown 
function (Wang, 1991). 
The DNA polymerase a gene from P.falciparum (White et al., 1993) was 
shown to be present as a single copy on chromosome 4. The gene of 5.7kb 
contains a single intron of 204bp. A transcript of approximately 7kb 
encodes a polypeptide of .1855 amino acids with a predicted molecular 
mass of approximately 205kDa (Figure 2). 
The P.falciparum DNA polymerase a polypeptide contains the 7 
conserved motifs (I-Vu) that characterise it as a DNA polymerase (see 
above). 4 of the 5 DNA polymerase a specific motifs (A-E) are present in 
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Figure 2. 
Schematic representing significant features of the catalytic subunits for 
DNA polymerases a and S and PCNA polypeptides from P.falciparum. 
Catalytic subunit of DNA polymerase a. I-Vu, conserved features of 
all DNA polymerases; B-E, conserved DNA polymerase a features; N1-4, 
polyasparagine tracts; 11-4, amino acid inserts. 
Catalytic subunit of DNA polymerase 8. I-VT, conserved features of all 
DNA polymerases; exo I' and I-Ill, putative proof reading function; ZnF1-
2, putative zinc fingers. 
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P.falciparum DNA polymerase a. Motif A is missing from the DNA 
polymerase a of both P.falciparum and T.brucei. The highly conserved 
glycine of motif D, which is thought to be required for interaction with 
the primase subunits (Pizzigalli et al., 1988) is substituted in P.falciparum 
by leucine. P.falciparum DNA polymerase a polypeptide contains 4 
polyasparagine tracts (N1-4) and 4 further inserts (11-4) of which 2 (12 and 
4) contain degenerative repeats of short sequences. Reverse transcription-
PCR confirmed that these regions were present in the mRNA. The 
number of degenerative repeats in insert 2 and the polyasparagines in N3 
were different in DNA polymerase a from a different P.falciparum isolate 
(White and Kilbey, 1996). Polyasparagine tracts and inserts with 
polypeptide repeats are immunodominant and are generally cross 
reactive (Ridley, 1991). The immune system is thought not to be able to 
mount an effective challenge to the parasite due to the "smokescreen" 
presented by these regions. Other evidence suggests that these regions 
may be necessary to facilitate interactions with other macromolecules 
such as skeletal proteins, receptor molecules and nucleic acids. 
1.5 Eukaryotic DNA replication. 
1.5.1 Simian virus 40 (SV40) cell free system. 
The mechanisms of DNA replication in both E.coli and Phage T4 have 
been characterised extensively (Kornberg and Baker, 1992). A study of 
eukaryotic DNA replication along the same lines as those of E.coli and 
Phage T4, however, has been hampered by the lack of a suitable 
biochemical system. Using the SV40 cell free system, however, a valuable 
insight into the mechanism of eukaryotic DNA replication has been 
obtained (Stillman, 1989, 1994). Of the six proteins encoded by the SV40 
genome, 4 are essential of which 3 are structural proteins (Stillman, 1989). 
The remaining protein, the T antigen (TAg), plays an essential role in 
SV40 DNA replication. Extracts from HeLa cells containing the cell's 
replication apparatus is capable of replicating the SV40 genome when 
supplemented with the virally encoded TAg (Li and Kelly, 1984, Ishimi et 
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al., 1988, Weinberg et al., 1990, Wobbe et al., 1987). This system offers the 
opportunity to study the biochemistry of eukaryotic DNA replication with 
the caveat that the initial step is brought about by a viral protein. The 
SV40 genome is assembled into a chromatin structure not dissimilar to 
that of the host genome further lending credence to the study of 
eukaryotic DNA replication through a SV40 cell free system (Stillman, 
1986). 
1.5.2 Initiation of DNA synthesis. 
TAg is a large multi-functional protein which recognises and binds to the 
ori site on the SV40 genome (Figure 3). TAg binds to the SV40 ori as a 
complex consisting of a double hexamer wrapped around the DNA 
(Mastrangelo et al., 1989). The binding of TAg is an ATP dependent 
process, hydrolysis of ATP, however, is not required for binding 
(Borowiec and Hurwitz, 1988). The TAg complex undergoes a 
conformational change which results in a short region of the bound DNA 
unwinding and the strands separating (Borowiec et al., 1990). The region 
of separated duplex is further extended by the intrinsic helicase activity 
present in the TAg (Dean et al., 1987). Topoisomerase I or Ills required for 
the unwinding of the DNA, presumably to release the torsional stress that 
builds up in the duplex ahead of the separated DNA strands. The single 
stranded DNA is then stabilised by the binding of a single stranded 
binding protein, replication factor A (RF-A). 
RF-A consists of three subunits (70kDa, 34kDa and llkDa) and is essential 
for SV40 DNA replication (Kenny et al., 1990, Tsurimoto and Stillman, 
1989). The 70kDa subunit, independent of the other 2 subunits, binds to 
and stabilises the single stranded DNA (Kenny et al., 1990). RF-A, as well 
as TAg, recruits the DNA polymerase a-primase complex to the origin of 
replication (Dornreiter et al., 1990, Melendy and Stillman, 1993). The 
primase activity of the DNA polymerase cx-primase complex is associated 
with a pair of subunits (58kDa and 48kDa). The short RNA primer is laid 
down by the primase which is used by the DNA polymerase a to produce 
a short stretch of DNA (Diffley, 1992). RF-A is required for the efficient 
17 
Figure 3. 
Figure illustrating the series of events surrounding the initiation of DNA 
replication at the SV40 ori sequence (Diffley, 1992). 
The TAg hexarner recognises and binds the ori site (A). On strand 
separation the single stranded DNA is bound by RF-A complex (B). The 
DNA polymerase a-primase complex is recruited (C). The primase lays 
down a short RNA primer from which the DNA polymerase a 
synthesises a short stretch of DNA (D). RF-C recognises and binds to the 
primer-template junction (E) and recruits PCNA which in turn recruits 
DNA polymerase S. (F) The DNA polymerase 6 synthesises DNA in a 
highly processive manner. (G) As more template is exposed, DNA 
polymerase a-primase complex binds and prepares a primer (H) on the 
opposite strand of the DNA duplex. 
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activity of the DNA polymerase a-primase complex (Kenny et al., 1990, 
Tsurimoto and Stillman, 1989). The short DNA fragment prepared in this 
way serves as the primer for the assembly of the leading strand replication 
complex. 
1.5.3 Replication of the leading and lagging strands. 
Replication factor C (RF-C) consists of a 140kDa subunit with up to 4 
further subunits ranging in size between 30-4OkDa (Tsurimoto and 
Stillman, 1991). The 140kDa subunit recognises and binds to the primer-
template junction (Tsurimoto and Stillman, 1991). RF-C then recruits 
PCNA to the primer template junction (Produst et al., 1995). PCNA binds 
to DNA as a trimer surrounding the DNA and slides along until it meets 
the RF-C primer template junction (Prelich et al., 1987). PCNA recruits 
DNA polymerase 6 (Tsurimoto and Stillman, 1991) for which it acts as a 
sliding clamp, holding the now highly processive DNA polymerase 6 to 
the DNA template during elongation. Leading strand synthesis therefore 
requires a switch between the DNA polymerase a-primase complex to the 
DNA polymerase 6 complex. 
Lagging strand DNA synthesis was presumed to take place by the DNA 
polymerase a-primase complex synthesising a number of end to end 
Okazaki fragments which were eventually joined together (Tsurimoto et 
al., 1990, Diffley, 1992). It was subsequently shown, however, that a switch 
between the DNA polymerase a-primase complex to the DNA 
polymerase 6 complex was required for the completion of the Okasaki 
fragments (Waga and Stillman, 1994). When the DNA polymerase 6 
complex meets the start of another Okazaki fragment it is proposed that 
the RNA primer and short stretch of DNA, laid down by the DNA 
polymerase a-primase complex, are removed by the action of RNase H 
and the 5'-3' exonuclease MF1 (Figure 4). The region of DNA synthesised 
by DNA polymerase a would have to be removed as it would be prone to 
errors as DNA polymerase a does not have a proofreading 3'-5' 
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Figure 4. 
Figure representing a model for the switch between the DNA polymerase 
a primase complex and DNA polymerase 6 on the lagging strand 
(originally drawn by Waga and Stillman, 1994). As a large enough region 
of lagging strand template becomes available (A) the DNA polymerase a-
primase complex is recruited to prepare a short RNA primer from which 
DNA polymerase a synthesises a short stretch of DNA (B). RF-C binds, 
displacing the DNA polymerase a primase complex (C), and the DNA 
polymerase 6 complex is assembled (D). When the DNA polymerase 6 
complex reaches the tail of an Okazaki fragment the RNA primer and 
DNA polymerase a synthesised DNA are removed by the RNase H/MF1 
complex (E). The remaining gap is filled by DNA polymerase S (F) and the 
two DNA fragments are joined by DNA ligase I (C). 
A schematic of the multi-protein complex assembled at the replication 
fork based on this model is represented (H). This figure was originally 
prepared by J.H. White based on the figure from Stillman and Waga 
(1994). 
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exonuclease activity. DNA ligase I completes the synthesis of the lagging 
strand by joining the Okazaki fragments together. 
1.5.4 DNA polymerase : a third polymerase? 
Eukaryotic cells have 3 DNA polymerases (a, 6 and e) which take part in 
chromosomal DNA replication (Hubscher and Spadari, 1994). DNA 
polymerase e is a multi-subunit complex with a major subunit of 220kDa 
which has both DNA polymerase and exonuclease activities, and several 
smaller subunits between 70kDa and 30kDa of unknown function 
(Hubscher and Thommes, 1992). DNA polymerase c is essential for DNA 
replication in S.cerevisiae (Morrison et al., 1990). 
DNA polymerases 6 and c were originally confused for one another until 
DNA polymerase c was shown to be highly processive in the absence of 
PCNA (Morrison et al., 1990). Although DNA polymerase E is highly 
processive in the absence of PCNA, the presence of PCNA has been 
shown to be required by DNA polymerase c to be able to bind to the 
primer-template junction and for the stimulation of it's activity (Maga 
and Hubscher, 1995). A model has been proposed whereby DNA 
polymerases 6 synthesises either the leading or lagging strand, and DNA 
polymerase e the other, after initiation on both strands by the DNA 
polymerase a-primase complex (Hubscher and Thommes, 1992). 
1.6 Regulation of DNA replication. 
1.6.1 Initiation of DNA synthesis and the "licensing" factor. 
The events surrounding the initiation and progression of DNA synthesis 
in higher eukaryotes have been primarily determined from a 
reconstituted in vitro system using the SV40 origin of replication. Using 
the in vitro SV40 system TAg was shown to recognise and bind a specific 
origin sequence (Waga and Stillman, 1994). In Saccharomyces cerevisine a 
group of proteins, give rise to an origin recognition complex (ORC) which 
performs a similar function to the SV40 TAg in the recognition, binding 
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to and unwinding of the autonomously replicating sequences (ARS). The 
ORC is made up of a group of 6 proteins of sizes ranging between 50kDa to 
120kDa (Bell and Stillman, 1992). Homologues of several of the ORC 
subunits have been identified in a wide range of eukaryotes including 
Schizosaccharomyces pombe, Arabadopsis thaliana, Caenorhabditis 
elegans, Drosophila melanogaster and humans which suggests a 
conserved role for the ORC complex in origin recognition (Benbow et al., 
1992). The ORC complex in S.cerevisiae was shown to require ATP to bind 
to the ARS and was found to be continually bound to an ARS throughout 
the cell cycle. It is presumed that some form of post-translational 
modification may. be responsible for activation of the complex (Diffley et 
al., 1994). 
Sequence specific origins of replication have not been identified in higher 
eukaryotes despite several attempts. It has been proposed that there are 
many potential sequences capable of acting as origins of replication and 
that only a small group are activated during DNA replication 
(DePamphilis, 1993). Examination of the structure of chromatin in the 
nuclei of higher eukaryotes has identified a number of foci at which DNA 
replication is presumed to take place. It has been proposed that only 
origins of replication associated with these foci would be activated (Cox 
and Laskey, 1991, Adachi and Laemmli, 1994). The single stranded protein, 
RF-A, is strongly associated with these foci (Yan and Newport, 1995). 
A set of genes encoding proteins structurally related to subunits of the 
S.cerevisiae ORC were identified in a screen of yeast mutants which failed 
to replicate plasmids containing an ARS (Hennessy et al., 1991). These 
proteins, including; MCM2, MCM3 and MCM5/CDC46 from S.cerevisiae 
and cdc2l from Schizosaccharomyces pombe (Coxon et al., 1992, Maiorano 
et al., 1996) are conserved throughout eukaryotes with homologues found 
in Xenopus (Madine et al., 1995), human (Hu et al., 1993) and mouse cells 
(Thommes et al., 1992). Some members of this family of proteins were 
shown to exhibit cell cycle dependent nuclear localisation. The proteins 
were present in the nucleus after mitosis and throughout the Gi phase 
only disappearing when DNA replication starts in the S phase. These 
proteins have the characteristics of a "licensing" factor proposed to be 
24 
responsible for limiting DNA replication to a single round in a single cell 
cycle (Blow and Laskey, 1988). This factor would be essential for the start of 
DNA synthesis and would only be able to enter the nucleus when the 
nuclear envelope forms at the end of mitosis and would be inactivated by 
DNA synthesis. Some homology to DNA dependent ATPases has led to 
the proposition that the "licensing" factor may be a DNA helicase 
responsible for the unwinding of DNA during the initiation of DNA 
synthesis (Koonin, 1993). 
1.6.2 Cyclin dependent kinases. 
The role of a cyclin dependent kinase (cdk) in the regulation of the 
transition between the Cl and S phases has been shown to be a universal 
mechanism in eukaryotes (for review see Reed, 1992). The progression of 
the cell cycle of S.cerevisiae is determined by a number of extracellular 
factors such as the level of nutrients and the presence of mating 
pheromones. The transition through a point during the Gi phase,. termed 
START, was shown to commit a cell to completion of the cell cycle 
(Hartwell, 1974). Characterisation of temperature sensitive START 
mutants led to the identification of the CDC28 gene. The activation of the 
gene product of CDC28, a 34kDa protein kinase, by association with Gi 
cyclins (gene products of CLN1-3) was shown to be responsible for 
commitment to START (Reed, 1980). The cyclin activated kinase 
phosphorylates targets which are responsible for the initiation of a 
number of cellular activities including DNA replication and budding 
(Figure 5). 
One possible target for the p34 kinase is a transcription factor (MBF, 
described in more detail later) required for the coordinated expression of 
DNA synthesis genes (Lowndes et al., 1991). p34  has already been 
demonstrated to be able to phosphorylate the SWI41SWI6 transcription 
factor complex which shares extensive homology to components of the 
MBF (Marini and Reed, 1992). 
The S.pombe CDC28 homologue, called cdc2, is able to complement a 
temperature sensitive CDC28 mutant in S.cerevisiae at the restrictive 
temperature (Nurse and Bissett, 1981). The ability to complement 
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cdc2/CDC28 temperature sensitive mutants at the restrictive temperature 
has been used to screen for cdks in a wide range of other eukaryotes. 
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Figure 5. Schematic representing role of the gene product of CDC28 during 
the transition Of the GuS phase boundary inS.cerevisiae. 
During the Cl phase of higher eukaryotes a point, known as the 
restriction point, has been identified at which cells are committed to the 
cell cycle (Pardee et al., 1986, Pardee 1989). This point is analogous to 
START in S.cerevisiae, but not identical. After passing the restriction 
point it was observed that the cell was no longer sensitive to growth 
factors or a range of protein synthesis poisons. It was suggested that to pass 
the restriction point the cell had synthesised enough proteins to carry out 
a range of activities such as DNA synthesis without any further protein 
synthesis. 
The determination of whether cdc2/CDC28 homologues play a role in the 
transition of the Cl/S phase boundary in higher eukaryotes is 
complicated by the presence of several isoforms of the 34kDa protein 
kinase (reviewed in Pines and Hunter, 1991). cdc2/CDC28 homologues 
have been characterised from a wide range of organisms. A putative 
homologue, Pfcdk5, has been cloned and isolated from P.falciparum 
(Ross-McDonald et al., 1994). Pfcdk5 was identified by sequence homology 
rather than the ability to complement yeast mutants. 
The human cdk2 homologue associates with cyclin throughout the cell 
cycle. Two Cl cyclins, A and E, associate with cdk2 in a temporal fashion. 
A cyclin A/cdk2 complex is thought to play a role in the initiation and 
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elongation of DNA synthesis, possibly by phosphorylation of RF-A 
(Pagano et al., 1992, Salah-ud-Din et al., 1990). Cyclin E associates with cdk2 
early in the Gi phase (Lew et al., 1991). This complex is thought to be 
responsible for the deactivation of p107-Rb (retinoblastoma gene product), 
a general negative regulator of cell cycle progression, by its 
hyperphosphorylation (Bandara and LaThangue, 1991, Shirodkar et al., 
1992). p107-Rb is also found during the Gi phase in a complex with cdk2, 
cyclin A and.E2F-DRTF1 (Pagano et al., 1992). This complex may play a 
role in the cell cycle regulated expression of a number of proteins required 
for DNA replication which have an E2F-DRTF1 binding site in their 
promoter (Blake and Azizkhan, 1989, LaThangue, 1994). Another negative 
regulator of cell cycle progression, p53, is also regulated by the activity of - 
cdk2 (Bischoff et al., 1990). p53  is a transcription factor that represses the 
activity of a wide range of proteins and plays a role in the response of 
PCNA to cell damage (Shivakumar et al., 1995). The interactions of cdk2, 
p107-Rb and p53 are not entirely understood but do suggest a key role for 
cdk2 in the GuS phase boundary transition (Figure 6). 
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Figure 6. Schematic representing the role of the cdk2 gene product during 
the transition of the G1 /S phase boundary in humans. 
1.6.3 Transcriptional regulation of the expression of DNA replication 
proteins. 
The replication of chromosomal DNA is regulated, in part, by the 
coordinated accumulation of proteins responsible for DNA synthesis at 
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the start of the S phase. In this section a brief review of the transcriptional 
mechanisms responsible for the expression of DNA synthesis genes from 
S.cerevisiae and Drosophila will be made. The expression of DNA 
replication proteins from serum starved higher eukaryotic cells after 
serum stimulation will also be covered. 
The genes encoding many of the proteins required for DNA synthesis in 
S.cerevisiae are expressed at the Cl/S phase boundary (Johnston and 
Lowndes, 1992. Table 1). This periodic transcription is mediated by a cis-
acting sequence described as the MluI cell cycle box (McIntosh et al., 1991), 
or MCB. The MCB binds a transcription factor, the MluI cell cycle box 
binding factor (MBF)(Lowndes et al., 1991) which is also known as the 
DNA synthesis control 1 complex (DSC1). This transcription factor is 
comprised of the gene product of SWI6 and a 120kDa protein (Lowndes et 
al., 1992a, Primig et al., 1992, Verma et al., 1991). The SWI6 gene product is 
thought to be regulated by phosphorylation by the CDC28 gene product 
(Reed, 1992, Andrews and Mason, 1993). In this way a direct link between 
cell cycle progression and the induction of proteins responsible for DNA 
synthesis may be demonstrated (Andrews, 1992). 
Gene 	 Function 
POLl DNA polymerase I (a) 
POLII DNA polymerase II (E) 
POLIII DNA polymerase ifi () 
POL30 Proliferating Cell Nuclear Antigen 
PRI1 DNA primase 1 
PRI2 DNA primase 2 
RFA1 Replication factor A 70kDa subunit 
RFA2 Replication factor A 341)a subunit 
RFA3 	 Replication factor A 14kDa subunit 
CDC9 DNA ligase 
CDC21 	 Thymidylate synthase 
CDC8 Thymidine kinase 
RNR1 	 Ribonucleotide reductase M2 
Table 1. S.cerevisiae DNA synthesis genes transcribed at the Cl/S phase 
boundary under the control of the MBF/DSC1 transcription factor. 
Only the gene product of cdc22+, encoding a ribonucleotide reductase 
subunit, is under periodic control, in S.pombe, with a peak of expression 
at the Cl/S phase boundary (Merril et al., 1992). The promoter of this gene 
contains an MCB element which is recognised by the S.pombe MBF/DSC1 
homologue. This complex of cdclO and resl is phosphorylated by cdc2 
(Tanaka et al., 1992) providing a link between cell cycle progression and an 
essential protein required for DNA synthesis. 
The role of DSC1/MBF homologues and MCB elements may be a 
common mechanism of the regulation of the expression of some of the 
critical DNA synthesis proteins in all yeasts. MCB elements have been 
found within the promoter of the Candida albi cans thymidylate synthase 
and putative DSC1 component homologues have been identified in 
Kluyveromyces lactis (Koch et al., 1993). 
Transcripts encoding several DNA synthesis proteins, including: PCNA, 
DNA Polymerase cx and ribonucleotide reductase subunit 2, have been 
shown to accumulate at the Cl/S phase boundary during Drosophila 
embryogenesis (Duronio et al., 1994). A cis-acting sequence in the 
promoter of PCNA and DNA Polymerase a has been identified to be the 
binding site for the transcription factor, Drosophila DNA replication 
related factor (DREF, Hirose et al., 1993). This factor, which probably binds 
as a homodimer, has been strongly implicated in the expression of 
proteins required for DNA synthesis. Analysis of sequences in databases 
have identified the DREF binding site in the promoters of a range of genes 
which have some function relating to cell proliferation (Matsukage et al., 
1995). 
A mammalian cell starved of serum is in a quiescent state (Go) in which 
the levels of DNA replication proteins are extremely low (Moore and 
Wang, 1994). Stimulation of the cell to proliferate by the addition of 
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serum leads to the coordinated expression of a range of DNA synthesis 
proteins which peak at the Cl/S phase boundary (Baserga, 1991, 
Bjorklund et al., 1992, Coverly and Laskey, 1994, Zeng et al., 1994). During 
subsequent rounds of cell division the levels of many DNA replication 
proteins remain stable (Baserga, 1991, Wahl et al., 1988, Zeng et al., 1994). 
There is, however, a small group of proteins whose levels do change 
throughout the cell cycle peaking at the Gl/S phase boundary, these 
include; thymidine kinase (Gudas et al., 1988), ribonucleotide reductase 
subunit R2 (Bjorkland et al., 1992) and dthydrofolate reductase (Collins et 
al., 1984). The genes encoding all these proteins have an E2F-DRTF1 
transcription factor binding site in their promoters (Blake and Azizkhan, 
1989). 
The mechanisms underlying the co=ordinated accumulation of DNA 
synthesis proteins appears to be conserved throughout the eukaryotic 
kingdom. A strong sequence similarity exists between the binding sites of 
the DSC1 complex for both S.cerevisiae and S.pombe and the E2F/DRTF1 
binding site of mammalian (Table 2. Analysis of the secondary structures 
of the transcription factors that bind these similar sequences reveals a 
region of homology that is thought to be responsible for the sequence 
specific interaction with the DNA. A second region, known as the 
ankyrin motif, has been identified in both S.cerevisiae and S.pombe 
(Andrews and Mason, 1993). A role for this motif has not been defined, 
although it is thought to be required for protein-protein interactions 
(Lamangue and Taylor, 1993). 
DNA motif organism DNA sequence 	component/ complex bound 
MCB S.cerevisiae TNACCCCT p120/ DSC1 
MCB S.pombe TNACGCCT cdc10/ DSC1 homologue 
E2F site Mammalian TflCCCGC E2F/ DRTF1 
Table 2. A comparison of the sites to which transcription factors 
responsible for expression of DNA synthesis proteins bind (LaThangue 
and Taylor, 1993). 
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1.7 Proliferating Cell Nuclear Antigen (PCNA). 
1.7.1 Structure. 
PCNA is the eukaryotic homologue of the 13  subunit of E.coli DNA 
polymerase III and gp45 of the T4 phage (Kuriyan and O'Donnell, 1993). 
Although the sequence homology between these three proteins is 
extremely low, in the order of 5-10%, elucidation of the crystal structures 
of two of them, PCNA and the 0 subunit (Kong et al., 1992, Krishna et al., 
1994), has shown that the overall structure is strongly conserved. PCNA 
and the 13 subunit are ring shaped with a central cavity large enough for 
- the DNA duplex -to pass through. -The two crystal structures when 
superimposedare nearly identical (Kelman and O'Donnell, 1995a) even 
though the 13 subunit is a dimer and PCNA a trimer. The PCNA 
polypeptide is 2/3rds the length of the 13 subunit polypeptide and contains 
two clearly identifiable domains compared to the three of the 13 subunit. 
The organisation of both PCNA and the 13 subunit suggest that both 
proteins share a psuedo-6-fold symmetry which surrounds the DNA 
duplex. 
A sequence alignment of PCNA from a range of eukaryotes indicates that 
relatively few residues are absolutely conserved (Figure 7). Most of the 
conserved residues are orientated towards the solvent exposed surface 
and may therefore play a role in interactions with other proteins (Kelman 
and O'Donnell, 1995a, Krishna et al., 1994). 
1 	 50 
Glymax .......... .......... .......... SSTGFSLQAM DSSHVALVAL 
Daucar MLELRLVQGS LLKKVMDSIK DLVNDANFDC SATGFSLQAM DSSHVALVAV 
Catros MLELRLVQGS LIKKVLESLK DLVTDANFDC SASGFSLQAN DSSHVALVAL 
Orysat MLELRLVQGS LLKKVLEAIR ELVTDANFDC SGTGFSLQAM DSSHVALVAL 
Ratnor MFEARLIQGS ILKKVIJEALK DLINEACWDI SSGGVNLQSM DSSHVSLVQL 
Homsap MFEARLVQGS ILKKVLEALK DL,INEACWDI SSSGVNLQSM DSSHVSLVQL 
Musmus MFEARLIQGS ILKKVLEALK DLINEACWDV SSGGVNLQSM DSSHVSLVQL 
Xertlav MFEARLVQGS ILKKVLEALK DLJIDEACWDI TSSGISLQSM DSSHVSLVQL 
Dromel MFEARLGQAT ILKKILDAIK DLLNEATFDC SDSGIQLQAN DNSHVSLVSLJ 
Schpom MLEARFQQAA LLKKLLDAIK ELJVTDANFDC NDNGISLQAN DSSHVALVSM 
Saccer MLEAKFEEAS LFKRIIDGFK DCVQLVNFQC KEDGIIAQAV DDSRVLLIVSL 
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Plafal MLEAKLNNAS ILKKLFECIK DLVNDANVDA DESGLKLQAL DGNHVSLVSL 
* * 	 * 	 * 	* 	* 	* ** 
51 	 100 
Glymax LLRSEGFEHY RCDRNISMGM NLNNMAKNLK CAGNDDIITI KADDGSDTVT 
Daucar LLIRSEGFEHY RCDRNISMGM NLGNMAKMLK CAGNDDIITI KADDGSDTVT 
Catros LLRSEGFEHY RCDRNPSMGM NLNNMAKMLK CAGNDDIITL KADDGSDTVT 
Orysat LLRSEGFEHY RCDRNLSMGM NLNNMAKMLR CAGNDDIITI KADDGSDTVT 
Ratnor TLRSEGFDTY RCDRNLAMGV NLTSMSKILK CAGNEDIITL RAEDNADTLA 
Homsap TLRSEGFDTY RCDRNLANGV NLTSMSKILK CAGNEDIITL RAEDNADTLA 
Musmus TLRSEGFDTY RCDRNLANGV NLTSMSKILK CAGNEDIITL RAEDNADTLLA 
Xenlav TLRSDGFDTY RCDRNQSIGV KMSSMSKILK CAASDDIITL RAEDNADTVT 
Dromel TLRSDGFDKF RCDRNLSMGM NLGSMAKILK CANNEDNVTM KAQDNADTVT 
Schpom LIKSDGFEPY RCDRNIALGI NLNALSKVLR CAQNEDLVTLJ KAEDTPEVLN 
Saccer EIGVEAFQEY RCDHPVTLGM DLTSLSKILR CGNNTDTLTL IADNTPDSII 
Plafal HLLDSGFSHY RCDRERVLGV NIASLNKVFK LCGANESVVI SSKDDEDNLN 
* **** 	* 	* 
101 	- - 	 ----- 	 150 
Glymax FMFESPTQDK ISDFEMKLMD IDSEHLGIPE AE. .YHAIVK MPSSEFARIC 
Daucar FMFESPTQDK IADFEMKLMD IDSEHL.GIPE AE. .YHAIVR MPSAEFARIC 
Catros FMFESPTQDK ISDFEMKLMD IDSEHL1GIPE AE. .YHAIVR MPSAEFARIC 
Orysat FMFESPNQDK IADFEMKLMD IDSEHLGIPD SE. .YQAIVR MPSSEFSRIC 
Ratnor LVFEAPNQEK VSDYEMKLMD LDVEQLGIPE QE. .YSCVVK MPSGEFARIC 
Homsap LVFEAPNQEK VSDYEMKLMD LDVEQLGIPE QE. .YSCVVK MPSGEFARIC 
Musmus LVFEAPNQEK VSDYEMKLMD LDVEQLGIPE QE. .YSCVIK MPSGEFARIC 
Xenlav MVFESPNQEK VSDYEMKLMD LDVEQLGIPE QE. .YSCVIK MPSGEFARIC 
Dromel IMFESANQEK VSDYEMKLMN LDQEHLGIPE TD. . FSCVVR MPAMEFARIC 
Schpom LJVFESEKNDR ISDYDVKL1MD IDQEHLGIPD IE. .YDATIT MPAAEFQRIT 
Saccer LLFEDTKKDR IAEYSLKLMD IDADFLKIEE LQ. .YDSTLS LPSSEFSKIV 
Plafal FVFENNKEDK VTNFSLKLJMS IELDSLNIPD CEEGFDAEVE LSSKELTNIF 
** 	 *** 	* * 	 * 	* 
151 	 200 
Glymax KDLSSIGDTV VISVTKEGVK FSTKGDIGTA NIVCRQNTSV DKPEEATVIE 
Daucar KDLSSIGDTV VISVTKEGVK FSTRGDIGTA NIVCRQNTTV DKPEEATVIE 
Catros KDLSSIGDTV VISVTKEGVK FSTRGDIGTA NIVCRQNTTV DKPDEATIIE 
Orysat KDLSSIGDTV IISVTKEGVK FSTAgDIGTA NIVCRQNKTV DKPEDATIIE 
Ratnor RDLSHIGDAV VISCAKDGVK FSASGELGNG NIKLSQTSNV DKEEEAVSIE 
Homsap RDLSHIGDAV VISCAKDGVK FSASGELGNG NIKLSQTSNV DKEEEAVTIE 
Musmus RDL1SHIGDAV VISCAKNGVK FSASGELGNG NIKLSQTSNV DKEEEAVTIE 
Xenlav RDLSQIGDAV VISCAKDGVK FSASGELGTG NVKLSQTSNV DKEEEAVTIE 
Dromel RDLIAQFSESV VICCTKEGVK FSASGDVGTA NIKLAQTGSV DKEEEAVIIE 
Schpom RDLLTLSDSV TINASKEGVR FSCKGDIGNG STTLKQHTDL SDQDQSIEIS 
Saccer RDLSQLSDSI NIMITKETIK FVADGDIGSG SVIIKPFVDM EHPETSIKLE 
Plafal RNLSEFSDTV FIEIDSNCIK FTTKGIVGDA EVALKPRDST SEDDIGVTIK 













LSNELIPVVVE YKIAE ..... 
LJSSELPVVVE YKIAE ..... 
IJSSELPVVVE YKIAE ..... 
LSSELPVVVE YKIAE ..... 
MSADVPLVVE YKIAD ..... 
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Homsap MNEPVQLTFA LRYLNFFTKA TPLSSTVTLS MSADVPLWE YKIAD. 
Musmus MNEPVHLTFA LRYLNFFTKA TPLSPTVTLS MSADVPLVVE YKIAD ..... 
Xenlav MNEPVQLTFA LRYLNFFTKA TPLSPTVILS MSADIPI,VVE YKIAD ..... 
Dromel MQEPVTLTFA CRYLNAFTKA TPLJSTQVQLS MCADVPLVVE YAIKD ..... 
Schpom LTQAVTLTFS LKYLAQFTKA TPLATRVLS MSNDVPLLVE YKM.E ..... 
Saccer MDQPVDLTFG AKYLLDIIKG SSLSDRVGIR LSSEAPALFQ FDLKS ..... 
Plafal SKKKIKQSFA IKYLNLFSKS NILADVVVLG tSDSRPIEFK YEIKDTSPDS 
* 	* * * 
251 279 
Glymax . . . .MGYVRF YLAPKIEEDE EDTKPQV (P22177) 
Daucar . . . .MGYIRF YLAPKIEEEE DESKP (Q00268) 
Catros . . . .MGYIRF YLAPKIEEDD EEQSIjEYQA (P24314) 
Orysat .. . .MGYIRF YLAPKIEEDE ENKS ..... (P17070) 
Ratnor ... .MGHLKY YLAPKIEDEE GS ....... (P04961) 
Homsap . . . .MGHLJKY YLAPKIEDEE GS ....... (P12004) 
Musmus . . . .MGHLKY YLAPKIEDEE AS ....... (P17918) 
Xenlav . .. .MEHVKY YLAPKIEDEE AS ....... (P18248) 
Dromel ... .LGHIRY YLAPKIEDNE T ........ (P17917) 
Schpom.... SGFLRF YLAPKIGEED EE ....... (Q03 392) 
Saccer ..... GFLQF FLAPKFNDEE ......... (P15873) 
Plafal DTLKIGFVKF FLAPKMDDDM DNKD ..... (P31008) 
Figure 7. Amino acid sequence pileup of PCNA. Identical amino acids are 
indicated by a * below the sequence. Inserted amino acids in P.falciparum 
are bolded. Glymax, Glycine max (partial sequence, soya bean); Daucar, 
Daucus carota (small form, carrot); Catros, Catharanthus roseus 
(madagascan rosey periwinkle); Orysat, Oryza sativa (rice); Ratnor, Rattus 
norvegicus (rat); Homsap, Homo sapiens (human); Musmus, Mus 
musculus (mouse); Xenlav, Xenopus laevis (african clawed frog); Dromel, 
Drosophila melanogaster (fruit fly); Schpom, Schizzosaccharornyces 
porn be (fission yeast); Saccer, Saccharomyces cerevisiae (baker's yeast); 
Plafal, Plasmodium falciparum (Ki isolate). The SwissProt data base 
accession number is indicated for each organism. The numbering of 
amino acids corresponds to PfPCNA polypeptide. 
Using the co-ordinates from the S.cerevisiae crystal structure (Krishna et 
al., 1994) a computer prediction for the structure of a P.falciparum PCNA 
monomer has been made (Sturrock, S., pers comm.). The high degree of 
conservation between these polypeptides is reflected in the stereogramatic 
representation of these structures (Figure 8a-b). The insertions (11-2) do 
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Figure 8. 
Three dimensional structure of PCNA. 
Ribbon schematic of the S.cerevisiae PCNA monomer. The position of 
the N and C terminals of the polypeptide are indicated. The 4 (X-helices 
which interact with DNA are indicated (1-4). 
Ribbon schematic predicted for the P.falciparum PCNA monomer. The 
position of the N and C terminals of the polypeptide, the 4 a-helices 
which interact with DNA and the position of the 2 inserts (Ii [133-134] and 
12 [246-254]) are indicated. 
Schematic illustrating the structure of the S.cerevisiae PCNA 
monomer. 
The N and C terminals are indicated as are the a-helices. The PCNA 




not appear to interfere with the positioning of the a-helices or 13-sheets. 
A schematic representation of the PCNA monomer (Figure 8c) indicates 
that there are two domains, each consisting of a pair' of 13 —a- 13- 13  motifs. 
The antiparallel 13 sheets form an arched backbone which place the a 
helices on the inside of the arc. The two domains are joined by a large 
loop which interacts with the antiparallel 13 sheets. The loop is on the 
surface of the protein and is highly antigenic (Krishna et al., 1994). PCNA 
has a strong positive charge arrayed on the inside of the ring which would 
favour its interaction with DNA. The a helices are positioned so that they 
may interact non-specifically with the backbone of the DNA rather than a 
more specific interaction within the major and minor grooves. The 
central cavity is slightly ovoid with a diameter of approximately 34A, 
more than adequate to surround the diameter of DNA (18-21A). 
The interfaces between the monomers are formed principally by the 
outermost 13 sheets. On trimerisation the antiparallel 13 sheets form a 
continuous ring shaped backbone structure. Hydrogen bonds, 
hydrophobic forces and ionic pair interactions contribute towards the 
interaction at the interfaces between the monomers. Charged amino acids 
at the interface are thought to be required for the correct head-to-tail 
orientation of the monomers as well as interactions to RF-C and DNA 
polymerase 6 (Kelman and O'Donnell, 1995a). 
Site specific mutational analysis has identified a number of regions of 
PCNA required for its functional activity. The substitution of uncharged 
for charged residues in the a helices limits the ability of PCNA to 
stimulate DNA polymerase 6 processivity (Fukuda et al., 1995). When the 
negatively charged residues in the C terminus, which form a loop that 
projects out of the face of the ring, were substituted the ability of PCNA to 
stimulate the ATPase activity of RF-C was limited (Fukuda et al., 1995). 
These observations led to the proposal that PCNA interacts with RF-C and 
DNA polymerase 6 in an orientation specific manner which influences 
the complexes ability to track along the DNA. Substitution of a tyrosine at 
the interface between monomers (Tyr 114) disrupted the formation of the 
0. 
trimer (Jonsson et al., 1995). P.falciparum and several plant species have a 
phenylalanine at this position. The opposing face of the monomer from 
these species use different amino acids which presumably interact with 
the phenylalanine. 
The reason as to why the 0 subunit and PCNA have an almost identical 
structure based on a different protomer design is unknown. A protein 
consisting of a trimer may be more unstable than a dimer and therefore 
could have some regulatory role based on its stability (Kelman and 
O'Donnell, 1995a). Interestingly a "long" form of PCNA has been 
identified from carrot embryos (Hata et al., 1992) which is almost the same 
size as the 13  subunit monomer. A PCNA transcript and anti-PCNA cross 
reacting protein corresponding to a "dimeric" form of PCNA have been 
identified during Xeno pus oogenesis (Leibovici et a!, 1990). These 
observations have led to some speculation as to whether there is an 
embryonic form of PCNA which is related to a distant prokaryotic f3 
subunit ancestor (Kelman and O'Donnell, 1995b). 
1.7.2 PCNA interacts with a wide range of proteins. 
PCNA is essential for both leading and lagging strand synthesis during 
which it interacts with DNA polymerase 5 and RF-C (Waga and Stillman, 
1994). PCNA is thought to be loaded onto the DNA in a process which 
requires the ATPase activity of RF-C (Burgers and Yoder, 1993, Produst et 
al., 1995). Presumably the energy derived from ATP hydrolysis is required 
to open the PCNA ring allowing the DNA to pass through to the central 
cavity. The complex then slides along the DNA until a 3' hydroxyl group 
is encountered. PCNA then transforms into a competent clamp which 
holds DNA polymerase S onto the template. On completion of an Okasaki 
fragment the PCNA remains attached to the DNA after the DNA 
polymerase S has dissociated (Yao et al., 1996). The ATPase activity of RF-C 
is also thought to be required to unload PCNA from the DNA to allow it 
to be recycled to another Okasaki fragment. 
The joining of Okasaki fragments requires that a short stretch of DNA 
synthesised by DNA polymerase a is removed. The 5'-3' exonucleases, 
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FEN-1 (humans and mice) and RTH1 (S.cerevisiae), have been implicated 
in the maturation of the Okasaki fragments (Li et al., 1995). The FEN-1 
protein requires PCNA to facilitate its binding to its site of action, this 
sequestration enhances the exonuclease activity between 10-50 fold (Li et 
al., 1995). 
PCNA is essential for the nucleotide excision repair (NER) pathway 
(Shivji et al., 1992) which suggests that the gap filling is performed by 
some of the same components of the chromosomal replication 
machinery. Both chromosomal replication and NER require the RF-C 
dependent loading of PCNA to the DNA (Aboussekhra et al., 1995). 
However, the issue of which DNA polymerase (8 or c) is required for 
chromosomal replication or NER, or both, has not been resolved. 
In response to DNA damage, higher eukaryotes arrest cell cycle 
progression at either the C1 or G2 checkpoints (Maltzman and Czyzyk, 
1984). During GI arrest the levels of the transcription factor p53 increase 
stimulating the expression of a number of cell cycle regulators. One such 
regulator, p21, is a cyclin dependent kinase inhibitor, which arrests DNA 
synthesis in vitro through its interaction with PCNA (Li et al., 1994). p21 
does not, however, interfere with the PCNA dependent NER (Shivji et 
al., 1994). PCNA also interacts with a second cell cycle regulator, Gadd45, 
in competition with p21 (Chen et al., 1995). p21  and Gadd45 might play a 
significant role in the coordination of cell cycle progression and 
chromosomal DNA replication during DNA repair through their 
interactions with PCNA. 
1.7.3 Regulation of PCNA expression during the cell cycle. 
The regulation of the expression of the S.cerevisiae (POL30) and 
Drosophila PCNA have been covered elsewhere in the introduction. 
Since the characterisation of the human cyclin gene which revealed that 
PCNA was stage specifically regulated (Almendral et al., 1987, Bravo, 1986) 
the regulation of the PCNA gene in higher eukaryotes has been the focus 
of intense interest (Baserga, 1991). 
When quiescent (Go) cells are stimulated with serum PCNA accumulates 
at the Cl/S phase boundary (Bravo, 1986). This identified the gene as a 
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member of a group of late-response genes which includes; histones, 
dihydrofolate reductase, thymidylate synthase, DNA polymerase a, 
primase and ligase. The level of the protein remains relatively constant 
until the G2/M phase boundary is reached when the protein is 
presumably degraded. The PCNA mRNA is absent in C0 cells and 
accumulates after serum stimulation until a peak at around 16-18 hours, a 
point which coincides with the onset of the S phase (Almendral et al., 
1987). This indicated that the regulation of PCNA was principally brought 
about at the level of transcription. In continually proliferating cells the 
PCNA mRNA and protein levels do not appear to vary (Morris and 
Matthews, 1989). 
Initial attempts to map the human PCNA promoter showed that 2lObp of 
sequence upstream of the transcription start site was sufficient for the 
expression of PCNA (Ottavio et al., 1990a). Further analysis revealed that 
an enhancer-like element was located between 45bp and 73bp upstream of 
the transcription start site (Ottavio et al., 1990a, Piertzkowski et al., 1991). 
This region contained a SV40 core enhancer and a CREB (cyclic-AMP 
binding site) sequence. The introduction of mutations into either 
sequence abolished PCNA expression and gel retardation assays indicated 
that a protein was bound to this sequence in vivo (Piertzkowski et al., 
1991). 
During the course of the promoter analysis an attempt to use mini-genes 
led to PCNA mRNA levels increasing dramatically in Go cells. An 
element within the 4th intron was shown to be responsible for the correct 
temporal accumulation of transcripts (Ottavio et al., 1990b). 
The PCNA promoter is active in both the Go cells and serum stimulated 
cells (Chang et al., 1990). Examination of the relative stability of PCNA 
mRNA from the two cell types showed that mRNA isolated from 
proliferating cells was approximately 4 times more stable than in the Go 
cells (Chang et al., 1990). To account for the increase in the mRNA levels 
observed, however, the serum stimulated mRNA would need to be 
approximately 40 times more stable. Baserga and co-workers have 
suggested that the transcriptional regulation of PCNA may be brought 
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about by processing of the heterologous nuclear RNA (hnRNA). 
Transcriptional pausing which is released at a particular time point, as 
observed for murine ribonuclease reductase regulatory 2 subunit 
(Bjorklund et al., 1992), is one possibility. The human PCNA gene 
contains five introns (Almendral et al., 1987) presenting the possibility 
that regulation may be introduced at the level of intron splicing. 
Polyadenylation and the transport of the mature transcript from the 
nucleus offer further possibilities. Baserga (1991) has proposed a model for 
the expression of PCNA in serum-stimulated cells. The PCNA gene is 
continually transcribed with a basal level regulated by elements within 
the promoter and the 4th intron. In Go cells the transcripts are not 
completed; only upon serum-stimulation does this occur. Although 
posttrariscriptional phósphorylatión of PCNA does not appear to occur 
(Zeng et al., 1994), the activity of PCNA is likely to be influenced by its 
interactions with a wide range of proteins. 
1.8 Rationale and scope of thesis. 
The study of regulation of the expression of DNA replication proteins 
from P.falciparum during intraerythrocytic schizogony has been 
fragmentary. We therefore proposed to determine when, during 
intraerythrocytic schizogony, PfPCNA and PfPolö mRNAs and 
polypeptides accumulate and to simultaneously determine the activity of 
their promoters. These experiments would provide us with information 
regarding the temporal control of the expression of a pair of cofunctional 
gene products. This analysis would provide evidence of whether there is a 
coordinated unitary control for these cofunctional proteins, or whether 
their expression is simultaneous but differently regulated. 
In order to identify potential regulatory sequences the intention was to 
map transcription start sites of both the PfPCNA and PfPol8 genes using 
both primer extension and RNase protection. The combination of these 
protocols to map the transcription start sites would allow these sites to be 
more reliably identified in the extremely AT-rich sequences. Should 
consensus sequences be found we would try identify whether proteins 
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bind to these sequences, and whether this binding is stage specific. If this 
was the case we would try and clone these potential regulatory proteins. 
We had set up a collaboration with Dr. Christian Doerig to develop a 
transfection system for intraerythrocytic stage cultures. We proposed to 
use the extensive PfPCNA flanking sequences available with a novel 
reporter gene, the Green Fluorescent Protein. Should a transfection 
system be developed we hoped to modify the PfPCNA 5' flanking 






Unless stated otherwise, chemicals were supplied by Sigma Chemical Co. 
Ltd., UK or BDH plc., UK, and were all of analytical grade. Cell culture 
materials were supplied by Gibco-BRL, UK. Solvents were supplied by 
FSA Laboratory Supplies, UK. Radiolabelled nucleotides were supplied by 
Amersham International plc., UK. 
2.1.2 Equipment. 
Benchtop centrifugation was carried out using a Heraeus Biofuge 13 
(Eppendorf, Germany) or Juoan CR322 (Saint-Herbain, France). High 
speed spins were made using either a Sorvall RC5-B high speed centrifuge 
(DuPont Instruments) or Sorvall OTB50-B ultracentrifuge (DuPont 
Instruments). PCR were carried out using a PHC-2 thermal cycler (Techne 
Instruments). Hybridisations were done in HB1/HB2D heated cabinets 
(Techne Instruments). Plasticware and culture materials were supplied by 
Beckton Dickinson Labware, UK. 
2.1.3 Restriction and modifying enzymes. 
Restriction endonucleases and buffers were supplied by Boehringer 
Mannheim UK (Diagnostics and Biochemicals) Ltd., UK. One-phor-all 
restriction endonuclease buffer was supplied by Pharmacia Biotechnology, 
UK. Modifying enzymes were supplied by Gibco-BRL, UK, Boehringer 
Mannheim UK Ltd., UK, and CAMBIO Ltd. through React Scientific, UK. 
2.1.4 Imaging. 
KODAK X-OMAT AR and X-OMAT LS autoradiography film was 
supplied by IBI Molecular Biology Products, UK. UV-iradiated ethidium 
bromide gels were photographed using either HP5 film, ILFORD Ltd., UK, 
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or by Mitsubishi Video Processor to heat sensitive film. 
2.1.5 Microbiology. 
2.1.5.1 Bacterial strains. 
Strain 	 Genotype 	 Reference 
DH5a 	F'endAl recAl hsdRl7(rk, mk) 	 Hanahan (1983) 
supE44 thi -1 gyrA96 relAl 080dlacZAM15 
zX(lac ZYA-argF)U169 deoR 
INVcx F 	F'endAl recAl hsdRl7(rk, mk) 
supE44 thi-1 gyrA96 relAl 4801acZAM15 
A(lac ZYA-argF)U169 deoR A7 
Y1090 	F' it(lacU169) proA+ A(lon) araD139 strA 	Huynh et al. 
sup F [trpC22::TnlO(tet )] (pMC9) hsdR 	(1985) 
(rk-, mk) 
NM494 	hfl E(hsdMS mcrB) mcrA 	 Murray N. 
(pers comm.) 
BL21 (DE3) F- hsdD z(lacU169) gal(,xI857 indl Sam7 	Studier and 
nin 5 lacUV5-T7 genel) (rB, mB) 	Moffat (1986) 
(+pLysS) 	 Studier (1991) 
2.1.5.2 Bacteriophages. 
Bacteriophage 	 Genotype 	 Reference 
?gt11 	A, lac 5, nin 5, c 1857, SamlOO 	Young and Davis, 
(1983) 
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NM1149 	A imm 4 'b538 
	
Murray (1983) 
2.1.5.3 P.falciparum DNA libraries. 
Library 	 Source 	 Reference 
NM1149, Hindifi 
restricted Ki genomic 
DNA. 
NM1149, EcoRI 
restricted Ki genomic 
DNA. 
Agt11, partial Dral 
restricted Ki genomic 
DNA. 
M. Goman, University 
of Edinburgh. 
M. Goman, University 
of Edinburgh. 
U. Certa, Hoffmann- La-
Roche, Basel. 
Goman et al., 
(1982) 
Goman et al., 
(1982) 
Certa et al. / 
(1988) 
Certa et al. / 
(1988) 
?gt11, sheared Ki genomic U. Certa, Hoffmann- La-
DNA. EcoRI linkers. 	Roche, Basel. 
pJFE14, cDNA from 	A. Craig, 1MM, Oxford. 
trophozoites, XhoI linkers. 
2.1.6 General stock solutions and media. 
BBL bottom agar (supplied by ICMB media service). 
1% Baltimore Biological Laboratories trypticase, 0.5% sodium chloride, 
1.5% agar. 
BBL top agar (supplied by ICMB media service). 
As for BBL bottom agar except contains only 0.65% agar. 
45 
Denaturation solution. 
1.5M sodium chloride and 0.5M sodium hydroxide. 
Luria-Bertanj medium (LB. supplied by ICMB media service). 
1% bacto-tryptone, 0.5% Bacto-yeast extract, 1% sodium chloride adjusted 
to pH7.2 using 1M sodium hydroxide. 
LB agar (supplied by ICMB media service). 
LB supplemented with 1.5% agar. 
Neutralising solution. 
1M ammonium acetate, 002M sodium hydroxide. 
Oligonucleotide hybridisation buffer. 
2XSSC, 0.2% SDS, 0.1% sodium pyrophosphate, 500 j.tgml 1 heparin. 
Phage buffer (supplied by ICMB media service). 
0.3% potassium dihydrogen orthophosphate, 0.7% disodium hydrogen 
orthophosphate (anhydrous), 0.5% sodium chloride, 1mM magnesium 
sulphate, 0.1mM calcium chloride, 1% gelatin. 
Phosphate buffered saline (PBS). 
137mM sodium chloride, 2.7mM potassium chloride, 4.3 mM disodium 
hydrogen orthophosphate, 1.4mM potassium dihydrogen 
orthophosphate. 
Random-label hybridisation buffer. 
0.25M sodium phosphate pH7.2, 7% SDS. 
Standard saline citrate (SSC) 20x stock solution. 
3M sodium chloride, 100mM trisodium citrate pH7.0. 
Tris-acetate-EDTA (TAE) 50x stock solution. 
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2M Tris-acetate, 2m1N4 EDTA pH 8.0. 
Tris-borate-EDTA (TBE) lOx stock solution. 
0.9M Tris-borate, 20mM EDTA pH8.0. 
Tris-EDTA (TE). 
10mM Tris-HC1 pH8.0, 1mM EDTA pH8.0. 
Tris-EDTA-saline (TES). 
20mM Tris-HC1 pH7.5, 10mM EDTA, 100mM sodium chloride. 
Unless otherwise stated, the methods described in the following text were 
based on those found in either Sambrook et al. (1989), Harlow and Lane 
(1988) or Ausubel et al. (1992). Unless otherwise stated, microcentifugation 
was for 30 seconds at 12,000rpm. 
2.2 DNA Methods. 
2.2.1 Isolation of DNA. 
2.2.1.1 Preparation of P.falciparum DNA. 
P.falciparum culture was grown until 10 9 parasites were available. The 
culture was harvested by centrifugation (2500g, 10 minutes, 4 C ) and 
resuspended in 50m1 of PBS. The washed erythrocytes were collected by 
centrifugation, resuspended in 1xSSC, 0.1% saponin and incubated at 
room temperature for 5 minutes. The released parasites were collected by 
centrifugation (3000g, 15 minutes, 4°C) and washed with 1xSSC, 0.1% 
saponin. The washed parasites were collected by centrifugation (3000g. 15 
minutes, 4°C) and resuspended in 9m1 of 1xSSC. 2m1 of 20% sodium 
lauryl sarcosine was added, mixed carefully by inversion and the 
suspension incubated on ice for 5 minutes. The suspension was made up 
to 21m1 by the addition of 1xSSC containing 20.9g of caesium chloride and 
0.2m1 of ethidium bromide (10mgml 1 ) then divided into 2 heat sealed 
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tubes (11.5ml tubes for Ti50 rotor). The DNA was banded by caesium 
chloride gradient ultracentrifugation (120000g, 48 hours, 18 °C). A single 
central band, visible under a UV light, containing the genomic DNA was 
collected and the ethidium bromide removed by repeated extractions with 
isoamyl alcohol. The DNA was dialysed against 2L of TE overnight at 4 °C, 
ethanol precipitated (2.2.1.7) and resuspended in lml of TE. The DNA was 
analysed using UV spectroscopy (2.2.1.5). 
2.2.1.2 Maxipreparation of plasmid DNA. 
Preparation of approximately 1mg of plasmid DNA from Escherichia coli 
was made using either an alkaline lysis/caesium chloride method or 
WizardTM Maxipreps. The protocols for both are described below. DNA 
prepared by both these methods was used primarily for transfection 
experiments. A comparison of the DNA produced by both methods shows 
that the DNA is comparable in terms of the results from a transient 
transfection assay (Brondyk et at., 1994). - 
Alkaline lysislcaesium chloride method 
A single colony was used to inoculate 500m1 of LB supplemented with 
ampicillin (100xgml 4) and grown overnight at 37°C with shaking. The 
culture was centrifuged (2500g, 10 minutes, 4°C) and the bacterial pellet 
resuspended in 20m1 of solution 1(50mM glucose, 25mM Tris-HC1 pH8.0 
and 10mM EDTA pH8.0). 2m1 of lysozyme solution (10mgml 1 in 10mM 
Tris-HC1 pH8.0) was added and gently mixed by inversion. 40ml of freshly 
prepared solution II (0.2M sodium hydroxide, 1% SDS) was added, mixed 
by inversion and incubated at room temperature for 10 minutes. 20m1 of 
ice-cold solution III (3M potassium acetate pH5.0) was added, mixed by 
inversion and incubated on ice for 15 minutes with periodic mixing. 
The lysate was centrifuged (2500g. 10 minutes, 4°C) to pellet the cell 
debris. The supernatant was collected, mixed with 0.6 volumes of room 
temperature isopropanol and incubated at room temperature for 10 
minutes. The nucleic acids were pelleted by centrifugation (12000g. 15 
minutes, 4°C) and washed with ice-cold 70% and 100% ethanol. The pellet 
was allowed to dry for 5 minutes at room temperature before being 
resuspended in 3m1 of TE (pH8.0). The 3m1 of DNA solution was added to 
18ml of sdH20 containing 20.9g of caesium chloride and 0.2 ml of 
ethidium bromide (lOmgmll) and divided into 2 heat sealed tubes 
(11.5m1 tubes for Ti50 rotor). The DNA was banded by caesium chloride 
gradient ultracentrifugation (120000g, 48 hours, 18°C). The lower of the 
two central bands, visible under a UV light, was collected and the 
ethidium bromide removed by repeated isoamyl alcohol extractions. The 
plasmid DNA was dialysed against 2L of TE overnight at 4 °C, ethanol 
precipitated (2.2.1.7) and resuspended in lml of TE. The DNA was 
analysed using UV spectroscopy (2.2.1.5). 
- WizardTM Maxiprep protocol 
The solutions and protocol were supplied with this commercially 
available kit (Promega). 
A single colony was used to inoculate 300m1 of LB supplemented with 
ampicillin (100p.gml4) and grown overnight at 37°C with shaking. The 
culture was pelleted by centrifugation (2500g. 10 minutes, room 
temperature) and resuspended in 15m1 of cell resuspension solution 
(50mM Tris-HC1 pH7.5, 10mM EDTA, 100pgml 1 RNase A). 15m1 of cell 
lysis solution (0.2M sodium hydroxide, 1%SDS) was added and mixed by 
gentle inversion and left for 20 minutes at room temperature. 15m1 of 
neutralising solution (1.32M potassium acetate pH4.8) was added, mixed 
completely and incubated at room temperature for 20 minutes. 
The bacterial debris was pelleted by centrifugation (3000g. 10 minutes, 4°C) 
and the supernatant mixed, by inversion, with 0.5 volumes of room 
temperature isopropanol. The DNA was pelleted by centrifugation 
(12000g. 15 minutes, room temperature) and resuspended in 2ml of TE 
(pH7.5). 
lOmi of WizardTM  Maxiprep DNA purification resin was mixed with the 
2m1 of DNA solution and transferred into a WizardTM  Maxicolumn. A 
vacuum pump was used to draw the resin through the column slowly. 
Two 13ml aliquots of wash solution (100mM sodium chloride, 10mM 
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Tris-HC1 pH7.5, 2.5mM EDTA, 55% ethanol) were added to the column to 
wash the resin, followed by a final 5m1 wash with 80% ethanol. Air was 
drawn through the column for a further 1 minute after the column was 
emptied. The column was placed into a 50m1 falcon tube and centrifuged 
(2000g, 5 minutes, room temperature) to dry the resin completely. 1 .5m1 of 
sdH20, prewarmed to 65°C, was added to the column. After waiting 1 
minute the column was centrifuged (2000g. 5 minutes, room temperature 
) and the eluted DNA analysed using UV spectroscopy (2.2.1.5). 
2.2.1.3 Midipreparation of plasmid DNA. 
Approximately 100-150p.g of plasmid DNA from Escherichia coli was 
prepared using the commercially available Plasmid Midi Kit (QiagenTM). 
A single colony was used to inoculate lOOm! of LB supplemented with 
ampicillin (100p.gm1 1 ) and grown overnight at 37 °C with shaking. The 
cells were collected by centrifugation (2500g, 10 minutes, 4 °C) and the 
pellet resuspended in 4ml of buffer P1 (50mM Tris-HC1 pH8.0, 10mM 
EDTA, 100.tgml4 RNase A). 4m1 of buffer P2 (200mM sodium hydroxide, 
1%SDS) was added, mixed by inversion, and the suspension incubated at 
room temperature for 20 minutes. The addition of 4ml of buffer P3 (2.55M 
potassium acetate pH4.8) to the suspension was followed by a 15 minute 
incubation on ice. Cell debris was pelleted by centrifugation (10000g. 10 
minutes, 4 ° C) and the supernatant filtered through medium-fast 
Whatman filter paper (90mm circles no. 1) to ensure the bacterial debris 
was completely removed. 
The supernatant was added to a QiagenTM Tip-100 column, which had 
been equilibrated using 4ml of buffer QBT (750mM sodium chloride, 
50mM MOPS, 15% ethanol pH7.0, 0.15% Triton X-100), and allowed to 
enter by gravity flow. The column was washed using 20m1 of buffer QC 
(1M sodium chloride, 50mM MOPS, 15% ethanol pH7.0). The DNA was 
eluted using 5m1 of buffer QF (1.25M sodium chloride, 50mM MOPS, 15% 
ethanol pH8.2). The DNA was pelleted by the addition of 0.7 volumes of 
room temperature isopropanol and centrifugation (12000g. 20 minutes, 
4 °C). The DNA pellet was washed with 2m1 of ice-cold 70% ethanol and 
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allowed to air dry before being resuspended in 100p1 of TE (pH8.0). The 
DNA was analysed using UV spectrophotometry (2.2.1.5). 
2.2.1.4 Minipreparation of plasmid DNA. 
Approximately lOp.g of plasmid DNA from Escherichia coli was prepared 
using the commercially available WizardTM  Minipreps kit (Promega). 
A single colony was used to inoculate 5m1 of LB supplemented with 
ampicillin (lOOjxgmll) and grown overnight at 37 °C with shaking. 3m1 of 
the cells were pelleted using a microcentrifuge for 20 seconds and 
resuspended in 200j.il of cell resuspension buffer (50mM Tris-HC1 pH7.5, 
10mM EDTA, 100p.gml4 RNase A). The cells were lysed by the addition of 
200p1 of cell lysis buffer (0.2mM sodium hydroxide, 1% SDS). After the 
addition of 200jtl of neutralisation solution (1.32M potassium acetate 
pH4.8) the cell debris was pelleted by microcentrifugation for 5 minutes. 
The supernatant was added to imi of DNA purification resin and mixed 
by inversion. The mixture was pushed into a column, using a 2m1 
syringe, and washed with 2ml of wash solution (100mM sodium chloride, 
10mM Tris-HC1 pH7.5, 1mM EDTA, 70% ethanol). The column was dried 
by microcentrifugation for 2 minutes before elution of the DNA by 
adding 50p.l of TE to the column and microcentrifugation for 20 seconds. 
2.2.1.5 UV spectrophotometry. 
UV spectrophotometry allows the ready quantification of nucleic acids 
and a check of their purity. Typically, a sample of nucleic acid was diluted 
1:200 in lml of sdH20. Using the protocol supplied with the Perkin-Elmer 
?15 machine a sample of sdH20 was scanned between 200nm and 300nm 
to give a base value against which a subsequent scan of the diluted nucleic 
acid was made. The concentration of nucleic acid (mgml'-) within a 
sample was calculated using the following formulas: 
DNA concentration = absorbtion at 260nm (A 260) X 50 X dilution factor. 
RNA concentration = absorbtion at 260nm (A260 ) X 40 X dilution factor. 
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The purity of the nucleic acid sample, with respect to protein 
contamination, was determined from the ratio A 260/ A280, where a value 
greater than 1.8 indicates that the sample is free from protein 
contamination. 
2.2.1.6 Phenol/chloroform extraction. 
Phenol was saturated and equilibrated with TE (pH7.5) before use in 
extraction. 20m1 of TE (pH7.5) was mixed with 20ml of phenol, mixed 
thoroughly, and the phases separated by centrifugation (2000g, 5 minutes, 
room temperature). The upper layer was removed and the pH checked 
using litmus paper. The process was repeated until the TE removed 
remained at pH7.5. An equal volume of chloroform (containing 1/25th 
volume isOamyl alcohol) was then added to the phenol before being 
stored in the dark at 4°C. Fresh phenol /chloroform was prepared every 4 
months. 
An equal volume of phenol/ chloroform was added to the DNA solution 
to be treated and vortexed before microcentrifugation for 1 minute. The 
upper aqueous phase was transferred to a fresh Eppendorf tube and a 
second phenol /chloroform extraction made on this. The aqueous phase 
was again collected and the DNA ethanol precipitated (2.2.1.7). 
2.2.1.7 Ethanol precipitation. 
0.1 volumes of 3M sodium acetate (pH5.0) and 2 volumes of ice-cold 100% 
ethanol were added to the nucleic acid solution to be precipitated. The 
nucleic acid was pelleted by microcentrifugation for 20 minutes. The 
nucleic acid pellet was washed with a small volume of both 70% and 
100% ice-cold ethanol before being left to air dry at room temperature. 
The nucleic acid pellet was resuspended in either TE or sdH20. 
2.2.2 Endonuclease restriction. 
DNA restrictions were typically carried out for 2-3 hours at 37 °C using 
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commercially available restriction endonucleases. 3-10 units of enzyme 
were usually used to restrict 1ig of DNA in a 20jii volume of the 
recommended buffer. For larger quantities of DNA the reaction 
components were scaled up appropriately. 
Restriction endonuclease buffers were supplied at lox the final 
concentration. The Boehringer Mannheim incubation buffer range (Table 
1) was used for single enzyme restrictions. Where more than one 
restriction endonuclease was required, and the buffer compositions were 
incompatible, "One-Phor-All" (Pharmacia) was used (100mM Tris-acetate, 
100mM magnesium acetate, 500mM potassium acetate pH7.5). 
Table 1. Composition of Boehringer restriction endonuclease buffers. 




L M H 
Tris-acetate 33 - - - - 
Tris-HC1 - 10 10 10 50 
Magnesium acetate 10 - - - - 
Magnesium chloride - 5 10 10 10 
Potassium acetate - 100 - 50 100 
Dithioerythritol - - 1 1 1 
Dithiothreitol 0.5 - - - - 
3-meracptoetanol - 1 - - - 
pH at 37°C 7.9 8.0 7.5 7.5 7.5 
• Sma I restrictions made at 30°C 
• Kpn I restrictions supplemented with 100j.tgml 1 BSA. 
2.2.3 Agarose gel electrophoresis and DNA fragment isolation. 
2.2.3.1 Preparation of agarose gels. 
Multipupose agarose was supplied by Boehringer Mannheim and low 
melting point agarose by Sigma. 
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Table 2. Range of efficient separation of linear DNA molecules in agarose 
gels of different concentration. Sambrook et al. (1989). 
Percentage agarose 	Efficient range of separation 
in the gel. 	 of linear DNA molecules. 
	
0.7 	 0.8-10kbp 
0.9 0.5-7kbp 
1.2 	 0.4-6kbp 
1.5 0.2-3kbp 
- The appropriate amount of agarose as determined using Table 2 was 
dissolved in 1XTAE (2.1.6) and heated while stirring until the agarose was 
completely dissolved. For each 50m1 of agarose solution 1il of ethidium 
bromide (10mgml4) was added. The molten gel was poured into the 
appropriate casting tray and allowed to set at room temperature. For low 
melting point agarose the gels were cast at 4°C to aid setting. 
2.2.3.2 Running agarose gels. 
The cast gel was submerged in 1XTAE (2.1.6). Samples and DNA markers 
(2.2.3.3) were mixed with a 0.1 volume of loading buffer (30% glycerol, 
0.25% bromophenol blue, 0.25% xylene cyanol). Samples were run in the 
agarose gel at 15Vcm 1 until sufficient separation of the DNA bands of 
interest was achieved. 
2.2.3.3 DNA markers. 
The DNA markers commonly used were; ?. restricted with Hin dill and 
EcoRI (Promega), 1km ladder (Gibco-BRL), Ox174 restricted with HaeIII 
(Promega) and a lOObp ladder (Gibco-BRL). lp.g of the DNA markers were 
used on each gel. 
2.2.3.4 Imaging of the gel. 
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The DNA was visualised using a short wave UV transilluminator. The 
image was recorded on either heat sensitive film or a negative was 
produced on FP5 film (2.1.4). A ruler was photographed beside any gel 
which was to be subsequently southern blotted (2.2.4). 
2.2.3.5 DNA fragment isolation from a low melting point agarose gel. 
DNA fragments were routinely isolated from low melting point agarose 
gels. The resolving capability of this gel, however, is lower than those 
made using multi-purpose agarose. In cases where the resolution of DNA 
fragments in low melting point agarose was poor, electroelution from 
multipurpose agarose gels was used instead (2.2.3.6). 
A band of interest was cut from the gel using a clean scalpel blade and 
added to an equal volume of 1XTAE/0.2M sodium chloride and incubated 
at 65°C for 15 minutes. 0.75 volumes of phenol saturated with 
1XTAE/0.2M sodium chloride was added, vortexed, and microcentrifuged. 
The upper aqueous layer was transferred to a fresh Eppendorf tube and 
the phenol extraction repeated. 100il of butanol was added the the 
aqueous phase, vortexed, microcentrifuged for 1 minute and the butanol 
layer removed. This removed any contaminating phenol from the 
aqueous phase. The DNA in the remaining aqueous phase was ethanol 
precipitated (2.2.1.7). 
2.2.3.6 Electroelution of isolated DNA fragment. 
Dialysis tubing was prepared by boiling it in 2% sodium bicarbonate/lmM 
EDTA for 10 minutes. After washing repeatedly in fresh sdH20 the 
dialysis tubing was boiled for a further 10 minutes in 1mM EDTA. The 
prepared dialysis tubing was then stored at 4°C in 70% ethanol.Before the 
dialysis tubing was used it was washed repeatedly in sdH20. 
The agarose gel fragment was placed into a small piece of washed dialysis 
tubing with 300pi of 1XTAE and the ends closed with clips. The tubing 
was submerged in 1XTAE and a current passed through for 30 minutes, 
typically at 90-100mA. The current was reversed for the final 2 minutes of 
the run to - help remove DNA that had attached to the dialysis tubing. 
Elution of the DNA was checked using a short wave UV 
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transilluminator. The DNA solution was transferred into a fresh 
Eppendorf tube and ethanol precipitated (2.2.1.7). 
2.2.4 Southern transfer. 
2.2.4.1 "Dry" southern transfer. 
This was a quick method of capillary transfer of DNA to a nylon 
membrane when the quantity of DNA in an agarose gel was sufficiently 
large (>75ng per band). The gel was submerged in 0.2M hydrochloric acid 
for 10 minutes to depurinate the DNA. The gel was washed several times 
in sdH20 before being submerged in denaturing solution (2.1.6) for 10 
minutes with gentle shaking. The gel was again washed several times in 
sdH20 before being submerged in neutralising solution (2.1.6) for 20 
minutes with gentle shaking. 
Genescreen Plus membrane (DuPont) cut to the size of the gel was wet 
completely with neutralising solution and placed on the surface of the gel 
ensuring that all air bubbles were excluded. 4 pieces of Whatman (3MM) 
paper, cut to size, were placed on top of the membrane. A small stack of 
paper towels and a light weight were then added. 
The transfer of DNA took place over 5-6 hours. The membrane was 
removed, washed in 2XSSC (2.6.1) for 2 minutes and air dried. It was then 
ready for prehybridisation (2.2.4.3). 
2.2.4.2 "Wet" southern transfer. 
A "wet" transfer was used when the DNA of interest is present in small 
quantities (eg. genomic southern analysis). The initial preparation 
(depurination, denaturation and neutralisation) of the gel is the same as 
that described for "dry" southern transfer (2.2.4.1). 
The prepared gel was placed on a "wick" consisting of 2 pieces of 
Whatman (3MM) paper cut to the same width as the gel, but longer, so 
that the ends could be submerged in a reservoir of neutralising solution 
(2.1.6). The gel was surrounded with saran wrap to prevent the 
neutralising solution by-passing the gel into the stack of paper towels. A 
piece of Genescreen Plus membrane (DuPont), cut to the correct size, was 
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wet completely with neutralising solution and placed on the gel ensuring 
that all the air bubbles were excluded. 6 pieces of Whatman (3MM) paper 
were cut to the correct size. 2 of these were wet with neutralising solution 
and placed on the membrane and then the remaining 4 pieces were 
added, again eliminating air bubbles. A stack of paper towels 
approximately 10cm high were added to the blot and a glass plate placed 
on top. A 300-400g weight was placed on top of the glass plate. The transfer 
was left overnight. 
The next day the blot was carefully taken apart, the membrane washed in 
2XSSC (2.6.1) for 2 minutes and air dried. The membrane was ready for 
prehybridisation (2.2.4.3). 
2.2.4.3 Prehybridisation and hybridisation of radiolabelled probes. 
Prehybridisation and hybridisation were done using the same buffer, 
although the composition of the buffer varied depending upon the type of 
radiolabelled probe used (end-labelled oligonucleotide or random 
labelled). The membrane was placed in a hybridising tube, with 25m1 of 
the appropriate hybridisation solution (2.6.1), and incubated overnight. 
The next day the buffer was replaced, the probe added and the membrane 
incubated overnight. 
2.2.4.4 End-labelled oligonucleotide probes. 
These were used for membranes where reasonable quantities of DNA 
were available (>25ng). The prehybridisation and hybridisation were done 
at 37°C unless an oligonucleotide of greater than 20 bases in length was 
used, in this case 40°C would be used. The oligonucleotide was end-
labelled in the following reaction; 
1il oligonucleotide (20ngpJ4 ) 
4jxl 5X Forward reaction buffer (300mM Tris-HC1 pH7., 50mM 
magnesium chloride, 1.65j.tM ATP, 75mM -mercaptoethanol) 
131.d sdH20 
ijil [y.32P] ATP (10mCiml 1 ) 
lp.l T4 Kinase (10UR1 1 ) 
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The reaction was incubated at 37°C for 3 hours after which the probe was 
ready to be added (2.2.4.3). 
2.2.4.5 Random labelled probes. 
Random labelled probes were prepared using the commercially available 
Prime-ItTMII Random Primer Labelling kit (Stratagene). With the 
exception of the T7 DNA polymerase all materials were supplied with the 
kit. 
bOng DNA in Xpi 
lOp.l random primers (9-mers at 8ngpil) 
26.5 - Xjil sdH20 
The above were heated to 95-100°C for 5 minutes before being allowed to 
cool slowly to room temperature. The following were then added; 
10p.1 5X random label (dCTP) buffer (250mM Tris-HC1 pH8.0, 
100mM magnesium chloride, 20mM 3-mercaptoethanol, 0.5mM 
each of dGTP, dTTP and dATP) 
3p.l [cx.32P] dCTP (10mCiml 1) 
0.5p.l T7 DNA polymerase (8.5Up.l -1 ) 
The reaction was incubated at 37°C for 4 hours before 2p.l of stop mix 
(0.5M EDTA) were added. 
To remove the unincorporated dNTPs the commercially available 
NucTrapTM Probe Purification Columns (Stratagene) were used. 70p.l of 
1XSTE (100mM sodium chloride, 20mM Tris-HC1 pH7.5, 10mM EDTA) 
was pushed slowly through the column using a lOm! syringe. 20p.1 of 
1XSTE was added to the prepared probe and the 70p.l of the reaction 
pushed through the column. Finally a further 70p1 of 1XSTE was added to 
the column and pushed through. The eluate from the column was 
collected in a fresh Eppendorf tube and heated to 95-100°C for 5 minutes 
before being added to the prehybridised membrane (2.2.4.3). Random 
labelled probes were typically used at a hybridising temperature of 65°C. 
2.2.4.6 Washing and exposing a membrane. 
End-labelled oligonucleotide probes. 
The probes were poured off and stored at -20°C either for reuse or to allow 
the radiolabel to decay before safe disposal. 25m1 washes of 6XSSC/ 
0.1%SDS were added to the filter at 37°C. Usually 2-3 washes of 10 
minutes were used. Monitoring of the membrane with a n-geiger counter 
was used to ensure that the probe was still attached. 
Random labelled probes. 
The probes were stored as described for end-labelled oligonucleotides. 
Before reuse these probes required heating to 95-100°C for 5 minutes. 
25m1 washes at 65°C for 10 minutes each were used. Initial washes were 
made with 6XSSC/0.1% SDS increasing in stringency to 0.1-0.2XSSC/0.1% 
SDS over a series of twice repeated washes. Monitoring the membrane 
with a a-geiger counter defined the background noise to signal ratio and 
indicated whether a more stringent wash was required. 
Washed membranes were carefully sealed in a thin plastic bag and placed 
in an autoradiographic cassette with an image intensifying screen. The 
position of the membrane was indicated using a Stratagene fluorescent 
marker strip. Exposure to preflashed film (2.1.4) was made at -70°C. 
Exposure was usually overnight but longer exposures for weaker signals 
were sometimes required. After the appropriate length of exposure the 
film was developed using a X-OGRAPH Xl (IBI Ltd.) automatic X-ray film 
processor. 
2.2.4.7 Stripping a membrane. 
The membrane to be stripped was placed in a hybridising tube, at 65°C, 
containing lOOml of 0.4M sodium hydroxide. After 30 minutes the 
sodium hydroxide solution was replaced with lOOml of a neutralising 
solution (0.1XSSC, 0.1%SDS, 200mM Tris-HC1 pH7.5). Two 15 minute 
incubations, at 65°C, in neutralising solution were carried out. The 
membrane was exposed overnight to ensure all signals had been stripped. 
2.2.4.8 Slot-blots. 
The sample DNA was denatured by adding 0.1 volumes of 20mM EDTA/ 
2M sodium hydroxide and incubated at 37°C for 15 minutes. The DNA 
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sample was made up to a 100,.l volume by adding TE (pH8.0) and placed 
on ice until blotting. 
Slot-blotting was done using apparatus supplied by Bio-Rad. The 
Genescreen Plus membrane was soaked with 2XSSC and placed in the 
apparatus on 4 pieces of Whatman (3MM) paper. A vacuum source was 
attached to the apparatus and lOOjil of 2XSSC drawn through each well to 
be used. The denatured DNA was added to a well and drawn through 
onto the membrane. After blotting all the samples of denatured DNA the 
apparatus was taken apart and the membrane left to dry before 
prehybridisation (2.2.4.3). 
2.2.5 Ligations. 
2.2.5.1 Phosphatase treatment of restricted vector. 
To prevent self-ligation of restricted vector the 5' phosphates were 
removed using calf intestinal alkaline phosphatase (ClAP). The restriction 
endonuclease was removed either by phenol/ chloroform extraction 
(2.2.1.6) or DNA fragment purification (2.2.3.5 or 2.2.3.6) and the restricted 
DNA ethanol precipitated (2.2.1.7) The DNA was resuspended in 20j.tl of 
1XCIAP buffer (50mM Tris-HC1 pH8.5, 1mM EDTA, 1mM magnesium 
chloride, 1mM zinc chloride) with ipi of ClAP (1Up1 1) and incubated at 
37°C for 30 minutes. To inactivate ClAP, 2jil of 0.5M EGTA (pH8.0) was 
added and the reaction incubated at 70°C for 10 minutes. The ClAP was 
removed by phenol /chloroform extraction and the DNA ethanol 
precipitated before use. 
2.2.5.2 Filling of recessed 3' termini. 
To generate a blunt end from a recessed 3' terminus the 5' to 3' 
polymerase activity of the Klenow fragment of E.coli DNA polymerase I 
was used. The restricted DNA was ethanol precipitated (2.2.1.7) and taken 
up in 20pl of sdH20 to which 4p.l of 5X kienow buffer was added (0.2mM 
of each of dCTP, dGTP, dATP and dTTP, 500mM Tris-HC1 pH7.8, 50mM 
magnesium chloride, 100mM -mercaptoethano1) and ipi of kienow 
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fragment (lUp.14). The reaction was incubated at 37°C for 1 hour, 
phenol/chloroform extracted (2.2.1.6) and the DNA ethanol precipitated. 
2.2.5.3 Blunting a recessed 5' terminus. 
To generate a blunt end from a recessed 5' terminus the 3'-5' exonuclease 
activity of either the kienow fragment or T4 DNA polymerase were used. 
In both cases the restriction buffer supplies all the necessary requirements 
for enzyme activity. The T4 DNA polymerase is preferred as its 3'-5' 
exonuclease activity is much more active on single stranded DNA than 
that of the kienow fragment. 
0.1 volume of a 2mM mix of dCTP, dGTP, dATP and dTTP were added to 
the restriction followed by 1U of either T4 DNA polymerase or kienow 
fragment. The kienow fragment reactions were incubated at 37°C for 30 
minutes and the T4 DNA polymerase for 15 minutes at 14°C (T4 DNA 
polymerase 3'-5' exonuclease activity is equivalent to its 5'-3' polymerase 
activity at this temperature, thus preventing the enzyme "nibbling" back 
too far). The reactions were phenol/ chloroform extracted (2.2.1.6) and the 
DNA ethanol precipitated (2.2.1.7). 
2.2.5.4 Ligation reaction. 
The vector and insert DNA molecules were restricted and the ends 
modified if necessary (2.2.5.1 to 2.2.5.3. Typically, 50ng of vector was ligated 
to insert at a range of molar ratios between 3:1 and 10:1 (insert:vector). 
Vector and insert DNA were added to lox ligation buffer (500mM Tris-
HC1 pH7.5, 100mM magnesium chloride, 100mM DTT, 10mM ATP) with 
1U of T4 DNA ligase. Blunt ended ligations were done in a total volume 
of 10.t1 and ligations with "sticky" ends in 20il. Reactions were incubated 
overnight at 16°C. 
2.2.5.5 Cloning of PCR products. 
PCR fragments were cloned using the TATM  Cloning Kit (Invitrogen). 
1il of a freshly prepared PCR was added to 2jil of TA vector (25ngjit 1 ), ipi 
of lox ligation buffer (60mM Tris-HC1 pH7.5, 60mM magnesium chloride, 
50mM sodium chloride, 1mgml -1 BSA, 70mM 3-mercaptoethanol, 1mM 
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ATP, 20mM DU, 10mM spermidine), 5ji1 of sdH20 and ijil of T4 ligase 
(4Uil 1) and incubated overnight at 16°C. 
2pi of 0.5M 13-mercaptoethanol was added to an aliquot of supplied 
competent cells (INVa F) and gently mixed. 2.d of the ligation reaction 
was added, mixed gently, and incubated on ice for 30 minutes. The cells 
were heat shocked at 42°C for 30 seconds before replacing on ice for 2 
minutes. 450p.l of room temperature Soc (2% tryptone, 0.5% yeast extract, 
10mM sodium chloride, 2.5mM potassium chloride, 10mM magnesium 
chloride, 10mM magnesium sulphate, 20mM glucose) were added before 
incubation for 1 hour at 37°C while being agitated by rotation. 
25p.l and 100il samples of the transformed cells were plated on LB plates 
supplemented with 25mgml 1 of kanamycin (2.2.6;2) and 0.004% X-gal. 
Plates were incubated, inverted, overnight at 37°C. White and light blue 
colonies were tested for the presence of the required insert. 
2.2.6 Preparation of competent Escherichia coli and transformation. 
2.2.6.1 Preparation of competent Escherichia coli. 
A single colony of DH5a was picked into 5m1 of LB (2.6.1) and incubated, 
while shaking, overnight at 37°C. 0.5ml of the overnight culture was used 
to inoculate 50m1 of fresh LB which was then incubated for a further 2 
hours at 37°C while shaking. The culture was then chilled on ice for 30 
minutes before collection by centrifugation (1500g, 10 minutes, 4°C). The 
pelleted cells were resuspended in lOml of ice-cold sterile 100mM 
magnesium chloride and collected by centrifugation (1500g, 10 minutes, 
4°C). The washed pellet was resuspended in 10m1 of 100mM calcium 
chloride and incubated on ice for a minimum of 4 hours. The competent 
cells were collected by centrifugation (1500g. 10 minutes, 4°C) and 
resuspended in 2m1 of 100mM calcium chloride/14% glycerol. 200tl 
aliquots of competent cells were stored for up to 6 months at -70°c. 
2.2.6.2 Preparation of selective media plates. 
Ampicillin at a concentration of 1OOj.tgml 1 in LB media was used as a 
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selective medium for all experiments with DH5a cells. 
Initial selection of clones from the .TATM  Cloning Kit (2.2.5.5) was made 
using kanamycin (25pgml 1 ) as the TA vector contains a gene conferring 
kanamycin resistance where other vectors present in the PCR reaction as a 
template do not. Subsequent selection was then made using ampicillin, to 
which the TA vector also confers resistance, at 100igml 1 . 
2.2.6.3 Transformation. 
Half of the ligation reaction was added to 200p1 of competent cells (2.2.6.1), 
mixed gently, and incubated on ice for 30 minutes. The cells were heat 
shocked at 42°C for 30 seconds before replacing on ice for 2 minutes. 450p1 
of room temperature SOC (2% tryptone, 0.5% yeast extract, 10mM sodium 
chloride, 2.5mM potassium chloride, 10mM magnesium chloride, 10mM 
magnesium sulphate, 20mM glucose) were added before incubation for 1 
hour at 37°C while being agitated by rotation. Typically lOOjil and 300.tl of 
transformed cells were spread on selective media and incubated 
overnight, inverted, at 37°C. 
2.2.6.4 Blue/white colour selection. 
The insertion of a DNA fragment into the multiple cloning site (MCS) of 
the commonly used pBluescriptll SK+ (Strategene) vector during the 
course of this work was tested using a blue/white colour test. Selective 
plates were supplemented with 200 jtM IPTG (imi of 100mM IPTG stock in 
sdH20 added to 500ml of LB agar) and 0.004% X-gal (imi of 2% stock in 
DMF added to 500m1 of LB agar). White colonies or, in the case of small 
DNA fragments, light blue colonies, were subsequently selected for 
further analysis. 
2.2.7 Colony screening. 
2.2.7.1 Colony lifts. 
This protocol was adapted from that described by Buluwela et al. (1989). 
Hybond-N (Amersham) membranes, cut to the correct size, were placed 
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on the surface of the plates and marked for orientation before being 
carefully lifted off. The membranes were placed colony side up on blotting 
paper soaked in 2XSSC/5% SDS for 2 minutes. The membranes were 
microwaved at full power for 45 seconds, this lyses the cells and denatures 
and fixes the DNA. The membranes were then available for 
prehybridisation (2.2.4.3). 
2.2.7.2 Patching. 
Small numbers of colonies were screened using this protocol for ease of 
subsequently selecting positive clones. Using autoclaved toothpicks 
individual colonies were scratched across the surface of a Hybond-N 
(Amersham) membrane which had been stamped with a 100 square 
matrix and placed on a selective media plate. The same olony was also 
scratched on a selective media plate at the same position as indicated from 
a matrix stuck to the underside of the plate. Both plates were incubated 
overnight at 37°C. The colonies on the membrane was treated as 
described in 2.2.7.1. 
2.2.8 DNA sequencing and analysis. 
2.2.8.1 Sequencing of double-stranded DNA template. 
DNA sequence determination was made using the chain termination 
method described by Sanger et al. (1977). The commercially available 
Sequenase® v.11 kit (USB) was used. Sequencing primers were supplied by 
OSWEL DNA service (Chemistry Dept., University of Edinburgh) or 
Perkin-Elmer. 
As double stranded DNA template was always used, the DNA was 
denatured before annealing to the oligonucleotide primers. lOj.tg  of 
template was resuspended in a total volume of 30R1  of denaturing 
solution (200mM sodium hydroxide, 2mM EDTA) and incubated for 30 
minutes at 37°C. The template was ethanol precipitated (2.2.1.7) and 
resuspended in 7p.l of sdH20. 
The 7iil  of template was quickly mixed with 2.il of reaction buffer (200mM 
Tris-HC1 pH 7.5, 100mM magnesium chloride, 250mM sodium chloride) 
and lp.l of oligonucleotide primer (20ngp1 1 ). The annealing mix was 
incubated at 37°C for 15 minutes before the sample was allowed to cool to 
room temperature. 
The labelling reaction consisted of lOjil annealed primer/ template, 2il of 
dGTP labelling mix (1.5p.M of dGTP, dTTP and dCTP), ipi of 100mM DTT, 
0.5,.tl [a35S] dATP (10mCiml 1 ) and 2p1 of Sequenase® DNA polymerase 
(1.6 Uptl). The labelling reaction was incubated at room temperature for 
2-5 minutes before 3.5p.l aliquots were removed and added to 2.5p.l of each 
termination mix (ddc, ddA, ddT and ddC) prewarmed to 37°C. Each 
termination mix consisted of the following; 80p.M dGTP, dCTP, dATP and 
dTTP, 50mM sodium chloride and 8p.M of the appropriate 
dideoxynucleoside (ddGTP, ddCTP, ddATP and ddTTP). To compensate 
for the A-T bias in the P.falciparum genome termination mixes 
containing ddGTP and ddCTP were diluted 1 in 2 compared to 1 in 8 for 
ddATP and ddTTP. The termination reactions were incubated at 37°C for 
2-5 minutes and then stopped by the addition of ice-cold loading buffer 
(95% formamide, 20mM EDTA, 0.05% bromophenol blue, 0.05% xylene 
cyanol FF) and placing the reaction on ice. 
2.2.8.2 Sequencing gel electrophoresis. 
Sequencing reactions were separated on a 6% polyacrylamide gel (20:1 
acrylamide:bisacrylamide) containing 7M urea in 1XTBE (2.6.1) available 
commercially from Scotlab. 40ml of polyacrylamide mix was polymerised 
by the addition of 240il of 10% ammonium persulphate and 24p.l TEMED. 
The gel was cast between a pair of plates (380mm X 170mm) separated by 
spacers (0.3mm). 
2.5jil of each termination mix (2.2.8.1) was heated for 5 minutes at 95-
100°C before being quickly cooled on ice. The termination mixes were 
loaded onto a "sharks tooth" comb, in the order; ddGTP, ddATP, ddTTP 
and ddCTP. Electrophoresis was carried out at a constant 50 Watts. After 
the appropriate length of run the gel was fixed by placing blotting paper 
soaked in fix (10% glacial acid, 12% methanol) on the surface for 10 
minutes. The gel was lifted onto Whatman 3MM paper and dried under 
vacuum at 80°C. Gels were exposed to film (2.1.4) overnight at room 
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temperature. 
2.2.8.3 Sequence analysis. 
Storage of sequence, mapping of restriction sites and comparison to other 
database sequences was made using the University of Wisconsin Genetics 
Computer Group Sequence Analysis Software Package v.7 and v.8 
(Devereux et al. , 1984). 
2.2.9 Polymerase Chain Reaction (PCR). 
2.2.9.1 Standard PCR. 
A typical PCR reaction (Saiki et al., 1988, Innis et al., 1990) was modified as 
described below to compensate for the extreme A-T richness of -the 
template DNA. PCR reactions were assembled on ice in 500il Eppendorf 
tubes. Extreme care was used to ensure that contaminants were not 
introduced into the reactions. 
bOng template DNA 
lOjil lox PCR buffer (200mM, Tris-HO pH8.4, 500mM 
potassium chloride) 
lOjil Primer #1 (20ngp.1 1 ) 
lOjil Primer #2 (20ngitl) 
3pi 50mM magnesium chloride 
2.5jtl 40mM dNTP (10mM each of dATP, dTFP, dCTP and 
dGTP) 
0.5jtl Taq DNA Polymerase (5Upt 1 ) 
sdH20 to a total of 100il 
The Taq DNA polymerase and buffer were supplied by Gibco-BRL. The 
reaction was overlaid with lOOjil of mineral oil and the lid of the tube 
punctured before being placed on the thermocycler. 
A typical programme for the thermocycler for a pair of 18-mer 
oligonucleotide primers to a genomic DNA template to amplify a 1kb 
product is described below. Modifications were made to this basic 
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programme to allow for the optimisation of each reaction. 
95°C for 5 minutes 
37°C for 1 minute 	 1 cycle 
72°C for 2 minutes 
93°C for 3 minutes 
37°C for 1 minute 	 1 cycle 
72°C for 2 minutes 
93°C for 1 minute 
40°C for 1 minute 	 28 cycles 
72°C for 2 minutes - 	 - 
72°C for 5 minutes 	 1 cycle 
The maximum ramp rate (1°Csec 1 ) between each step was used in all 
PCR reactions. 
10-15il of each reaction were typically analysed by agarose gel 
electrophoresis (2.2.3). 
2.2.9.2 Reverse Transcription-PCR (RT-PCR). 
Reverse transcription from an oligonucleotide hybridised to a mRNA of 
interest was used to give a first-strand cDNA which was used in a 
subsequent standard PCR reaction (2.2.9.1). 
ipi of an oligonucleotide (20ngpkl) was added to 5-10jig of total RNA 
which had been treated with RNase-free DNase to ensure that no 
genomic DNA was contaminating the sample. The volume was made up 
to 20i1 with DEPC-treated sdH20 and incubated at 70°C for 10 minutes. 
The sample was collected by microcentrifugation and the mix allowed to 
cool slowly to room temperature. 3jil of lox reverse transcription buffer 
(200mM Tris-HC1 pH8.4, 500mM potassium chloride and 60mM 
magnesium chloride), liii  of mixed dNTPs (2.5mM each of dATP, dTTP, 
dCTP and dGTP), 3p.l of 100mM DTF and DEPC-treated sdH20 to a total of 
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30pi were added. The reaction was incubated at 42°C for 2 minutes before 
the addition of ijil of Superscript II reverse transcriptase (Gibco-BRL, 
8Up.l 4 ). The reaction was incubated for a further 90 minutes at 42°C. 
Typically 2-4j.tl of the first-strand cDNA reaction mix was used as template 
for a standard PCR. 
2.2.10 Micrococcal nuclease. 
The protocol used was adapted from that described by Cary et al. (1994). 
Approximately 10 9 parasites were cultured and then isolated from the 
erythrocytes by saponin lysis (2.2.1.1). The isolated parasites were collected 
by centrifugation (2000g, 10 minutes, 40)  and washed in 1XSSC, 0.1% 
saponin before being collected by centrifugation. The washed parasite 
pellet was resuspended in 3m1 of hypotonic buffer (10mM Tris-HC1 pH8.0, 
1.5mM magnesium chloride, 15mM potassium chloride, 2mM PMSF, 
2gml-1 leupeptin, 2pgml-1 pepstatin, 2p.gm1 1 chymotrypsin, 2p.gm1 1 
antipapain). The parasites were lysed using 20 strokes of a prechilled 
dounce homogeniser B-type pestle. The nuclei were isolated by sucrose 
gradient centrifugation after the resulting suspension was layered on 3m1 
of hypotonic buffer containing 0.34M sucrose (12000g, 3 minute, 4°C, no 
brakes). The nuclei pellet was resuspended in lml of hypotonic buffer 
supplemented with 2mM calcium chloride. 
50U of micrococcal nuclease was added to the nuclei suspension and 
incubated at 30°C. Samples were removed at time points (0, 1, 3, 5 and 20 
minutes). EGTA was added to a final concentration of 10mM before 
incubating the samples on ice. When all the samples were collected 
proteinase K was added to a final concentration of 100j.tgml 1 and 
incubated at 37°C for 30 minutes. For the final 10 minutes of incubation 
RNase A was added to a final concentration of 100j.tgml 1 . The DNA was 
phenol/ chloroform extracted (2.2.1.6) and ethanol precipitated (2.2.1.7) 
before analysis on an agarose gel. 
2.3 RNA Methods. 
2.3.1 Total RNA isolation. 
This protocol was based on the acidic guanidinium-phenol-chloroform 
protocol described by Chomczynski and Sacchi (1987). P.falciparum 
culture was grown until approximately 10 9 parasites were available when 
the culture was harvested by centrifugation (2500g, 10 minutes, 4°C). The 
erythrocyte pellet was resuspended in 5 volumes of 1XSSC, 0.1% saponin, 
mixed by inversion and incubated at room temperature for 5 minutes. 
The released parasites were collected by centrifugation (3000g, 10 minutes, 
4°C), washed in 1XSSC, 0.1% saponin and collected by centrifugation. 
The washed parasite pellet was resuspended 7ml of solution D (4M 
guanidinium isothiocyanate, 25mM sodium citrate, 0.5% sodium lauryl 
sarcosine, 100mM -mercaptoethanol) and repeatedly passed through an 
18 gauge needle to completely disrupt the parasite pellet. 0.7m1 of 2M 
sodium acetate (pH4.0), 7m1 of water saturated phenol (pH5.0) and 1.4m1 
of chloroform/isoamyl alcohol (24:1 v:v) were sequentially added - and 
mixed by vortex. The suspension was incubated on ice for 20 minutes 
before centrifugation (10000g, 20 minutes, 4°C) to separate the phases. The 
upper aqueous phase was collected and 1 volume of isopropanol added 
before incubation at -20°C for 1 hour. The RNA was pelleted by 
centrifugation (12000g. 20 minutes, 4°C) and resuspended in 500j.tl of TE, 
0.1%SDS. A phenol/ chloroform extraction (pH5.0, 2.2.1.6) was made on 
the RNA solution after which imi of ice-cold 100% ethanol was added to 
the aqueous phase. The RNA was pelleted by microcentrifugation for 20 
minutes. The RNA pellet was resuspended in 300j.tl of TE, 0.1%SDS and 
stored, in lOOp.g aliquots, at -70°C. The RNA was analysed using UV 
spectrophotometry (2.2.1.5). 
2.3.2 Northern analysis. 
Total RNA was fractionated on a 1% agarose/1.85% formaldehyde gel 
prepared and run in 1XMOPS buffer (25mM MOPS, 5mM sodium acetate, 
1mM EDTA, pH7.0). Typically 10-20p.g of total RNA, or 8g of 9.5-1.4Kb 
RNA markers (Gibco-BRL) were added to an equal volume of 
formaldehyde sample buffer (2XMOPS, 50% formamide, 25% 
formaldehyde, 0.25% bromophenol blue, 0.25% xylene cyanol) and 
incubated at 65°C for 5 minutes. The sample was cooled quickly on ice 
and ipi of ethidium bromide (1mgml 4) added before loading on the gel. 
The gel was run at 100V for 4 hours using a pump to circulate the 
1XMOPS buffer. 
On completion of separation of the total RNA the gel was washed for 20 
minutes in 1XSSC to remove the formaldehyde, soaked in 50mM sodium 
hydroxide for 10 minutes then washed for 5 minutes with sdH20. A blot 
was assembled essentially as described for a wet southern blot (2.2.4.2) 
except that the transfer was made in 10XSSC. The following day the 
Genescreen Plus membrane was washed with 10XSSC before 
prehybridisation. The hybridisation was made using the conditions for a 
random labelled probe (2.2.3.4, 2.2.4.6) at 60°C. 
2.3.3 Primer extension. 
Between 5-10ng of the required oligonucleotide was end-labelled (2.2.3.5) 
overnight to ensure completion of the labelling. The end-labelled 
oligonucleotides were ethanol precipitated (2.2.1.7) to remove 
unincorporated radiolabelled nucleotides. The oligonucleotide pellet was 
resuspended with 5p.g of total RNA in a total volume of 18p.l. The 
mixture was incubated at 70°C for 10 minutes and collected by 
microcentrifugation for 10 seconds. 2.5pi of lOX extension buffer (200mM 
Tris-HC1 pH8.4, 500mM potassium chloride, 60mM magnesium chloride), 
ipi of 10mM dNTP mix (2.5mM of each of dATP, dTTP, dCTP, dGTP) and 
2.5pi of 100mM DIT were sequentially added. The reaction was incubated 
at 42°C for 2 minutes before ipi of Superscript II Reverse Transcriptase 
(Gibco-BRL, 8Ufr 1 ) was added. The reaction was incubated for a further 
90 minutes at 42°C. 
The reaction was stopped by incubation at 70°C for 10 minutes. This was 
allowed to cool to 50°C when ipi of RNase H (1Uil 1) was added and the 
reaction incubated for 10 minutes at 37°C. The cDNA was ethanol 
precipitated and resuspended in 4p.l of formaldehyde sample buffer 
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(2.2.1.3). 
The primer extension reactions were run on a denaturing polyacrylamide 
gel (2.2.8.2) with end-labelled lOObp markers (Gibco-BRL) run alongside. 
2.3.4 In vitro transcription. 
2.3.4.1 In vitro transcription reaction. 
In order to produce large quantities of full length radiolabelled transcript 
from an AT-rich template the commercially available AmpliscribeTM 
transcription kit (Epicentre technologies) was used. In vitro transcription 
was made from a plasmid template that has been linearised by 
endonuclease restriction. The restriction was made at the 3' end of the 
transcribed sequence so that all the transcripts terminate at the same 
point. The restriction site was either blunt ended or had a 5' protruding 
end as 3' protruding ends act as sites for non-specific transcription 
initiation. 
The following components were mixed in the order described; DEPC-
treated sdH20 to give a total volume of 20j.fl, 2p1 lox transcription buffer 
(400mM Tris-HC1 pH8.0, 80mM magnesium chloride, 20mM spermidine 
and 500mM sodium chloride), 1.5il of each of CTP, ATP, GTP (100mM), 
2.tl of 100mM DTT, ljtg of linearised template, 0.5 p.1 of 100mM UTP and 
3p1 of [a32P] UTP (3000Cimmol 1 ). 2pi of AmpliscribeTM T7 RNA 
polymerase (contains an RNase inhibitor) was added and the reaction 
incubated for 2-3 hours at 37°C. 1d of RNase-free DNaseI was added at 
this time and the reaction incubated for a further 20 minutes. The 
reaction was ethanol precipitated (2.2.1.7) to allow unincorporated 
nucleotides to be removed in the supernatant. The pellet was 
resuspended in 5p.l of loading buffer (95% formamide, 20mM EDTA, 
0.05% bromophenol blue, 0.05% xylene cyanol FF) and run on a 
denaturing polyacrylamide gel, with end-labelled lOObp markers, to isolate 
the full-length transcripts. 
2.3.4.2 Isolation of in vitro transcripts from denaturing polyacrylamide 
gel. 
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Typically 70-90% of transcripts prepared from in vitro transcription were 
full length. After separating products on a polyacrylamide gel, this was 
briefly exposed to film to allow the position of the full length transcripts 
to be identified. A gel slice containing the full length transcripts was cut 
out using a clean scalpel and placed in 350p.1 of elution buffer (0.5M 
ammonium acetate, 1mM EDTA, 0.2% SDS). The gel slice was incubated 
at room temperature overnight, while rotating, to allow the transcript to 
be eluted. The gel slice was pelleted by microcentrifugation for 1 minute. 
The supernatant was removed and 2.5 volumes of ice-cold 100% ethanol 
added and the transcripts pelleted by microcentrifugation for 25 minutes. 
The pellet was washed with ice-cold 70% ethanol and stored at -70°C 
until use. 
2.3.5 RNase protection. 
RNase protection was carried out using the commercially available RPA 
JJTM kit (Ambion) using a protocol described by M. Lanzer (pers comm.). 
The radiolabelled transcript was prepared using the protocols described 
above (2.3.4). The RNA used in the assays was treated with RNase-free 
DNase I to remove any contaminating genomic DNA. 
Freshly prepared radiolabelled transcript was resuspended in 25p.l of 
DEPC-treated sdH20 and a 3j.fl aliquot added to an Eppendorf for each of 
the assays to be carried out plus 3 additional control tubes. To each of the 
assay tubes 10.tg of P.falciparum total RNA was added and the volume 
taken to 20j.il with DEPC-treated sdH20. To two of the control tubes 10ig of 
yeast total RNA was added and the volume made up to 20j.tl as described 
for the assay tubes. 2.t1 of 5M ammonium acetate was then added to each 
of the tubes containing total RNA and mixed completely. 2.5 volumes of 
ice-cold 100% ethanol was added, mixed by inversion and 
microcentrifuged for 25 minutes to pellet the RNA. After washing the 
RNA pellets carefully with ice-cold 70% ethanol they were resuspended in 
20.t1 of hybridisation buffer (80%formamide, 100mM sodium citrate 
pH6.8, 300mM sodium acetate pH6.4, 1mM EDTA). The samples were 
heated to 90-95°C for 5 minutes and incubated overnight at 30°C. 
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The incubated samples were microcentrifuged briefly to collect the 
condensation. 200j.tl of diluted RNase(s) were added to one tube 
containing the yeast total RNA and all the assay tubes. Two RNase 
concentrated mixes were available; RNase A/Ti (250UmF 1 RNase A and 
10,000 Um1 1 RNase Ti) or RNase Ti (5000Uml 1 ). These were diluted 
appropriately into 200i.il of dilution buffer, usually 1:250 or i:iOO. The 
reactions were incubated at 37°C or room temperature for 30 minutes 
before 300tl of termination mix were added to all tubes containing total 
RNA. The reactions were incubated at -20°C for 30 minutes before 
microcentrifugation for 25 minutes to pellet the RNA. The supernatant 
was removed and the pellet carefully washed with ice-cold 70% ethanol. 
5jil of loading buffer (95% formamide, 0.025% brornophenol blue, 0.025% 
xylene cyanol, 0.5mM EDTA, 0.025% SDS) were added to each of the 3 
control tubes and the P.falcipa rum assay tubes. The samples along with 
end-labelled lOObp markers (Gibco-BRL) were loaded onto a denaturing 
polyacrylamide gel and run as previously described (2.2.8.2). The gel was 
dried under vacuum at 80°C on to a Whatman 3MM blotting paper 
support and exposed to film overnight. 
2.3.6 Nuclear run on analysis. 
This protocol was adapted from that described by Sultan (1995) and 
originally that of Marzluff and Huang (1989). All steps were carried out on 
ice to help preserve nuclear structure and RNA polymerase activity. 
P.falciparum culture was grown until approximately 10 9 parasites were 
available. The parasite culture was harvested by centrifugation (2000g, iO 
minutes, 4°C). The erythrocyte pellet was washed with 5 volumes of PBS 
and again collected by centrifugation (2000g, iO minutes, 4°C). 5 volumes 
of ice-cold 1XSSC, 0.1% saponin were added to the pellets followed by 
incubation on ice for iO minutes. The released parasites were collected by 
centrifugation (2000g. 10 minutes, 4°C) and washed by resuspension in 
3ml of buffer E (250mM sucrose, 20mM PIPES 6.3, 0.5mM calcium 
chloride, 1mM PMSF, 2pgml 1 leupeptin, 2pgml 1 apotinin, 2p,gml 1 
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pepstatin A, 2pgml4 antipain, 0.1mM benzamidine, 0.1mM sodium 
metabisulphite). The washed parasites were collected by centrifugation 
(3000g, 10 minutes, 4°C) and the wash with buffer E was repeated twice. 
The washed parasites were finally resuspended in 3ml of buffer E 
supplemented with 200il of 10% NP-40 and transferred into a prechilled 
dounce homogeniser. Using 15-20 strokes of a B-type pestle the parasites 
were broken open. The intact nuclei were collected by centrifugation 
(12000g, 10 minutes, 4°C) and then washed three times as previously 
described using 3ml of buffer E. 
The nuclear pellet was resuspended in 600p.l of buffer B (50mM HEPES 
pH7.9, 50mM sodium chloride, 10mM magnesium chloride, 1.2mM DTT, 
10mM creatine phosphate, 1mM GTP, 1mM CTP, 4mM ATP, 25% glycerol, 
3U RNase inhibitor [Inhibitace], 0.2mgml 1 creatine kinase, lp.M [a. 32P] 
UTP [3000 Cimmol4]) and incubated for 20 minutes at 37°C. 
RNA from the nuclei was isolated using the standard total RNA isolation 
protocol (2.3.1.1). The RNA pellet, containing the nascent radiolabelled 
transcripts, was resuspended in Sml of random label hybridisation buffer 
(2.2.3.4). The probe was added to a prehybridised membrane on which lpg 
of denatured gene probe had been immobilised. Hybridisations for 
nuclear run on analysis were carried out at 55°C overnight. 5pl of 
lOmgml- ' RNase A was added to the first wash in 6XSSC/0.1% SDS 
(2.2.4.6). 
2.4 Protein methods. 
2.4.1 SDS-polyacylamide gel electrophoresis (SDS-PAGE). 
2.4.1.1 Preparation and running SDS-PAGE. 
Protein extracts were fractionated by SDS-PAGE using a discontinuous 
buffer system. Atto gel rigs (CR1 Instruments) 150mm x 150mm x 1mm 
and Mighty Small II rigs (Hoefer) 80mm x 70mm x 0.75mm were used. 
The gel mixes were prepared as shown in table 3. Large gels were cast with 
a 130mm resolving gel and a 20mm stacking gel while small gels were cast 
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with a 50mm resolving gel and a 10mm stacking gel. 
The resolving gel was poured and overlaid with a small volume of water- 
saturated butanol. The stacking gel was allowed to set for an hour before 
pouring off the butanol and washing the top with sdH20. The stacking gel 
was poured off and the comb positioned before leaving the stacking gel to 
set. The comb was removed and the wells rinsed with sdH20 before use. 
Table 3. SDS-PAGE resolving and stacking gel mixes (volumes sufficient 
for 2 large gels or 5 small gels, in ml). 
Component Resolving gel 
8% 	10% 
Stacking gel 
Acrylamide/ bis acrylamide 16 20 2.6 
(30:2.67) 
sdH20 28.7 24.7 12.3 
1.5M Tris-HC1 pH8.8 15 15 - 
0.5M Tris-HC1 pH6.8 - - 5 
20% SDS 0.3 0.3 - 
10% Ammonium persulphate 0.3 0.3 0.1 
TEMED 0.03 0.03 0.018 
Protein samples were added to an equal volume of 2x sample buffer 
(125mM Tris-HC1 pH6.8, 4%SDS, 20% glycerol and 10% 13-
mercaptoethanol, 0.25% bromophenol blue) and heated to 95-100°C for 3 
minutes. Gels were run in running buffer (25mM Tris, 192mM glycine, 
1% SDS) at 20mA/gel and approximately 100V. Small gels were run for 
approximately 40-60 minutes and large gels for 3.5 hours, usually until the 
blue dye reached the bottom of the gel. 
2.4.1.2 Protein molecular weight markers. 
Two types of protein markers were used; SDS-6H markers (Sigma) for gels 
which were stained with coomassie brilliant blue or, if the gels were to be 
western blotted, prestained broad range markers (New England Biolabs). 
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10tl of SDS-6H markers in a sample buffer (0.0625M Trizma-HC1 pH6.75, 
2% SDS, 5% 13-mercaptoethanol, 10% glycerol, 0.001% bromophenol blue) 
were loaded on a minigel rig, 20pi were used for the larger Attorigs. The 
range of markers included were; 205kDa, 116kDa, 97.4kDa, 66kDa, 45kDa 
and 29kDa. 
5pl of the prestained markers were added to 10p1 of sample buffer 
(187.5mM Tris-HC1 pH6.8, 50mM sodium chloride, 1mM EDTA, 1mM 
sodium azide, 125mM dithiothreitol) and heated at 95-100°C for 60 
seconds before loading on a minigel. For a larger gel the volumes were 
doubled. The range of markers included were; 175kDa, 85kDa, 62kDa, 
47.5kDa, 32.5kDa, 25kDa, 16.5kDa and 6.5kDa. 
2.4.1.3 Coomassie brilliant blue staining (fixing). 
In order to visualise the separated proteins a gel was submerged in 
coomassie fixing stain (0.25% w/v coomassie brilliant blue R-250 in water: 
methanol: glacial acetic acid, 5:5:1 v:v:v) for 30 minutes at 37°C. The 
coomassie fixing stain was poured off and replaced with destain (water: 
methanol: glacial acetic acid, 5:5:1 v:v:v). The destain was replaced every 
30 minutes until the background was clear. The gels were dried, under a 
vacuum, against Whatman 3MM blotting paper at 80°C. 
2.4.2 Glutathione-S-transferase (GST) expression and harvesting. 
pGEX1, containing the Schistosoma japonicum glutathione-S-transferase 
open reading frame, was transformed (2.2.6.3) into the E.coli strain BL21 
(DE3) pLysS and grown overnight at 37°C while shaking in 50ml of LB 
supplemented with 100p.gml 4 ampicillin. SOml of pGEX1 culture was 
added to 500m1 of LB supplemented with 100pgml 1 ampicillin and 
grown at 37°C while shaking for 1 hour. A imi sample was removed 
before induction with 0.5ml of 100mM IPTG (final concentration of 
0.1mM). The culture was shaken for a further 3 hours, at 37°C, before 
pelleting the culture by centrifugation (2000g. 10 minutes, 4°C). 
The bacterial pellet was resuspended in 5ml of ice-cold PBS. The 
resuspended culture was lysed, by sonication (5mm diameter probe) for 20 
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seconds on ice, until the suspension was coloured a dull grey-brown. 
0.5m1 of 10% Triton X-100 was added to the lysed culture and gently mixed 
by inversion. The culture was divided into 5 x lml aliquots and 
microcentrifuged (9500rpm) for 5 minutes to pellet the cell debris. The 
supernatant, containing the GST, was removed and stored in 0.5ml 
aliquots at -20C. 
2.4.3 Preabsorption of immune serum. 
2.4.3.1 Preparation of glutathione-sepharose beads. 
500mg of glutathione-sepharose beads were washed 4 times in 3.5m1 of 
ice-cold PBS to remove the lactose stabiliser. The beads were allowed to 
settle between washes rather than pelleting by centrifugation. Brief 
centrifugation (3500g. 2 minutes, 4°C) was, however, used after the final 
wash to ensure all the beads were pelleted. 
An equal volume (approximately 500p.l) of PBS was used to resuspend the 
beads, giving a 50% slurry. The slurry could be stored, at 4°C, for up to a 
week before use. 
2.4.3.2 Absorption of GST onto glutathione-sepharose beads. 
500i.1 of a 50% slurry of glutathione-sepharose beads will absorb up to 2mg 
of GST. The concentration of the GST in a sample was estimated on a 
coomassie stained 10% SDS-PAGE (2.4.1.3) by comparison of various 
volumes of GST supernatant (2.4.3.1) to known quantities of the 30kDa 
protein marker. 
The appropriate volume of GST supernatant was added to the bead slurry 
and incubated on ice, with frequent shaking, for 30 minutes. The GST-
slurry was microcentrifuged to pellet, the beads, and the supernatant 
removed. The beads were washed 4 times with 0.5m1 of ice cold PBS and 
microcentrifuged in between washes to pellet the beads. The beads were 
finally resuspended in 0.5m1 of ice cold PBS to give a 50% GST-bead 
slurry. 
Samples of beads, supernatant and washes were run on a 10% SDS-PAGE. 
This ensures that the beads contain GST, the supernatant still contains 
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GST (indicating the beads were saturated) and the washes eventually 
contain no GST (as all free GST was washed from the beads). 
2.4.3.3 Absorption of anti-GST antibodies from immune serum. 
5p.1 of final bleed antisera was added to lOOpi of 50% GST-bead slurry and 
incubated at room temperature while shaking gently for 30 minutes. The 
sample was microcentrifuged (9500g) for 5 minutes to completely pellet 
the GST-beads. The supernatant was carefully removed ensuring that no 
beads were removed. The anti-GST depleted antiserum (1:10 dilution) was 
then available for use. 
2.4.4 Preparation of total protein from P.falciparum. 
Approximately 10 9 parasites were cultured and released from erythrocytes 
by saponin lysis (2.2.1.1). The parasites were collected by centrifugation 
(2000g, 10 minutes, 4°C) and the pellet washed in 5 volumes of ice cold 
PBS to remove erythrocyte debris. The washed parasites were collected by 
centrifugation (3500g, 5 minutes, 4°C). The parasite pellet was lysed by the 
addition of an equal volume of sdH20 followed by an equal volume of 2x 
loading buffer (2.4.1.1). The lysed parasites were passed through a 25 guage 
needle to break up chromosomal DNA. The parasite preparation was 
stored until use at -70°C. 15xl of parasite preparation was heated at 95-
100°C for 3 to 5 minutes before loading on a polyacrylamide gel (2.4.1). 
2.4.5 Indirect immunofluorescence assay (IFA). 
Thin blood smears were prepared from culture with a parasitaemia of 
between 8-12%, dried overnight at room temperature and stored at -20°C 
in a bag with silica gel. 
Slides were fixed in acetone for 5 minutes and allowed to dry at room 
temperature then divided using nail varnish. On to each section, 40pi of 
the appropriate first antibodies diluted in PBS was added. The antibodies 
were incubated, in a moist chamber, for 1 hour. The antibodies were 
aspirated and the slide washed twice with PBS and once with sdH20 for 5 
minutes each. The slide was then left to dry completely at room 
temperature. 40p.l of a 1:80 dilution of rhodamine isothiocyanate 
conjugate of immunosorbant-purified anti-rabbit immunoglobin (RITC- 
anti IgG, Sigma) containing 5igml 1 DAPI in PBS was added to each grid. 
The slides were incubated, washed and dried as previously described for 
the first antibody. 
The slide was mounted in Citifluor (City University, London) and 
examined by fluorescence microscopy using a RITC filter set (Leitz). 
2.4.6 Western blot analysis. 
Western blot were done using the method of Towbin et al. (1979) using a 
Hybond-c membrane (Amersham). The SDS-PAGE gel was assembled 
into a sandwich in a blotting cassette; Scotchbrite pad, 3 sheets of blotting 
paper (cut to the size of the gel), the gel, hybond-C membrane (cut to the 
size of the filter and carefully placed on the gel), 3 sheets of blotting paper 
and a second Scotchbrite pad. The blotting cassette was submerged in a 
transfer chamber (Biorad) containing transfer buffer (25mM Iris, 150mM 
glycine, 20% methanol, 0.1% SDS). The gel was blotted at 40mA and 
approximately 100V for 4 hours. The filter was carefully removed from 
the sandwich and submerged in blocking solution (lxTS [150mM sodium 
chloride, 10mM Tris-HC1 pH7.41 and 5% fat-free milk powder) for 1 hour. 
The filter was allowed to dry completely overnight at room temperature. 
The filter was subsequently submerged in blocking solution containing 
the appropriate dilution of the first antibody while being gently shaken at 
room temperature for 2 hours. The filter was washed once with 1xTS, 
twice with 1xTS/0.05% NP-40 and once with lxTS for 5 minutes each 
while gently shaking. 
The filter was then submerged in blocking solution containing a 1:7500 
dilution of alkaline phosphatase conjugated to immunosorbant-purified 
anti-rabbit immunoglobin (AP-anti IgG, Promega). This was incubated at 
room temperature for 2 hours while gently shaking. The filter was then 
washed as described for the first antibody. 
5m1 of alkaline phosphatase buffer (100mM Tris-HC1 pH9.5, 100mM 
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sodium chloride, 5mM magnesium chloride) containing 33p.l of NBT 
(nitro-blue tetrazolium) and 16.5p1 BCIP (5-brom-4-chloro-3-indolyl 
phosphate) was added to the filter. The filter was shaken gently at room 
temperature while the signal developed, for a maximum of 5 minutes. 
When the signal had developed to a suitable extent the reaction was 
stopped by adding an excess of sdH20. The filters were then washed with 
sdH20 and left to dry on blotting paper. 
2.5 Parasite culture and transfection methods. 
2.5.1 Parasite culture. 
2.5.1.1 Parasite source. 
The Ki isolate of Plasmodium falciparum (Thiathong and Beale, 1981) 
was used during the course of this work. Stocks were either from samples 
stored at -70°C at ICMB or from the WHO Registry of Standard Strains of 
Malaria Parasites held at the Centre for Parasite Biology, University of 
Edinburgh. 
2.5.1.2 Human erythrocytes and serum. 
The erythrocytes and serum used in this work was obtained from the 
Edinburgh and Southeast Scotland Blood Transfusion Service. Fresh 
whole blood, group 0 Rh +ve and pooled serum was used in parasite 
culture. 
Whole blood was washed 3 times in 4 volumes of incomplete RPMI 1640 
medium (Gibco-BRL), to remove the citrate stabiliser, with centrifugation 
(1500g, 10 minutes, 4°C) between washes. The "buffy coat" of white blood 
cells was removed after each wash step. The erythrocyte pellet was 
resuspended in incomplete R2M11640 medium to give a 66% haematocrit. 
The washed blood was stored at 4°C for up to 2 weeks. 
Human serum packs were pooled, usually 6 to 10 packs, and centrifuged 
(2000g, 10 minutes, 4°C) to pellet any blood cells. The serum was removed 
and incubated at 56°C for 1 hour. 50m1 aliquots were stored at -20°C for 
up to 6 months. 
2.5.1.3 P.falciparum intraerythrocytic stage culture. 
This protocol was originally described by Trager and Jensen (1976) and 
Zoig et al. (1982) described a range of conditions which improved parasite 
yields. Cultures were maintained in 50ml of complete medium 
(RPMI1640 medium, 10% processed human serum, 50p.gml 1 gentamycin 
sulphate, 50jtgml4 hypoxanthine) at a 3-5% haematocrit. The average 
percentage parasitaemia, as determined using methanol fixed thin blood 
smears stained with 10% giemsa, was usually kept at 1-2%. Cultures were 
maintained at 37°C and gassed with 3%02, 2CO2 and 95% N2. 
When large numbers of parasites were required the average percentage 
parasitaemia would be allowed to increase up to 10%. To maintain a 
healthy culture the numbers of flasks were increased rather than increase 
the haematocrit within a small number of flasks. 
2.5.1.4 Synchronisation of intraerythrocytic stage cultures. 
Sorbitol treatment of intraerythrocytic stages of the parasite to obtain a 
synchronous culture of ring forms was made using a protocol adapted 
from that described by Lambros and Vandenberg (1979). 
A culture with an average percentage parasitaemia of 5% containing 
predominantly ring forms was used as the starting material. The culture 
was centrifuged (2000g, 10 minutes, 4°C) and the erythrocyte pellet 
resuspended in 5 volumes of sterile 5% sorbitol. The culture was 
incubated at room temperature for 5 minutes and the culture collected by 
centrifugation (2000g, 10 minutes, 4°C). The erythrocyte pellet was washed 
in 5 volumes of complete medium (2.4.1.3), collected by centrifugation 
(2000g, 10 minutes, 4°c) and resuspended in complete medium at a 5% 
haematocrit. The culture was gassed then incubated at 37°C. The culture 
was examined after 48 hours, and if necessary the protocol repeated to 
ensure tight synchrony. 
2.5.2 Transfection of intraerythrocytic stages. 
2.5.2.1 Electroporationof intraerythrocytic stage cultures. 
RN 
Electroporation of intraerythrocytic stage cultures was first described by 
Wu et al. (1995). This protocol has been adapted from her original 
method. 
Either synchronised or asynchronous cultures were used, which were 
typically at a 5% haematocrit and with an 8-12% parasitaemia. The culture 
was harvested by centrifugation (2000g, 10 minutes, 4°C) and washed in 5 
volumes of ice cold PBS. The culture was collected by centrifugation 
(2000g. 10 minutes, 4°C) and 200jii of pelleted blood resuspended in 800 jil 
of cytomix (van den Hoff et al. (1992) 120mM potassium chloride, 0.15mM 
calcium chloride, 2mM EGTA, 5mM magnesium chloride, 25mM HEPES, 
10mM potassium phosphate pH7.6.) containing 60pg of plasmid to be 
transfected. 
Electropóratioris were made using a Bio-Rad Gene Pulser with a pulse 
control unit. Conditions were typically set at 2.1kVcm, 20OL2 serial 
resistance and 25j.tF capacitance using 0.4cm cuvettes. These conditions 
gave time constants of 0.9 +1- 0.1 sec-1 . Immediately after electroporation 
samples were pipetted into 25m1 flasks containing lOmi of prewarmed 
complete medium (2.4.1.3). Samples were gassed (2.4.1.3) before 
incubation at 37°C. The medium was replaced after 24 hours. 
2.5.2.2 Lucif erase Assay. 
The commercially available Luciferase Assay System kit (Promega) was 
used. All solutions were supplied with the kit and the protocol was 
adapted from that described by Goonewardene et al. (1993). 
Luciferase assays were done 48 hours after the electroporation using the 
parasites from two flasks which had been electroporated with the same 
construct. The cultures from the flasks were pelleted by centrifugation 
(2000g, 10 minutes, 4°C) and the erythrocytes lysed in 5 volumes of 
1XSSC, 0.1% saponin (2.2.1.1). The released parasites were collected by 
centrifugation (2000g. 10 minutes, 4°C) and washed in 5 volumes of PBS 
before collection by centrifugation (2000g, 10 minutes, 4°C). The washed 
parasite pellet was resuspended in room temperature lysis buffer (25mM 
Tris-phosphate pH7.8, 2mM DTT, 2mM 1,2-diaminocyclohexane-N, N, N', 
N'-tetracetic acid, 10% glycerol, 1% Triton X-100). Where indicated the 
lysis buffer was supplemented with a 1/25 volume of protease inhibitor 
cocktail in 1XPBS (Complete TM, Boehringer Mannheim). The parasites 
were disrupted using 3 cycles of freezing on dry ice and thawing at 37°C 
before pelleting the cell debris by microcentrifugation for 1 minute. The 
lysate was quickly added to 100tl of luciferase assay reagent (20mM tricine, 
1.07mM (MgCO3)4Mg(OH)2.5H20, 2.67 magnesium sulphate, 0.1mM 
EDTA, 33.3mM DTT, 270j.tM coenzyme A, 470jiM luciferin, 530p.M ATP, 
pH7.8). The light produced by the samples was measured at 25°C using a 
Hamamatsu Argus-SO Image Processor (Hamamatsu Photonics K.K.) 
controlled by the Argus Photon Counter Programme v3.0. Sampling was 




Antisera raised against PfPCNA and PfDNA polymerase 6 (PfPolö) have 
been used against extracts from synchronised parasites to show that both 
proteins accumulate in trophozoites and persist in schizonts. The steady- 
state transcripts from both PfPCNA and PfPol6 accumulate in the 
trophozoite stage. In contrast to these results, nuclear run on analysis 
suggests that, whereas PfPolö promoter activity is absent in rings but 
present in trophozoites and schizonts, the PfPCNA promoter is active 
throughout the intraerythrocytic cycle. This suggests that mechanisms 
regulating the expression of these two genes must be different although 
their coordinated activity is required for DNA synthesis. 
The construction of the pGEX1/66 construct and raising of anti-PfPol6 
serum was done by Mandy Jackson supervised by Sandie Cheesman and 
John White. The anti-PfPol6 serum was raised by Jennifer Daub and John 
White. 
3.1 Introduction. 
Chromosomal DNA replication in Plasmodium takes place at 5 points 
during the parasite's life cycle (White and Kilbey, 1996). During the 
intraerythrocytic cycle of P.falciparum DNA synthesis was shown to start 
in mid-trophozoites and continue into the schizont stages. In 
P.falciparum there are up to four rounds of nuclear division which result 
in a schizont containing 16 nuclei (Tilney and Tilney, 1996). Cytokinesis 
divides the cytoplasm up between the 16 nuclei which then undergo 
merogony forming merozoites which are released when the erythrocyte 
bursts 
A number of genes encoding replication proteins of P.falciparum have 
now been isolated and characterised, including the two major DNA 
polymerases and PfPCNA (White et al., 1993, Ridley et al., 1991, Fox and 
Bzik, 1991, Kilbey et al., 1993). Little is known about the expression of 
these genes during the complex life cycle of this parasite, what work has 
been done has focussed on the cultured intraeythrocytic stages of 
development. Jaikaria et al. (1993) have shown that PfDNA polymerase a 
transcripts are absent in ring stage parasites but accumulate in 
trophozoites and schizonts. There is no evidence concerning the levels of 
the enzyme itself. Indirect immunofluorescence assays with antisera 
raised against PfPCNA show that the protein starts to accumulate in the 
mid-trophozoite stage and persists in schizonts, but there is no data 
available regarding stage specific transcript accumulation (Kilbey et al., 
1993). There is no reliable data on PfPol8 expression. Here we report a 
more complete picture of the regulation of PfPCNA and PfPolö which, by 
analogy to the SV40 system, are assumed to cooperate during DNA 
synthesis in the intraerythrocytic cycle. 
3.2 PfPCNA and PfPol8 expression is stage specific during the 
intraerythrocytic cycle. 
3.2.1 Initial screening of anti-PfPol6 serum. 
A 31 amino acid region from the murine DNA polymerase 5 sequence has 
been shown to be highly immunogenic (Cullman et al., 1993). The 
nucleotides encoding this region in the PfPol6 sequence were identified, 
amplified by PCR and expressed as a 58.5kDa GST fusion protein 
(pGEX1 /6). The antiserum obtained following immunisation with this 
fusion protein detected both the antigenic fusion protein and the 120kDa 
full length recombinant PfPolö after the GST moiety had been removed 
from the fusion protein using factor Xa (Figure 1). An expected band of 
120kDa was also detected when the anti-PfPol6 antiserum was used with 
parasite extract from an asynchronous culture (Figure 1). The pre-
immune serum failed to detect a band of this size from either western 
blot. 
3.2.2 Indirect immunofluorescence assays (IFA) with anti-DNA Polo 
serum were inconclusive. 
IFA (2.4.5) were made on thin film blood smears from an asynchronous 
culture at a parasitaemia of approximately 12%. The anti-PfPolö serum 
was used at dilutions of 1:80 and 1:200. The results of the analysis proved 
inconclusive as the intensity of the fluorescence from neither dilution of 
anti-PfPolö was significantly greater than that from a 1:80 dilution of the 
pre-bleed antiserum. 
As IFA with the anti-Pol6 serum was unable to give any indication of the 
stage specific nature of PfPolö expression it was decided to use western 
analysis with extracts from synchronised intraerythrocytic culture. 
3.2.3 Stage specific western analysis. 
Intraerythrocytic cultures were synchronised by sorbitol treatment 
(2.5.1.4), an initial treatment was followed 48 hours later by a second to 
ensure synchrony. The cultures were divided into 3 parts (each of 2X10 9 
parasites) and harvested 4h (rings), 20h (trophozoites) and 28h (schizonts) 
after the second sorbitol treatment (thin blood smears, stained with 
giemsa, were taken before each harvest to determine the degree of 
synchronisation). Equal amounts of each parasite extract (2.4.4) were size 
fractionated together with prestained size markers (Biolabs) on two 8% 
acrylamide gels by SDS-PAGE (2.4.1). The gels were then western blotted 
(2.4.6) to cellulose membranes. The membranes were probed with a 1:1000 
dilution of either anti-PfPCNA (Kilbey et al., 1993) or anti-PfPol serum 
(Figure 1). 
The results from the anti-PfPCNA serum agree with the data previously 
obtained by indirect immunofluorescence assays. A band of the predicted 
size, of approximately 30.5kDa, can be just detected in rings but protein 
levels increase dramatically in trophozoites and schizonts. The 120kDa 
band detected by the anti-PfPolö serum follows a similar pattern of 
accumulation to PfPCNA. 
The faint signals observed with both antisera in ring stage extracts are 
probably the result of trophozoite contamination of this stage (12%) or 
perhaps a low level of expression of both these proteins. 
Rob 
Figure 1. 
Analysis of the anti-PfPolb serum. Western blots of (A) total parasite 
extract with pre-bleed serum, (B) total parasite extract with anti-PfPolö 
serum and (C) recombinant PfPolb with anti-PfF'olb serum. 
Western analysis of parasite extract from synchronised intraerythrocytic 
stage cultures using (D) anti-PfPCNA serum and (E) anti-PfDNA PolO 
serum. The percentage of each stage (ring: trophozoite: schizont) in a 
sample were; R, rings (88:12:0), T, trophozoites (5:87:8) and S. schizonts 
(3:26:71). M, prestained markers (Biolabs) indicted in kDa. 
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3.3 PfPolb and PfPCNA transcripts accumulate in trophozoites. 
Intraerythrocytic cultures were synchronised by sorbitol treatment and 
harvested as described above. The synchrony of the harvested samples 
was checked on giemsa stained thin blood smears. 15p.g of total RNA 
from each major developmental stage was isolated (2.3.1) and size 
fractionated on a formaldehyde agarose gel together with RNA markers 
supplied by Gibco-BRL (2.3.2). The gel was blotted to Genescreen plus 
membrane and probed with gene specific probes (Figure2). 
The PfPCNA transcripts, sized at 1.85kb and 2.2kb, are apparently present 
in all stages but accumulate significantly in the trophozoite stage. 
Microscopic examination of the samples reveal a contamination of both 
the ring- and schizont stages by trophozoites, this is the result of the 
difficulty in achieving complete synchrony with large volumes of culture. 
The membrane was probed using a series of probes, specific to different 
stages of the intraerythrocytic cycle, to indicate whether the signals 
obtained from the PfPCNA probe in the ring and schizont samples were 
due to trophozoite contamination. The Actin I transcript, 2.5kb, 
accumulates only in the trophozoite and schizont samples (Wesseling et 
al., 1989). The 3.8 gene transcript, 3.8kb, accumulates in rings and 
trophozoites (Lanzer et al., 1992b). The GBP130 gene probe a 6.6kb 
transcript, which only accumulates in trophozoites (Lanzer et al., 1992b), is 
seen to follow the same pattern of accumulation as PfPCNA. Using a 
second northern blot where the trophozoite contamination of the ring 
sample was substantially reduced the PfPCNA signal was also 
proportionately reduced. The data suggest that the PfPCNA transcript 
accumulates mainly in the trophozoite stage, although low levels of 
transcripts may be present in rings and schizonts. The PIDNA Pol 
transcript of 5.2kb only accumulates in the trophozoite stage. 
Figure 2. 
Northern analysis of P.falciparum synchronised intraerythrocytic stage 
culture. The transcript detected, and its size in kb, are indicated. The 
percentage of each stage (ring: trophozoite: schizont), for A-D, sampled 
were: R, rings (79:20:1), T, trophozoites (5:81:14) and S, schizonts (4:12:84). 
The percentage of each stage (ring: trophozoite: schizont) for E and F: R, 
rings (87:13:0), T, trophozoites (6:85:9) and S, schizonts (0:28:72). 
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3.4 PfPCNA and PfPol8 promoter activity during the intraerythrocytic 
cycle differ. 
Intraerythrocytic cultures were synchronised as described in 3.2.3. The 
cultures were divided into 2, the first was harvested 6h (ring) and the 
second 24h (trophozoites and schizonts) after the second sorbitol 
treatment. Thin blood smears, stained with giemsa, were taken before 
each harvest to determine the degree of synchronisation. Nuclei 
harvested (5X10 9) from the cultures at either time point were allowed to 
continue transcription in the presence of radiolabelled UTP. The 
radiolabelled nascent RNAs were isolated and hybridised to a membrane 
on to which approximately ijig of single stranded PCR products of genes 
of interest had been immobilised. The PCR products were all 
approximately 1kb in size (Figure 3). 
The PfPol5 promoter did not appear to be active in the ring stages but 
activity was observed in the trophozoite and schizont nuclei preparation. 
In contrast the PfPCNA promoter appeared to be active throughout the 
intraerythrocytic cycle. Although equal amounts of nuclear RNA from 
the synchronised cultures were used in hybridisations, the experiment 
was repeated with a 1.2kb MSP-1 probe (P195) as an internal control. The 
promoter of the MSP-1 gene appears to be active throughout the 
intraerythrocytic cycle (Holder et al., 1985, Lanzer et al., 1992a). The results 
confirm that the PfPCNA promoter is active throughout the 
iritraerythrocytic cycle. 
1pg of P.falciparum genomic DNA had been immobilised to the 
membranes to demonstrate that the overall transcriptional activity of the 
latter stages of the intraerythrocytic cycle are greater than that of rings. 1.tg 




Nuclear run on analysis of P.falciparuin synchronised intraerythrocytic 
stage culture. (A) Initial comparison of P1PCNA and P1 DNA Polb. (B) 
Confirmation of PfPCNA with MSP-1 (P195). The percentage of each stage 
(ring: trophozoite: schizont) sampled were; R, rings (91:9:0), T/S, 
trophozoites! schizonts (2:62:34). pBS!! SKi-, pBluescriptll SK—. 









We have shown that PfPCNA and PfPol8 protein levels increase from 
very low levels in rings to high levels in trophozoites and schizonts. The 
transcript levels of both PfPCNA and PfPol6 show a similar increase as the 
parasite develops into a trophozoite, but these levels substantially 
decrease in the schizonts. In contrast to this, promoter activity for these 
two genes behaves differently. There is no detectable PfPol8 promoter 
activity in the ring sample but a dramatic increase is observed in the 
trophozoites/schizont sample. The promoter for PfPCNA, in contrast, 
remains active in both the ring and trophozoite/schizont samples. This 
suggests that although transcript and protein levels increase in parallel in 
preparation for DNA synthesis, the mechanism by which this is brought 
about is different for PfPCNA and PfPol& The parallel increase in 
transcript level and promoter activity for PfPol6 suggests that message 
levels are regulated at the level of transcription initiation, whereas 
PfPCNA transcript levels must be regulated post-transcriptionally. How 
the transcript is post-transcriptionally regulated will be examined further. 
One interesting observation from these studies is that the stage specific 
western data indicates that both the PfPCNA and PfPol6 protein are found 
at approximately the same level in trophozoites and schizonts even 
though the transcripts are probably only present in trophozoites. 
Presumably sufficient levels of polypeptide must be translated, while the 
transcripts are present in trophozoites, to complete schizogony. The 
mechanisms which regulate the supply of DNA replication proteins are 
probably distinct from those which control the initiation of DNA 
replication. How DNA synthesis is regulated during the individual 
rounds of replication during schizogony is yet to be investigated. In 
higher eukaryotes the levels of PCNA (Baserga, 1991), DNA polymerase S 
(Zeng et al., 1994) and DNA polymerase a (Wahl et al., 1988), in cells in a 
proliferative state, remain constant. The activity of DNA polymerase a 
(Nasheuer et al., 1991), and possibly DNA polymerase S (Zeng et al., 1994), 
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are regulated post-translatinally by phosphorylation. The investigation 
of DNA synthesis during schizogony in P.falciparum may reveal some 
form of post-translational regulation of the proteins required for DNA 
synthesis during the multiple rounds of DNA synthesis. However, 





The transcription start site of the PCNA gene from Plasmodium 
falciparum was mapped using a number of methods. These experiments 
indicated that there is a major start site approximately 960bp upstream of 
the ORF and a second, minor, transcription start site approximately 40bp 
further upstream. Sequence analysis revealed the presence of consensus 
transcription factor binding sequences. 
Comparison between the sequence at the 3' end of a cDNA clone with the 
genomic sequence identified a putative transcription stop site 
approximately 250bp downstream of the ORF. Northern analysis of the 
two PfPCNA transcripts indicates that the size difference may be due to 
differences in the sizes of the 3' UTRs. 
4.1 Introduction. 
Transcripts from P.falciparum are eukaryotic in nature; capping, intron-
splicing and polyadenylation all take place to some degree (Levitt, 1993). 
One striking feature of Plasmodium transcripts is their extremely long 5' 
untranslated regions (5'UTR). The transcription start sites mapped to date 
have an average 5'UTR of approximately 400 to 500bp (Table 1) compared 
to approximately lOObp for most eukaryotes. mRNA from the related 
apicomplexan,Toxoplasma gondii, also have long 5'UTRs (Nagel and 
Boothroyd, 1988, Roos, D., pers comm.). A role for the large 5'UTR has not 
yet been determined but suggestions include a role in the regulation of 
transcript stability, stage specific expression or even the targeting of the 
message. 
The enzymes responsible for transcription in eukaryotes are large 
multisubunit structures consisting typically of 2 large subunits with up to 
11 associated smaller subunits (Bzik, 1991). The large subunits for RNA 
polymerases I, II and III have been cloned and characterised for 
P.falciparum (Li et al., 1989, Li et al., 1991 and Fox et al., 1993) The 
P.falciparum RNA polymerases appear to have similar sensitivities to a- 
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amanitin (Lanzer et al., 1992a, 1992b) as other eukaryotic RNA 
polymerases which suggests that they may have the same transcriptional 
specificities. RNA polymerase I typically transcribes ribosomal RNAs, 
RNA polymerase III the transfer RNAs and small nuclear RNAs and 
RNA polymerase II the heterogeneous nuclear RNAs which are then 
processed to give messenger RNA. 
Genes transcribed by RNA polymerase II have regulatory sequences 
upstream from their transcription start site. The highly conserved TATA 
box (or Hogness box) is the binding site for the TFIID transcription factor. 
After recognition and binding to the TATA box by TFIID the RNA 
polymerase II complex is sequentially assembled. The TFIID homologue 
from P.falciparum, PfTBP, has been cloned and characterised (McAndrew 
et al., 1993). Although the primary sequence of PfTBP is divergent from 
that of other eukaryotes, the architecture of the protein is very similar. It 
is possible that these differences may help to facilitate recognition of a 
TATA box in the extremely AT-rich intergenic sequences found in 
Plasmodium genomic DNA. 
Other common transcription factor binding sites have been identified 
upstream of transcription start sites in Plasmodium including CAAT 
boxes, octomer immunoglobin factor (OCT1) and SP1 sequences (Table 1). 
Characterisation of the promoters from Plasmodium has not led to the 
identification of a common structure or of common transcription factor 
binding sites. Transcription start sites have been identified in a number of 
Plasmodium species, from genes encoding both house-keeping and 
antigenic proteins. To date it has only been possible to speculate on nature 
of putative transcription factor binding sites due to the lack of a 
functional assay. Only in the case of the SV40 element, found upstream of 
the KHARP gene (Lanzer et al., 1992a), has a protein actually been 
demonstrated to bind to the DNA. 
Transcription termination in Plasmodium takes place at a consensus 
sequence similar to that of mammals (Figure 1). Single transcription stop 
sites have been determined for P.falciparum actin I and II (Wesseling et 
al., 1989) and HSP90 (Su and Wellems, 1994), but multiple sites have been 
described downstream of the P.falciparum 3.8 gene (Lanzer et al., 1992b) 
and P.berghei circumsporozoite antigen gene (Ruvolo et al., 1993). Too 
few transcription stop sites have been characterised to speculate on 
whether transcription terminates at single or multiple sites, or both. The 
serine repeat antigen (SERA) of P.falciparum does not have a consensus 
polyadenylation site at the 3' end of the cDNA clone characterised (Fox 
and Bzik, 1994). 
AATAA ......... (N)o..23 ..... A ........ (N)6..54 ....... G+T rich Plasmodium 
AATAAA .... (N)10..30 .... A ........ (N)o..10 ....... G+T rich mammalian 
Figure 1. A comparison of the consensus sequences for putative 
polyadenylation signals of Plasmodium and mammalian transcription 
units (Lanzer et al., 1993). The suggested Plasmodium consensus 
polyadenylation signal is AATAA compared to that of AATAAA for 
mammals. In addition to these sequences Lanzer et al. suggest that long 
genomic stretches of poly d(A) and poly d(T) flank the consensus site in 
Plasmodium. A indicates the adenosine from which polyadenylation 
takes place. N indicates any nucleotide and the subscript figure indicates 
the number of nucleotides. 
Table 1. 
Comparison of the transcription start sites mapped in Plasmodium. The 
position of the transcription start site (relative to the A of the 
translational start site), the method(s) of mapping employed, any 
potential regulatory sequences identified and a reference are indicated in 
the table. 
5'RACE, rapid amplification of cDNA ends; RT-PCR, reverse 
transcription- PCR. 
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PlasmodiaumSpecies Gene product Transcription Start 
Site (TSS). 
Sequences around TSS. Methods of Experimental 
Determination. 
Reference. 
falciparum Heat Shock Protein Major at -655 CAAT box, TATA box, 
Primer extension Su and Wellems (1994) 
Family 90, HSP90 Minor at -659 SF1 binding site 
(pflzsp86) 
falciparum Serine Repeat Antigen Major at -146 and -234 None described 
Primer extension Fox and Bzik (1994) 
(SERA) Minor at -330 and -600 
falciparum Knob Associated Histidine Major at -849 Palindromic motif 
Primer extension Lanzer et al. (1992a) 
Rich Protein (KHARP) RNase protection 
falciparum Glycophorin Binding Major at -985 SV40 element 
Si nuclease protection Lanzer et al. (1992b) 
Protein (GBP130) Primer extension 
falciparum Calmodulin Major at -62 TATA box, CAAT box 
Primer extension Robson and Jennings (1991) 
falciparum Aldolase Site at -322 None described 
Primer extension Knapp et al. (1990) 
falciparum Merozoite Major Surface Several sites between TATA box, CAAT box 
Primer extension Myler (1989) 
Antigen -250 to -550 RNase protection 
knowlesi Circuntsporozoite Antigen App. 10 sites between Several TATA boxes, SV40 
51 nuclease protection Ruin i Altaba et al. (1987) 
(CS) -200 to -340 element, CACCCCTC boxes, 
Primer extension 
TGCATGCA boxes, OCT1 
binding site 
yoelii 230KDa Merozoite Antigen Major at -381 and -417 TATA boxes, OCTI binding 
Primer extension Lewis (1990) 
(Py230) Minor at -377 and -378 site 
and -402 
berghei Circumsporozoite Antigen Multiple sites between TATA boxes, CAAT box, 5' RACE 
Levitt et al., (1993) 
(CS) -246 to -343 TGCATGCA boxes, OCT1 
binding site  
4.2 Approximate mapping of the PfPCNA transcription start site. 
In view of the fact that the transcription start may be up to 1kb from the 
translational start site two methods, RT-PCR and transcriptional 
mapping, were employed to provide an approximate position. 
4.2.1 Reverse Transcription - Polymerase Chain Reaction (RT-PCR). 
First strand cDNA synthesis was primed from an antisense 
oligonucleotide (3661) designed to hybridise to total RNA at the start of 
the PfPCNA open reading frame (2.2.9.2). The cDNA synthesis is 
presumed to continue to the end of the template, the extreme 5' end of 
the PfPCNA transcript, where cDNA synthesis stops. All RNA was 
removed by - RNase digestion. The cDNA was then used as a template for 
PCR reactions between 366T and a series of sense-strand oligonucleotides 
located progressively further upstream of the translational start. An 
indication of the transcriptional start site is obtained by determining 
which sense-strand oligonucleotides give, and which do not give, a 
product. 
Genomic DNA (gDNA) contamination would give PCR products of the 
expected size with every oligonucleotide. To guard against gDNA 
contamination total RNA was treated with RNase free DNase before first 
stand cDNA synthesis. The total RNA was tested for contamination with 
gDNA by RT-PCR across the P.falciparum DNA polymerase a intron. 
Reverse transcription from oligonucleotide 973F (5' GAAGCATCTTCA 
CTCGT 3') was followed by a PCR reaction between 973F and 413E (5' TIT 
ATGGTTGTTTAGGA 3'). PCR using a gDNA template should give a 
product of approximately 940bp, whereas the cDNA template product 
should be 730bp. Both PCR products can be hybridised to with the internal 
oligonucleotide 456H (Figure 2, lanes 1-2). 
First strand cDNA synthesis from total RNA, tested as described above, 
was made from anti-sense oligonucleotide 366T (5' GCATTATTTAAT 
TTGGCC 3'). Subsequent PCR reactions were made between 3661 and 
G6589 (5' TTTGCAAAATGTTAGAATG 3'), 117V (5' GAATTACACATA 
AGTTATAC 3'), H0919 (5' ATTCCCACATATATTGTG 3'), and 9491 (5' 
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Figure 2. 
Schematic representation of the position of oligonucleotides, across the 
PfDNA polymerases a intron, used to check for gDNA contamination of 
total RNA. Both the cDNA and gDNA PCR products hybridise to the end-
labelled oligonucleotide 456H (5' AACIT1IGCGCATGCAT 3'). 
Schematic representation of the position of oligonucleotides used for 
the approximate mapping of the PfPCNA transcription start site. Both the 
cDNA and gDNA PCR products hybridise to the end-labelled 
oligonucleotide 543T (5' TGACAATrTrCTAATAGC 3'). 
Autoradiograph of the RT-PCR products hybridised to with the 
respective end-labeled oligonucleotide probe (see above). The sizes of the 
PCR products are indicated below, and on the figure, in bp. 
Lane 1. gDNA, DNA polymerase a control (940bp). 
Lane 2. cDNA, DNA polymerase a control (730bp). 
Lane 3. gDNA, 366T-G6589 (380bp). 
Lane 4. cDNA, 366T-G6589 (380bp). 
Lane 5. gDNA, 366T-117V (740bp). 
Lane 6. cDNA, 366T-117V (740bp). 
Lane 7. gDNA, 366T-H0919 (1060bp). 
Lane 8. cDNA, 366T-H0919 (1060bp). 
Lane 9. gDNA, 366T-949T (1440bp). 
Lane 10. cDNA, 366T-949T(1440bp). 
103 
RT-PCR control for gDNA contamination. 
ilOObp 
Pol a ORF 	 Pol a ORF 
Intron 	I 
- 
413E 	 456H 	 973F 
PfPCNA 5' flanking sequence. 
I 	'lOObp 
PCNA 5'UTR 
	 PCNA ORF 
949T 	H0919 	 117V 	G6589 543T 	366T 
AutoradiographS. 
1 2 	 3 4 5 6 7 8 9 10 
144O- 
940— MAI- 	IiL=Z"4 10 
38O- 
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CTATAGAGGAGCCAAAT 3') in turn (Figure 2). The results indicate that 
there may be a major transcription start site upstream of 117V but down 
stream of H0919, a region between 690 and 1000bp upstream of the ORF. A 
longer exposure of the autoradiograph shows a weak band in the H0919 
cDNA track (lane 8) that indicates that there may be a minor transcription 
start site upstream of 1000bp from the ORF. The absence of products from 
the PCR using cDNA as a template with 949T was expected. The 949T 
oligonucleotide binding site is too far upstream of the translational start 
for a transcriptional start site to be expected to be found upstream of this 
site. 
4.2.2 Transcriptional mapping of the PfPCNA locus. 
Using transcriptional mapping a second approach was available to 
approximately map the transcription start site. Nuclei from trophozoite 
parasites were isolated and allowed to continue transcription in a buffer 
containing radiolabelled UTP (see Nuclear Run On Analysis 2.3.1.7).. The 
radiolabelled nascent RNA was isolated from the nuclei (2.3.1.1) and used 
to probe a membrane to which were fixed PCR products derived from 
around the PCNA locus (Figure 3). The PCR products were checked on an 
ethidium bromide agarose gel to estimate the concentration of the DNA 
and approximately bOng of each was loaded onto an agarose gel and 
subsequently transferred to Genescreen Plus membrane (DuPont). The 
probed and washed membrane was exposed to a phosphoimager cassette 
before autoradiography at -70°C. 
The results from the phosphoimager were used to quantify the counts 
after an overnight exposure and is shown in Figure 3. The autoradiograph 
indicates that the transcription start site is located in the region 
represented by the product B. This region extends from 690bp to 1000bp 
upstream of the translational start and agrees with that identified by RT-
PCR (4.2.1). 
The intensity of the signals from the PCR products D to F decreases in 
intensity. This is probably due to the lack of incorporation of radiolabelled 
UTP during transcription through these regions in vitro. A subsequent 
check of the concentration of the DNA from product C on an ethidium 
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Figure 3. 
Schematic indicating the location of the PCR products used for the 
transcriptional mapping of the PCNA locus. The oligonucleotides used 
and the size of the PCR product are indicated. Bands A to C were 
amplified using clone p127.4 as a template, bands D to F used clone p120.2 
(Kilbey et al., 1993). The oligonucleotide sequences are; 
Uni (5' GTAAAACGACGGCCAGT 3'), 948T (5' CACAATATATGTGGG 
AAT 3'), H0919 (5' ATTCCCACATATATGTG 3'), 828T (GTATAACTT 
ATGTGTAATTC 3'), 117V (5' GAATTACACATAAGTTATAC 3'), 543T (5' 
TGACAATTTTCTAATAGC 3'), 534S (5' GTCTATTGAATTGGACTC 3'), 
322M (5' CATTTTGGGAGCTAAGAA 3'), 302S (5' ACAATCCITIGCCAT 
CAA 3'), H0666 (5' GAGGGTGAAAGGTGTTTT C 3') and H0665 (5' TGT 
ATGATGATTTATCACC 3'). 
Transciptional mapping autoradiograph. The membrane was also 
exposed overnight in a phosphoimager cassette and the counts indicated 
beside the appropriate band. pBluescriptll SK+ (pBSII) restricted with 
Hindlil was used as a negative control. 
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Figure 3A. PCNA locus 
PCNA ORF 
EcoRI 	 Hin dill 




Band. Oligonucleotides. App. Size (bp) 
A UNI 	948T 640 
B H0919 828T 380 
C 117V 	543T 500 
D 534S 332M 380 
E 302S 	H0666 400 
F 302S H0665 540 
Hindu! 
Hind!!! 




I 	I App. 200bp 
Ajjt'19.7 
B OmM 41.7 
C 	15.0 
D 1:  33.9 




bromide agarose gel indicated that the DNA concentration was 
approximately 1/3rd of that estimated which would account for the lower 
than expected intensity of this signal. 
The high background on the filter in the region where PCR product A is 
fixed may hide a signal from a weak transcription start site. The 
background is not high enough, however, to hide the signal from a major 
transcription start site 
4.3 Primer extension analysis. 
The results from RT-PCR and transcriptional mapping define a region 
which contains the transcription start site. Two, more precise, approaches 
were used, the first of which was primer extension analysis. End-labelled 
oligonucleotides were hybridised to total RNA which was shown to be 
free of gDNA contamination, and first strand cDNA synthesis performed. 
The extension products were separated on denaturing polyacrylamide gel 
with radiolabelled markers. 
Two oligonucleotides, 694T (5' GTGTAAAAATTTCTCTTC 3') and H0216 
(5' CTATGGAGAAAAAAACATATAATATATATATG 3'), were selected 
for primer extension (Figure 4A). The end-labelled oligonucleotides were 
hybridised to SRg  of P.falciparum total RNA and used as a primer for 
reverse transcription (2.3.3). 
The results of the primer extension are shown in Figure 4B. The products 
of primer extension from 694T indicate a single transcription start site at a 
position 960bp upstream from the ORE. The products from H0216 indicate 
a pair of transcription start sites, of apparently equal intensity, at sites 
approximately 970bp and 1005bp upstream of the ORE. Other faint bands 
present are probably signals from premature interruption of the reverse 
transcriptase on the AT-rich template. 
Controls were used to eliminate the possibility of aberrant signals (Figure 
4C). Primer extension from 694T using 5g of S.cerevisiae total RNA as 
template gave no signals indicating that oligonucleotide 694T did not 
cross-hybridise at random to RNA. A second control in which 694T was 
hybridised to 5jxg of P.falciparum total RNA but no reverse transcriptase 
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Figure 4. 
Schematic representing the relative positions of the oligonucleotides 
used for primer extension of PfPCNA. The triangles indicate the position 
of the transcriptional start site(s). The transcription start site identified by 
694T uses a hatched triangle, those identified using H0216 are identified by 
full triangles. 
B & C. Autoradiographs of the primer extension products; 
1. 	694T hybridised to P.falciparum total RNA. 
2. H0216 hybridised to P.falciparum total RNA. 
3. 	694T hybridised to S.cerevisiae total RNA. 
4. 
	
694T hybridised to P.falciparum total RNA without 
reverse transcriptase. 
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added again gave no signal indicating that the products observed were 
due to the action of reverse transcriptase. 
4.4 RNase protection analysis. 
Since reverse transcriptase can terminate prematurely on AT-rich 
templates, possibly accounting for the multiple transcription start sites 
reported (Table 1), RNase protection analysis was used to check the results 
of the primer extension analysis. 
A construct containing a 565bp fragment of the 5' flanking sequence, 
including the putative transcription start site, was cloned into 
pBluescriptll SK+. In vitro transcription from the T7 RNA polymerase 
promoter gave a radiolabelled antisense transcript which was hybridised 
to total RNA free of gDNA contamination. Single stranded RNA was 
digested using RNases, the protected RNA duplex products were isolated 
and fractionated on a denaturing polyacrylamide gel (Figure 5A-C). 
4.4.1 Construction of pRNase vector. 
Using gDNA as template for a PCR reaction, oligonucleotides 828T (5' 
GTATAACTTATGTGTAATTC 3') and PHi (5' GCTCTAGAGGGTGCT 
TTTAAAAGAATGG 3') were used to give a 565bp product. The product 
was cloned into the TA cloning kit vector (2.2.5.5) and sequenced to check 
for errors during amplification. 
The 565bp fragment was excised from the TA vector by restriction with 
XbaI and EcoRI and ligated into pBluescriptll SK+ vector (Stratagene) 
restricted with the same enzymes (Figure 5b). The pRNase construct 
junctions were checked by sequencing. Subsequent restriction and PCR 
analysis confirmed the correct orientation of the insert in the pRNase 
construct. 
4.4.2 Preparation of the riboprobe. 
The pRNase construct was linearised by restriction with XbaI and isolated 
IIIVA 
by gel electrophoresis (2.2.3.6). The linearised plasmid was used as a 
template for in vitro transcription (2.3.4.1) using the commercial T7 
Ampliscribe kit (Epicentre Technologies). The T7 Ampliscribe kit allows 
for the preparation of large quantities of RNA transcript of full length 
(approximately 630 bases) incorporating radiolabelled UTP. 
The products of in vitro transcription were fractionated on a denaturing 
polyacrylamide gel and full length transcripts isolated (2.3.4.2). 
4.4.3 Hybridisation of riboprobe to total RNA and RNase digestion. 
The full length riboprobe was used for RNase protection assays using the 
commercially available RPA IITM  kit (Ambion, Lanzer et al., 1992a). 
Protected fragments (Figure 5c) of approximately 270 bases and 310 bases 
were observed only when the hybridisation was treated with RNase Ti, a 
protocol recommended by the manufacturer when AT-rich genomic 
sequences are to be analysed. The major protected fragment, from 
digestion with a 1:100 dilution of the supplied RNase Ti, indicates a 
major transcription start site at 960bp upstream of the translational start. 
A second minor product, at 310 bases, indicates a transcription start site 
located approximately 1000bp upstream of the translational start (Figure 
5c). The same products were observed more clearly when a 1:250 dilution 
of RNase Ti was used. The other products in this lane are probably due to 
incomplete digestion of the riboprobe. 
Digestion with either a 1:100 or 1:250 dilution of RNase A/Ti completely 
digested the riboprobe, even when associated with the complementary 
PfPCNA transcript (Figure 5c). The riboprobe contains a large proportion 
of adenosine and uracil nucleosides which would lower the melting point 
of the RNA duplex, the essentially single stranded RNA is then available 
as a substrate for RNase A digestion. 
Control experiments using yeast RNA were used. Attempted 
hybridisation of the riboprobe to yeast RNA did not protect it from either 
RNase A/Ti or RNase Ti only. The riboprobe when mixed with yeast 
RNA, but not subjected to RNase digestion, is not degraded (Figure 5c). 
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Figure 5A. 
Schematic to describe the principle of RNase Protection. From the T7 RNA 
polymerase promoter, of a linearised plasmid containing the genomic sequence of 
interest, a radiolabelled transcript antisene to PCNA mRNA is produced 
(Riboprobe). The riboprobe extends past the putative transcription start site to give 
antisense RNA to which no complementary sequence is available in P.falciparum 
total RNA. 
After hybridisation the RNA-RNA duplex is treated with RNase which digest single 
stranded RNA. The protected radiolabelled fragment is separated on a denaturing 
polyacylamide gel with markers. 
Putative Transcription start site. 	 PCNA ORE 
XbaI 
XbaI. I 	 4 
I pRNase 	 117 RNA polymerase promoter. 
PfPCNA mRNA 
4 	 Riboprobe (aP32 UTP) 
Hybridise overnight 
- 	 - 
4 
Digest single stranded RNA 
with RNases. 
Polyacrylamide gel electrophoresis 
and exposure to film identifies the 
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Schematic of the pRNase construct (approximately 3.5kb). All positions 
are indicated in kb from the point 0 marked on the vector map. AmpR 
(ampicillin resistance gene). The PCNA flanking sequence orientation 
with respect to the ORF is indicated, note that transcription from the 
T7 promoter will give an antisense transcript. 
The multiple cloning site has been enlarged to indicate the relative 
positions of the T7 RNA polymerase promoter and relevant 
oligonucleotides (see text). Urn (5' GTA AAA CGA CGG CCA GT 3'), 
Rev (5' AAC AGC TAT GAC CAT C 3'). 
L's- 
Figure 5c. 
Autoradiograph of results of the RNase protection analysis. The position 
of the 270 bases and 310 bases products and the lOObp markers are 
indicated. 
riboprobe alone. 
riboprobe hybridised to S.cerevisiae total RNA. 
riboprobe hybridised to S.cerevisiae total RNA, digested 
with 1:100 dilution of RNase A/Ti. 
riboprobe hybridised to S.cerevisiae total RNA, digested 
with 1:100 dilution of RNase Ti. 
riboprobe hybridised to P.falciparum total RNA, digested 
with 1:100 dilution of RNase A/Ti. 
riboprobe hybridised to P.falciparum total RNA, digested 
with 1:250 dilution of RNase AM. 
riboprobe hybridised to P.falciparum total RNA, digested 
with 1:100 dilution of RNase Ti. 
riboprobe hybridised to P.falciparum total RNA, digested 
with 1:250 dilution of RNase Ti. 
Lanes 1-4 are the result of a 30 minute exposure to film and lanes 5-8 of a 2 
hour exposure to film. 
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4.5 Analysis of genomic sequence around putative transcription start sites. 
Analysis of sequences around the Plasmodium transcription start sites 
mapped to date revealed little homology (Table 1). A typical eukaryotic 
RNA polymerase II transcription start site, as characterised from work 
with the SV40 and yeast systems, has a TATA box around 25bp upstream 
with other sequences such as CCAAT boxes, GC boxes, AP1-AP5 boxes, 
then OCT1 and OCT2 boxes (Singer and Berg, 1991) upstream of this. 
Approximately 600bp of genomic sequence upstream of the PCNA 
putative transcription start site is available for analysis (Figure 6). 
Consensus TATA boxes have been identified approximately 35bp 
upstream of the major transcription start site (nt 590) and 35-40bp 
upstream of the minor transcription start site (nt 545). 
Two sites with good homology to OCT1 boxes (ATGCAAAT) have been 
identified. These oppositely orientated OCT1 boxes are approximately 
235bp and 275bp upstream of the major transcription start site. OCT1 is a 
90kDa protein that has been found in a variety of organisms and cell 
types. It is proposed to be a general enhancer of transcription required for 
the formation of a stable RNA polymerase complex. OCT1 boxes have 
been identified in a number of other Plasmodium promoters (Ruiz i 
Altaba et a!, 1987, Lewis, 1990, Levitt et al., 1993) 
No CCAAT boxes, typically found up to lOObp upstream of the 
transcription start site, were identified. A weak homology at nt526 
(CAAT) is present, approximately lOObp upstream of the transcription 
start site. The same sequence is found upstream of the P.knowlesi 
circumsporozoite antigen transcription site (Ruiz i Altaba et al, 1987). 
The AT content of the PfPCNA 5' flanking is in excess of 85% with large 
poly d(A), poly d(T) and poly d(AT) tracts. Analysis of the sequence has 
identified a number of "CC rich patches". These are sequences where 3 
guanosine or cytidine are clustered within 5 nucleotides (italiced on figure 
6). Interestingly these "GC rich patches" occur on or around the 
transcription start site or approximately 400-500bp upstream of the 
transcription start site. 
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Figure 6. 
Sequence of the 5' flanking DNA of the PCNA gene of P.falciparum. 
The start of the ORF (1581) is indicated by a bold enlarged ATG. The 
restriction sites Hindlil and EcoRI are overlined. Putative TATA boxes 
(nt550 and nt590) are in bold and enlarged. Oppositely orientated putative 
OCT1 boxes (nt350 and nt390) are over and underlined. "CC rich patches" 
(see above) positioned upstream and around the putative transcription 
start sites are italicised. 
The position of transcription start sites are indicated by large arrows; a, 
transcription start site mapped using primer extension (694T) and RNase 
protection, b, transcription start site mapped using RNase protection only, 
c, transcription start site mapped using primer extension (H0216) and & 
transcription start site mapped using primer extension (H0216). 
The position and orientation of oligonucleotides important in the 
mapping of the PCNA transcription start site are indicated by thin arrows 
under the sequence. 
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EcoRI 
1 GAATTCTTTA TTTTTACACA TATATATATA TATATATATA TATATAATAT 
51 ACATATCAAA TTGTTATGGT TTTTACTAGC CATTACAAAT ATGTATAAAT 
101 TTCTATATAT ATATATATAT ATATATATAA ACATACCGCA AATATTAGTT 
151 GCACTTTTTA TATATACAAA AACTATAGAG AGAGCCAA.AT AATAAAAAAA 
949T No- 
201 AAATTAATTA AATGATTTGA AATGGTTATA TATATTAAA.A CATTTTATAA 
251 GACAAAATTC ATAAGATATT AATAATTTTT ATATTTTATT TTCCTATTCA 
301 TTTTTAATAA TATATCATAT ATAAAAAGGG TGCTTTTAAA AGAATGGATT 
351 GAGATTCAAA TATAATATTA TAAATATATA AACATAATTA TATATGCATC 
401 - TTATATTAA.A AACTCATAGA ATAATATATA TAATAATATA TAGCTTAATT 
451 ATATATAATC TTTCTTAAAA AACAAACAAA CAAACAAACA AACAAACAAA 
501 AAAAAATTTT TTTTTTTATT AATTACAAAT AATTTATATA TATATATATA 
d 	 b 
551 ATATTCCCAC ATATATTGTG ATAATTCTTA TATGA CAA TATAAAAAAT 
H0919 	 c 	 a 
601 TGAAAAATAA AATAT TCT TT ATA ATGT GCATATATTA AAAATTAAAC 
651 ACCTAGGCAT ATATTACTCA TTATTTTATT CAAGATAGGA TAAAA1AAAA 
701 AAAAAAAAAA AAGAGAAAAG AGAATATTAA AATTATCATG ACC'rTTTATC 
751 ATTTTGATTT TTCTTCATCC TTATATTTTA TAAATAAAAT TAATATAATT 
801 CATAAAATAT TTAATATATT TATATATATA TTTTTTTTTT TCATATGCTA 
851 ATATAATAA.A CAATATATAT AATGAATTAC ACATAAGTTA TACATTAAGA 
117V 
901 AACATTTATA AATAAATATA TATATATATA TATATATATA TATATACATA 
951 TATATATTAT ATGTTTTTTT CTCCATAGTG TTAAAAAAAT AAACTAATAA 
H0216 
1001 ATATATATAT AATATTAATA TATATACAAT ATATATAATA TGCACATTAT 
1051 CATTTATATC TTTAAAAATA ACTTTTGAAG AGAAATTTTT ACACAATAGT 
- 	 694T 
1101 ATTTTTAAGG TATAAGTTTT TTTTTTTTTT TTTTTTCTCT TCTTTTCTAA 
I klo 
1151 CTAA.AAAGAA AAAAAATATT ACATATATAT ATTATCTAAA TATATGCATT 
1201 AAATTTTATG TAGTAATTTT TTTTATTTCT TTTTTTCGAA AATGTTATGA 
G6589 
1251 ATGAAAAAAA ATAAATAAGA ATACATAATA TTAA.AAATAG ATTGAATACT 
--Io- 
1301 TAAATATAAG AAAAAATATT AATAATAATA AAAATAATTA AAAATACTGC 
1351 TATTAGAAAA TTGTCAGCCA AAAAAAAAAA AAAAAAAAAA AAAAAAAAAA 
543T 
1401 AGAGAAAAAT ATACATTAAG ATATAAATAA ATAAAAACAT AAGTATTTAT 
1451 ATTTATATTC ATAATTTTTT ATTACACATA TAATAAAAAA TAAATAAATA 
1501 AAAATAAAAA ATAATATATA TATATATATA TATACAAATT TTATATAAAT 
Hindlil 	 - 	 - - - 
1551 AAGGAATTAT CATAAAAAGC TTAATTAAAA AATGTTAGAG GGCCAAATTA 
1601 AATAATGCAT CAATTTTAAA 
366T 
t2A 
4.6 Initial analysis of the 3' end of the PfPCNA transcription unit. 
An initial analysis of the Tend of the transcription unit was made by 
screening a plasmid cDNA library for PfPCNA clones. The cDNA library 
(constructed by P.Alano) was prepared by reverse transcription from an 
oligo d(T) primer with trophozoite total RNA template, linkering the 
products with a XhoI fragment and subcloning into the expression vector 
pJFE14. 
The library was used to transform the DH5a strain of E.coli and 
transformants were lifted on to nitrocellulose membranes (2.2.6.5). The 
filters were screened using a random radiolabelled HindIII-EcoRI DNA 
fragment containing 725bp of the PCNA ORF. Positive clones were 
purified and replated until individual clones were obtained. 
Three individual clones were identified and subsequently characterised by 
restriction and sequence analysis. The restriction analysis showed that 
each of the three clones contained a single Hind HI and EcoRI site. A single 
1350bp fragment was released from XhoI restriction of all the clones. 
Sequence analysis at both ends of the insertion from oligonucleotides 
hybridising to the multiple cloning site confirmed that all three clones are 
identical (Figure 7a). 
The sequence at the extreme 3' end of the cDNA clones was compared to 
sequence available from the genomic clone p120.2 (Kilbey et al., 1993). The 
sequences are identical until a polyadenosine tract is reached 
approximately 250bp past the stop codon of the ORF. The genomic clone 
has a tract of 12 adenosines and the cDNA clone a tract of 14 adenosines 
followed by a XhoI linker (Figure Th). The genomic clone sequence in this 
vicinity indicates that the sequence at the 3' end of the cDNA clone may 
correspond to a consensus Plasmodium transcription stop site (Lanzer et 
al., 1993). The genomic sequence contains the consensus AATAA 
sequence, several potential sites for polyadenylation and GT-rich 
sequences downstream of the AATAA site (Figure 7c). However, the 
precise point in the poly d(A) tract at which polyadenylation occurs 
cannot be identified from this analysis alone. 
Further screening of the cDNA library for other clones corresponding to 
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Figure 7a. Schematic representing position and size of PfPCNA 
cDNA clones isolated. 
PfPCNA genomic locus 
PfPCNA ORF 
PfPCNA cDNA clone. 
App. 500bp 
	 I 	 I 
Figure 7b. Comparison of the genomic and cDNA sequence at the 
extreme 3' end of the PfPCNA cDNA clone. The putative transcription 
stop site (Figure 1) is underlined. The cDNA linker is italicised with 
the XhoI site in bold. The distance in bp from the PfPCNA stop codon 
is indicated on the gDNA sequence. 
241 gDNA ttttgctctc attttgaatt ttctaataaa aaaaaaaaat 
cDNA ttttgctctc attttgaatt ttctaataaa aaaaaaaaaa 
281 gDNA ttttatatgt acacatatgt ataaaaacaa tatataacca 
cDNA aactttccag cacaattgga tctcgtg 
321 gDNA tattatatac tcatatataa tacttcctat aqqttaaaaa 
361 gDNA atttatgcTtg ataaatcatc 
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Figure 7c. 
PfPCNA ORF sequence is represented in capital letters and stops at nt 8-10 
(TAA). The putative transcription stop site (from nt255) is indicated in 
bold characters with potential polyadenylation sites underlined. Sequence 
analysis indicates a second consensus polyadenylation site starting at 
around nt120 (italicised). 
1 TAAAGATTAA tctcaataaa atattatata tatatatatg tacatatttt 
51 catatatata tttatcgtca tctatatatt gaccttacat attatataca 
101 tatatatata tatatgccaa ataagaaaat tatgagatct ttttaataac 
151 aaaatatttt aaacataaaa acaaaaaaaa tatgaaaaca cctttcaccc 
201 tcaaaatgaa aactgtcata taaatcaaac ttttgctctc attttgaatt 
251 t:t:ctaatDAa aaaaaaaaat ttttatatgt acactatgta taaaaacaat 
301 atataaccat attatatact catatata at agttcCtata ggttaaaaaa 
351 tttatggtga taaatcatca tacattataa aatataaaaa aatctatatc 
401 ccgaaaaaaa atgaatgtat ccatatttgt tcacacacac acatatttat 
451 atatatatat atatatatat atatatatat atttgttata attccacttt 
501 atttcaaagt taatacatat ttataaaatt tcaatttatt attttataat 
551 gtttttttta aatatctata tttagtagtt cttatatttg ataaaagaac 
601 acaacaaaat aatcgtcgta tatgaaaata aaaataaaaa atacgaatgt 
651 atctaaatat ttaacactct tagagaaaaa agaaacaaaa atataaacaa 
701 ttaacaaaca tgcaaatttt àaatgtgtat gaataaaact taaaaatgta 
751 gatgcttcta cttttatatg aatacacaca ggaatatata tatgtatata 
801 tata 
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other transcription stop sites yielded no new clones and although the 
genomic sequence was extended 500bp to approximately 800bp past the 
stop site of the ORF, analysis of the sequence revealed only one other 
potential transcription stop site approximately 120bp past the stop site 
(Figure 7c). 
4.7 Northern analysis of the 3' end of the PfPCNA transcript. 
The sizes of the PfPCNA transcripts were originally reported at 1.6kb and 
2.2kb (Kilbey et al., 1993). At the same time it was commented that the 
significance of two PCNA transcripts was unknown. Further northern 
analysis has revealed that the 1.6kb transcript is nearer 1.85kb in size and 
has confirmed the approximate size of the minor transcript. 
As described above, a pair of putative transcriptional start sites have been 
mapped between 960bp-1000bp upstream of the translational start, and a 
putative transcriptional stop site identified approximately 250bp 
downstream of the stop codon. These figures would predict a transcript of 
approximately 2035bp. If this transcript has a long polyadenylated tail it 
could represent the observed 2.2kb transcript. There does not appear to be 
a second transcription start site less than 960bp from the translational 
start. The RT-PCR analysis did not indicate whether regions in the 5'UTR 
were removed during processing, and the 5'UTR cDNA sequence 
available was colinear with gDNA sequence. All these results indicate that 
differences in the sizes of transcripts would be most likely the result of 
different sizes of the 3'UTRs. A second putative transcription stop site was 
identified approximately 120bp downstream of the translational stop site. 
The termination of transcription at this site would result in a transcript of 
1895bp, a possibility for the observed 1.85kb transcript, especially if the 
transcript is not polyadenylated. The cDNA library was screened several 
times but only the clones corresponding to what may be the longer 
transcript were isolated. Clones representing the shorter transcript 
derived from the potential transcription stop site are unlikely to have 
been lost from the library during amplification but may have been 
excluded if the transcript is not polyadenylated. 
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In order to assess whether other transcription stop sites exist 3' RACE 
(Froham et al., 1988) from an oligo d(T) to mRNA is generally used. This 
is very difficult in Plasmodium as extensive poly(A) tracts are common. 
In the case of the potential consensus stop site (120bp downstream of the 
PfPCNA ORF) a poly(A) tract exists immediately 3' of the site. Under these 
circumstances it would be difficult to decide whether a clone is amplified 
from a bone fide polyadenylated tail or from this fortuitous poly(A) tract. 
Ruvolo et al. (1993) circumvented a similar problem by tailing all the 
RNA with a poly (C) tail using polynucleotide phosphorylase (PNPase). 
Subsequent cDNA synthesis and PCR using a G-rich oligonucleotide can 
be used to amplify a region of interest including the poly(A) tail. 
Unfortunately PNPase is no longer commercially available and the 
method could not be tried here. 
We tried to investigate whether the difference in the transcript size was 
due to differently sized 3'UTRs using northern analysis. Two probes of 
approximately the same size were prepared: One from the region between 
the potential transcription stop site and the putative transcription stop 
site described (130bp, 3' probe) and the second from the PCNA ORF (140bp, 
ORF probe) to act, as a control (Figure 8). Two samples of 15jig of 
P.falciparum total RNA from an asynchronous culture were northern 
blotted (2.3.2) and each probed with one of the probes at 60°C using the 
same hybridising and washing conditions. The filters were exposed for 5 
days to film at -70°C against X-ray film (Figure 8). 
The film was scanned using a densitometer and the transmission values 
of the two transcripts compared. They were as follows; 
1.85kb transcript 	2.2kb transcript 
ORF probe 	1.96 	 0.45 
3' probe 	5.40 	 3.04 
The results show that although identical conditions were used to prepare 
the two probes, the specific activity of the 3' probe was greater than that of 
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Figure 8. 
Northern analysis of the two PfPCNA transcripts using probes derived 
from different parts of the PfPCNA locus. 
Schematic indicating the position of the ORF probe and 3' probe used 
in the northern analysis. The position of the potential (pot. T.S.S) and 
putative (put. T.S.S) transcription stop sites are indicated. The probes were 
randomly labelled PCR products using the following oligonucleotides 
with the cDNA clone as template; 534S (5' GTCTATTGAATTGGACTC 3'), 
PHil (5' GAATCAATTTCAATAAAAACGG 3'), G9210 (5' GCCAAA 
TAAGAAAATTATGAG 3') and PH10 (5' GAAAATFCAAAATGAGAGC 
3'). 
Northern blot using 15p.g of P.falciparum total RNA from an 
asynchronous culture hybridised to with the ORF probe. The position and 
transmission values of the major (M) 1.85kb and minor (m) 2.2kb 
transcripts are indicated. 
Northern blot using 15tg of P.falciparum total RNA from an 
asynchronous culture hybridised to with the 3' probe. The position and 
transmission values of the major (M) 1.85kb and minor (m) 2.2kb 
transcripts are indicated. 
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Schematic of PCNA locus 
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the ORE probe. The 2.2kb transcript should contain the hybridisation sites 
for both the ORE and 3' probe allowing the relative specific activities of 
the probes to be compared. The specific activity of the 3' probe is 6.75 times 
(3.04/0.45) greater than the ORF probe. When this is taken into account 
the data suggest that the 3' ORE probe hybridises to the 1.85kb transcript 
only about 40% ([5.4/6.75]! 1.96) as strongly as does the ORF probe. This 
might be the case if the 1.85kb transcript has a shorter 3'UTR than the 
2.2kb transcript and only hybridises to part of the 3' probe. 
4.8 Discussion. 
Combining the data from the mapping experiments we show that there 
appears to be a major transcription start site 960bp upstream of the 
translational start site. A second transcription start site may be present a 
further 40bp upstream. Using more than one method to map the 
transcription start site allowed us to counter potential errors that may 
arise when dealing with extremely AT-rich DNA. Where only one 
method is used to map a transcription start site multiple sites are 
generally reported (Table 1). 
Analysis of the sequence upstream of the PfPCNA transcription start sites 
has identified consensus transcription factor binding sites. TATA boxes 
and OCT1 boxes are sequences commonly found in other eukaryotic 
promoters for genes transcribed by RNA polymerase H. DNase I protection 
analysis is required to demonstrate that these sequences are actually 
protected by transcription factors binding to them. DNase I protection 
with extracts from nuclei isolated from the different major stages of the 
asexual cycle may give some indications of a stage specific transcription 
factor protection. This, however, may not occur in the case of PfPCNA as 
the promoter for this gene appears to be active throughout the asexual 
cycle (Chapter 3). 
Isolation of a cDNA clone and the subsequent comparison of the cDNA 
and gDNA sequences identified a consensus transcription stop site 
approximately 250bp downstream of the end of the ORE. Sequence 
analysis alone indicates that a second transcription stop site may be found 
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120bp downstream of the end of the ORE. 
Two PfPCNA transcripts of 1.85kb and 2.2kb have been identified, with 
the 1.85kb transcript predominating. Assignation of transcription start and 
stop sites for both these transcripts is difficult. The major transcription 
start site and the putative transcription stop site 250bp downstream of the 
PfPCNA ORF can be tentatively assigned to the larger, but minor, 
transcript of 2.2kb. However, it is not possible to assign a transcription 
stop site for the 1.85kb transcript. No cDNA clone has been cloned which 
use the potential transcription stop site 120bp downstream of the PfPCNA 
ORE. Although it is possible that amplification of the cDNA library has 
excluded clones which correspond to this potential site, this seems rather 
unlikely, it is also possible that the 1.85kb transcript is not polyadenylated. 
Transcripts lacking a polyadenylated tail can be translated by Plasmodium 
(Levitt, 1993) although in practice only a small group circumsporozoite 
- antigen transcripts of P.berghei have been demonstrated to lack a poly(A) 
tail (Ruvulo et al., 1993). The possibility that even these transcripts are 
precursor transcripts or the products of degradation was not fully 
investigated. 
Indications that there may be a transcription stop site before the 250bp site 
came from the finding that a probe that recognises the extreme 3' end of 
the cDNA clone hybridises less strongly to the 1.85bp transcript than to the 
2.2kb transcript. This would suggest that the probe has less overlap with 
sequences in the 1.85kb transcript than the 2.2kb transcript. To investigate 
this more completely further northern analysis, RNase protection and 
transient transfection analysis will be required. That PfPCNA is regulated 
at the post-transcriptional level and is apparently encoded by two 
transcripts, the prominent of which has no defined transcription stop site, 





An attempt was made to transiently transfect and express in Plasmodium 
falciparum a novel marker gene, the Green Fluorescent Protein (GFP). A 
vector containing the cDNA of the GFP gene from Aequoria victoria 
flanked by 5' and 3' PfPCNA non-coding sequences was constructed. 
Double pulse electroporation of intraerythrocytic stage culture was 
attempted using a wide range of experimental conditions. Although no 
heterologous expression of GFP was observed, experiments indicated that 
the plasmid DNA enters the parasite and appears to reach the nucleus. 
The electroporations and screening for GFP fluorescence was made with 
the assistance of Dr. Christian Doerig and Caroline Doerig. 
5.1 Introduction. 
A green light is produced at the fringe of the umbrella of the jellyfish 
A.victoria. The fluorescence is due to the action of two proteins, aequorin 
and GFP (Figure 1). Calcium activated aequorin produces a blue light in 
the absence of GFP, however, when GFP is present, the energy is 
transferred from aequorin to GFP by an unknown mechanism. The 
reason why two proteins are required for fluorescence is not understood 
although it has been suggested that efficiency of light transfer is greater 
through these two proteins. GFP will fluoresce green in the absence of 
aequorin if illuminated with a blue light. An absorption spectrum shows 
a maximum at around 395nm with a smaller peak at 490nm. Absorption 
at 395nm, however, leads to rapid photobleaching of the GFP but a stable 
fluorescence at 509nm can be obtained by excitation at 490nm (Inouye and 
Tsuji, 1994). 
The gene for GFP from A.victoria has been cloned (Prasher et al., 1992) 
and shown to encode a protein of 238 amino acids which is present as a 
monomer of 27kDa. The chromophore is contained completely within 
the coding sequence of the protein as a modified tripeptide. Cody et al. 
(1993) demonstrated that a ser-tyr-gly tripeptide is cyclised and oxidised to 
give rise to the para-hydroxybenzylidene-imidazolidonone chromophore 
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(Figure 2). 
The key to GFP's usefulness is that the protein can be heterologously 
expressed in a wide range of organisms, as diverse as Escherichia coli and 
Caenorhabditis elegans (Chalfie et al., 1994), and retain its fluorescent 
properties. The chromophore formation does not require any cofactors or 
exogenous substrates. This led to the conclusion that the chromophore is 
formed either by autocatalysis or as a by-product of a cellular pathway 
common to the organisms in which GFP has been expressed. Heim et al. 
(1994, 1995) report that chromophore formation in E.coli required oxygen 
and proceeded with a time constant of approximately 2 to 4 hours 
depending upon culture conditions. The time constant was unchanged 
when cell lysates were diluted implying that there were no requirements 
for enzymes-or cofactors and that the formation of the chromophore was 
more likely to be autocatalytic. 
After the initial demonstration that GFP could be used as an indicator of 
promoter activity in the nematode C.elegans, GFP has been used for the 
same purpose in a wide variety of other organisms including; Drosophila 
(Yeh et al., 1995), Potato Virus X (Baulcombe et al., 1995), Zebrafish (Peters 
et al., 1995), Xeno pus (Tannahill et al., 1995), mouse (Moss and Rosenthal, 
1994) and human (Rizzuto et al., 1995). GFP expression allows 
transformants to be identified and isolated by means of their fluorescence 
under UV light. More recently use has been made of GFP fused to 
proteins of interest to study their function in vivo. Previously, large 
quantities of relatively pure protein were conjugated to a fluorophore 
before being introduced into cells by some invasive technique such as 
reverse permeabilisation or microinjection. These techniques are not 
only difficult to control but the results from the disrupted cells may be 
suspect. GFP is a small protein and its fusion to another protein may not 
necessarily disrupt the function of the protein of interest nor the GFPs 
fluorescence. Wang and Hazelrigg (1994) demonstrated that fusion of GFP 
to either the N or C terminus of the Drosophila Exu protein did not affect 
the spatial and temporal pattern of GFP-Exu expression compared to the 
native Exu. Marshall et al.(1995) also showed that a GFP fusion to 
NMDAR1, a component of ion channels in human kidney cells, would 
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facilitate studies on NMDAR1 expression, localisation and processing. 
The function of the GFP-NMDAR1 protein did not alter the properties of 
the ion channel. 
GFPs have been found in several classes of Cnidaria (Prasher, 1995). The 
GFP of the sea pansy (Renilla reniformis) is thought to have a similar 
chromophore to that of A.victoria although it has a different absorption 
spectrum (Prasher, 1995). Heim et al. (1994) and Delagrave et al. (1995) 
both report altered emission and absorption spectra in mutated A.victoria 
GFP genes. These mutations include red shifted absorption spectra which 
are similar to that of the R.reniformis GFP, and mutants with increased 
fluorescence. Given a range of different Cnidaria GFPs, possibly with 
mutations introduced, a variety of GFP fusion proteins may be used 
within individual cells permitting gene expression cascades and the 
effects of drugs, toxins and hormones on protein expression and function 
to be more closely examined. 
134 
Figure 1. 
Schematic illustrating the mechanism of bioluminescence from the 
jellyfish Aquorea victoria. * indicates an activated form of 
coelenterazine. (a) is also described as the Blue Fluorescent Protein, in 
the absence of Green Fluorescent Protein a blue fluorescence at 
hV max470nm is observed. (b) is an unknown mechanism of energy 
transfer from the Blue Fluorescent Protein to the Green Fluorescent 
Protein. 
Aequorin (Apoprotein + Coelenterazine) 
Ca2 
Apoprotein + Coelenterazine * 
02 
Co2 
Apoprotein + Coelenteramide (a) 
j(b) 
Green Fluorescent Protein 
(hv .a max 508nm) 
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Figure 2. 
Illustration of the proposed biosynthetic formation of the GFP 
chromophore from A.victoria (Heim et al., 1994). 
Newly translated GFP (1) is either precipitated into inclusion bodies or 
remains soluble. cyclisation of the chromophore within soluble GFP 
takes place when the amino group of glycine 67 forms a Schiff base 
linkage onto the carbonyl group of serine 65 to form an imidazolidine-5-
one (2). The new N=C bond promotes dehydrogenaton of the adjacent 
carbon bond of the tyrosine 66 in the presence of oxygen. The autoxidation 
results in the formation of the parahyroxybenzylidene-imidazolidonone 
moiety which acts as a chromophore (3). 
Deprotonation gives the acidic forms (4 and 5) which are stabilised by 
resonance. As the chromophore can exist in a number of states it is 
thought that this is the reason why GFP absorbs light at 390, 470 and 
475nm. Excited phenols are more stable when acidic so emission is only 
thought to be from the deprotonated forms. 
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5.2 Construction of the GFP vector. 
Enough DNA sequences that flank the PfPCNA gene were placed on 
either side of the GFP gene so we could make the assumption that all the 
necessary 5' and 3' controlling elements for PfPCNA transcription were 
present. Initially 1.58kb of PfPCNA 5' flanking sequence was placed 
upstream of the GFP gene to give the pGFP1 construct, subsequently 1.5kb 
of 3' PfPCNA flanking sequence was added downstream of the GFP gene 
to give the pGFP2 construct. 
5.2.1 Construction of pFP1. 
The GFP open reading frame was amplified by PCR (2.2.9.1) from the 
plasmid pGFP10.1 (Chalfie et al., 1994, supplied by Douglas Prásher) which 
contains the cDNA of the GFP gene from A.victoria. The following 
oligonucleotide primers were used; GFP/F (5' CCCAAGCTTAATTAA 
AAAATGAGTAAAGGAGAAGAA 3') and GFP/R (5' CCCAAGCUGAA 
TTCTTATTTGTATAGTTCATCCAT 3') which introduce Hindill 
restriction endonuclease sites either side of the GFP gene (Figure 3a). The 
760bp DNA product was isolated, purified (2.2.3.6) and restricted (2.2.2) 
with HindilI. 
The PfPCNA gene was available as a pair of clones, p127.4 and p120 
(Figure 3b), from a genomic library (Kilbey et al., 1993). The PfPCNA 5' 
flanking sequence had subsequently been subcloned as an EcoRI/HindIII 
DNA fragment into pBluescript II SK+ (Stratagene) to give pPCNA15. 
pPCNA15 was restricted using HindIll and subsequently treated with 
phosphatase (2.2.5.1). The HindHI DNA fragment containing the GFP ORF 
was ligated (2.2.5.4) into the phosphatased HindHI restricted pPCNA15. 
The correct clone was selected by means of a PCR test. PCR between the 
oligonucleotides 117V (5' GAATTTCACATAAGTTATAC 3') and GFP/R 
give a product of a predicted size of approximately 1.4kb which would 
indicate that the GFP ORE had been placed in the correct orientation 
downstream of the PfPCNA 5' flanking sequence (Figure 3c). 
The HindIll junctions and the entire GFP ORF were sequenced (2.2.8). The 
only departure from the reported sequence of wild type GFP was that 
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Figure 3. 
Schematic representing the PCR amplification of the cDNA 
GFP gene from the pGFP10.1 plasmid. 
GFP/F /HindIII 
cDNA GFP gene 	
Ec ' 7 GFPIR 
Hindlil 
Schematic representing the PCNA genomic clones isolated by 
Kilbey et al. (1993) and the modified clones used to construct pGFP1 
andpGFP2. 
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PfPCNA 5' flanking 	Hindlil 	GFPORF 	 Hindu 
sequence 1.56kb  
117V
- 
- 	1.4kb PCR product. 
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pBluescript I! SK+ 2.9kb 
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described by Chalfie et al. (1994) where codon 80 of the GFP ORF is 
changed from CAG to CCC. The substitution of arginine for glutamine 
was known to have no detectable effect on the spectral properties of GFP 
and was known to be present in the pGFP10.1 plasmid template. Further 
confirmation of the construct was provided using a series of restrictions; 
HindIll, EcoRl and EcoRI/HindilI. All the DNA fragments of the expected 
sizes were obtained; 4.4kb and 780bp using Hindu, 2.9kb and 2.35kb using 
EcoRI and 2.9kb, 1.56kb and 760bp from EcoRI/HindIll ( Figure 3c). 
5.2.2 Construction of pGFP2. 
pGFP1 was partially restricted using EcoRI for 1, 3 and 5 minutes at both 
25°C and 37°C. DNA fragments of 4-4.5kb were isolated, purified (2.2.3.6) 
and phosphatase treated (2.2.5.1). 
A 1.5kb DNA fragment was isolated and purified from an EcoRI 
restriction of p120(11b). The 1.5kb DNA fragment, containing the extreme 
3' of the PfPCNA ORF and the following 1.4kb of 3' flanking sequence, 
was ligated into the isolated EcoRI restricted and phosphotased pGFP1. 
The correct clone (Figure 4) was isolated using a series of tests; 
An EcoRI restriction which resulted in DNA fragments of 2.9kb, 2.3kb 
and 1.5kb indicated that all the necessary DNA fragments were present in 
the clone. 
A KpnI/Hin dill restriction which resulted in DNA fragments of 4.4kb 
and 2.3kb indicated the PfPCNA 3' flanking sequence was inserted into 
the EcoRI site towards the 3' of the GFP ORF. 
A PCR between the oligonucleotides GFP/F and H0666 (5' GAGGGT 
GAAAGGTG'ITITC 3') which gave a product of 1kb indicated that the 
PfPCNA 3' flanking sequence was inserted in the correct orientation. 
The EcoRI junction between the PfPCNA 3' flanking sequence and the 
pGFP1 clone was sequenced. 
The pGFP2 plasmid was completely checked by restriction with a variety 
of restriction enzymes (2.2.2), southern blotted (2.2.4.2) and hybridised 
(2.2.4.3-4) to a series of end labelled oligonucleotides. The results of this 
analysis (Figure 5) indicate that the plasmid was correctly constructed. 
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Figure 4. 
Schematic representing the pGFP2 plasmid with endonuclease 
restriction sites and approximate oligonucleotide binding sites 
indicated. The position of the restriction sites are marked in kb from 
the arbitrary point 0 at the top of the plasmid map. 
Rev 	EcoRI 0.61 
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- - 	 PCNA 



















Results of the restriction endonuclease and southern analysis confirm the 
correct construction of pGFP2. The restricted pGFP2 DNA was separated 
by agarose gel electrophoresis, blotted and hybridised to using a range of 
end-labelled oligonucleotide probes. The position of the 2.02kb marker of 
7. HindIll /EcoRI markers is indicated by an arrow. The position of 1, 2 and 
3kb is indicated next to the autoradiographs. 
1. ? HindIIII /EcoR[ markers 
2. HindIll 
3. EcoRl 
4. HindHI /EcoRI 
5. NcoI 
6. NcoI /EcoRI 
Ethidium bromide stained agarose gel. 
Southern blot hybridised with the end-labelled oligonucleotide 543T (5' 
TGACAATTTTCTAATAGC 3') probe. 
Southern blot hybridised with the end-labelled oligonucleotide GFP/I 
(5' CTTATGGTGTTCAATGC 3') probe. 
Southern blot hybridised with the end-labelled oligonucleotide REV (5' 



















5.3 Establishing a transfection protocol for the GFP reporter gene. 
When this work commenced there was no established protocol for the 
electroporation of plasmid DNA into cultured P.falciparum. A series of 
experiments were required to establish the parameters for use in the 
electroporation experiments and the subsequent detection of the GFP 
luminescence. 
5.3.1 Effect of double pulse electroporation on P.falciparum survival. 
A set of parameters for the first and second pulse were supplied by the 
manufacturer of the electroporator (Flowgen Inc.). Using these conditions 
a series of electroporations on intraerythrocytic stage cultures were carried 
out. The parasitaemia of the culture before and 4 hours after the 
electroporation was measured by examination of giemsa stained thin 
smear slides in order to assess the effect of the pulse on parasite survival. 
The conditions suggested by the manufacturer to be initially assessed 
were; a first pulse 600V-1200V for 2.77msec at 25pF and 99, and a second 
pulse of 150V-300V for 150msec-2000msec, at 25p.F and 156. 
An intraerythrocytic stage culture was grown until the average 
parasitaemia reached 8-12% in a 5% haematocrit. 0.5ml of culture was 
microcentrifuged briefly and the supernatant removed. The erythrocyte 
pellet was resuspended in 0.5m1 incomplete medium (RPMI1640 
supplemented with 50gml4 gentamycin sulphate and hypoxanthine) 
and electroporated in a 1cm cuvette. This was immediately mixed with 
lml of complete medium prewarmed to 37°C. 0.1ml aliquots were made 
into a microtitre plate and incubated at 37°C in a gas chamber (3%02, 2% 
CO2. 95% N2). Samples were periodically removed and thin smear slides 
examined. 
A kill curve was produced and an arbitrary choice of a 50% kill was 
chosen to be the standard conditions for the experiments that followed. 
This was achieved by a first pulse of 700V for 2.77msec at 25j.tF and 99, 
and a second pulse of 150V for 234msec at 25xF and 156. These 
conditions appeared to consistently give a parasite survival of 50-55%. 
Although these determinations were made without plasmid DNA the 
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addition of plasmid DNA to the system was subsequently seen not to 
affect the parasite survival. 
5.3.2 Detection of GFP fluorescence. 
Chalfie et al.(1994) describe the detection of GFP fluorescence using a 
fluorescent microscope set up to detect fluorescein isothiocyanate (FITC) 
epifluorescence. To detect GFP fluorescence we used a Leitz Instruments 
microscope with a filter set for excitation at 450 - 490nm and emission at 
520nm which was illuminated using a mercury lamp. 
To establish that the microscope was able to detect GFP fluorescence E.coli 
were transformed with a TU#58 plasmid where GFP is under control of a 
T7 promoter (kindly made available by Douglas Prasher). TU#58 was 
transformed into the BL21 (DE3) pLysS strain of E.coli (2.2.6.3) 
Transformants were selected based on their ampicillin resistance (2.2.6.2) 
and grown overnight at 37°C in 5m1 of LB supplemented with ampicillin 
to a concentration of 100p.gml 4 (LB-amp). 2 samples of 200j.tl of the 
overnight culture were added to 5m1 of LB-amp, of which 1 contained an 
inducer of T7 polymerase expression (0.1mM IPTG), and were grown for 4 
hours at 37°C. 50jil of each culture was removed and placed on a slide 
under a coverslip and examined for GFP fluorescence, using the 
equipment described above. The GFP could only be observed in bacteria 
transformed with TU#58 and induced with IPTG (Figure 6). 
Any attempts to fix the E.coli culture with methanol or acetone abolished 
the GFP luminescence. Chalfie et al. (1994) also note that some fixing 
agents abolish GFP luminescence. Gluteraldehyde or formaldehyde were 
recommended as possible alternatives to fix slides. However, in all 
experiments with pGFP2 the intraerythrocytic stage cultures were not 
fixed to maximise the chances of detecting GFP fluorescence. 
The functionality of the GFP gene was tested by transforming pGFP2 into 
BL21 (DE3) pLysS, where, without an inducer, GFP fluorescence is 
detected (data not shown). This test was recommended by T.Wellems 
(pers comm.) who detected chloramphenicol acetyl transferase (CAT) 
activity in E.coli transformed with the CAT gene under the control of the 
P.falciparum HRP3 promoter. 
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Figure 6. 
Confirmation of the ability to detect GFP fluorescence. 0.1mM IPTG 
induced or non induced TU#58 transformed E.coli (BL21 [DE3] pLysS) 
were visualised at a bOX magnification (see above). 
IPTG induced E.coli visualised without the FITC filter set. 
IPTG induced E.coli visualised with the FITC filter set. 
Uninduced E.coli visualised without the FITC filter set. 
Uninduced E.coli visualised with the FITC filter set. 
Intraerythrocytic stages of P.falciparum transfected with the pGFP2 
construct 48 hours earlier. 
visualised without the FITC filter set. 











5.4 Transfection of P.falciparum with pGFP2. 
Using the standard conditions for double pulse electroporation and the 
protocol described above (5.3.1) an initial series of experiments was carried 
out with different amounts of plasmid DNA concentrations (0.1, 0.5, 1, 5, 
20, 50 and lOOp.g). Samples were taken at a number of time points after 
electroporation (4, 8, 16, 24, 36 and 48 hours) and examined for GFP 
luminescence. In the absence of information regarding the transfection 
efficiency, between 4X10 3 and 6X10 3  parasites, per time point, were 
examined at a 100X magnification. 
There was no clear evidence of GFP fluorescence, although some 
luminescence was observed. Using the fluorescein filter set, all 
fluorescence was green whether derived from GFP fluorescence, 
background autofluorescence from erythrocytes or parasites, or from 
debris. Possible cases of GFP fluorescence, characterised by a region of 
more intense fluorescence or fluorescence appearing to occupy all or part 
of an erythrocyte, were more carefully examined. In all cases the 
luminescence appeared to be associated with cell debris. 
The manufacturer of the electroporation equipment recommended a 
variety of pulse parameters which may need to be optimised for the 
introduction of plasmid DNA. These variations in experimental 
conditions and other changes in the protocol were made. 
Variation in the intensity of the pulses. Where the first pulse intensity 
was altered (500V-900V) a standard 150V second pulse was used. First 
pulses in excess of 900V were observed to be too high. Giemsa stained 
thin smears indicated not only a very low parasite survival rate but large 
numbers of lysed parasites. A standard first pulse of 700V was used while 
varying the second pulse intensity between 150V-300V. Variation of the 
second pulse did not appear to effect the parasite survival or erythrocyte 
viability. 
Increasing the length of the second pulse between 150msec-2000msec. 
This did not appear to effect the parasite survival or erythrocyte viability. 
Changing the cuvette size from a 1cm gap to a 0.4cm gap. This had the 
effect of increasing the intensity of the pulse as well as changing the 
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electric field within the cuvette. Using the same conditions for the two 
cuvette sizes it was observed that the parasite survival was much lower 
in the 0.4cm cuvette. 
Using parasite cultures synchronised for rings, trophozoites or 
schizonts. These experiments indicated that trophozoites or schizonts 
were less likely to survive electroporation than the ring stage. 
Increasing the frequency and overall time of parasite sampling. Time 
point samples were removed every 4 hours for the first 36 hours (except 
for an overnight time point) and every 8 hours until 76 hours. 
J) Increasing the number of fields observed. 
The modifications described above did not lead to the observation of GFP 
fluorescence, an example is shown in Figure 6. 
There are several possible reasons why GFP - fluorescence was not 
observed. These will be considered in more detail later, however, one 
obvious reason could be that the plasmid DNA does not reach the 
parasite, even though the changes in parameters a to c were made with 
this intention of minimising this problem. The parasite is protected by 
several plasma membranes (erythrocyte, parasitophorus vacuole and 
parasite membranes) through which the plasmid DNA must pass. A 
series of experiments was carried out to investigate how far the plasmid 
DNA did penetrate. 
5.5 Plasmid DNA penetrates to the parasite. 
5.5.1 Plasmid DNA passes through an uninfected erythrocyte plasma 
membrane on electroporation. 
Before examining the question of how many of the membrane barriers 
plasmid DNA may cross, we considered the first membrane barrier, that 
of the erythrocyte itself. We wanted to know if plasmid DNA when 
electroporated would pass through an erythrocyte membrane or whether 
electrostatic forces, for example, would attach the plasmid DNA to the 
membrane. Uninfected erythrocytes were used in these experiments as we 
were interested in the behaviour of plasmid DNA when confronted by a 
single plasma membrane. We recognise that the plasma membrane of an 
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infected erythrocyte is modified and that this may alter the ability of 
plasmid DNA to pass through. The conclusions from this work were used 
to plan experiments with infected erythrocytes. However, we 
acknowledge that infected erythrocyte membranes, or any of the other 
membranes, may behave differently. In the final analysis, the questions 
we asked here had less importance than was anticipated. 
Plasmid DNA doesn't adhere to the plasma membrane and can be 
easily removed by washing 
20g of plasmid DNA was added to 0.5m1 of erythrocytes at a 5% 
haematocrit and incubated for 10 minutes at room temperature. The 
erythrocytes were washed 4 times with 10 volumes of ice-cold PBS. They 
were then subjected to phenol-chloroform extraction (2.2.1.6) and the 
aqueous phase used in a PCR (2.9.1) using oligonucleotides from the GFP 
ORF. The aqueous extract was also southern blotted (2.2.4) and a 
radiolabelled HindIII-EcoRI DNA fragment of the GFP gene used as a 
probe. Both the PCR and southern blot failed to indicate (Figure 7, lanes 1) 
any evidence of plasmid DNA either attached to or in the erythrocyte. 
A second experiment with the same quantity of plasmid DNA and 
erythrocytes was prepared except that the mix was electroporated using 
the standard conditions described (5.3.1). The erythrocytes were again 
washed as described above to ensure that plasmid DNA surrounding the 
erythrocytes had been removed. The erythrocytes were then disrupted 
using a Potter homogeniser with a B type pestle. After 20 strokes the 
plasma membranes were isolated by centrifugation at 1000g for 20 
minutes at 4°C. The pelleted plasma membranes were washed to ensure 
that DNA from the cytoplasm had been removed. The washed plasma 
membrane was then phenol-chloroform extracted and the aqueous phase 
analysed by PCR and southern blotting as previously described. This 
analysis (Figure 7, lanes 2) showed that plasmid DNA did not remain 
attached to the plasma membrane after electroporation. 
50j.tg of plasmid DNA should be used in an electroporation to facilitate 
its subsequent detection. 
To demonstrate that the plasmid DNA is present within the cytoplasm of 
the erythrocyte and to have some indication of the optimal quantity of 
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plasmid DNA to use for transfection a series of electroporations with 
increasing amounts of plasmid DNA were carried out. The 
electroporations were made using 0, 1, 5, 20 and 50p.g of plasmid DNA 
with 0.5m1 of uninfected erythrocytes at a 5% haematocrit. The 
erythrocytes were washed and then subjected to phenol-chloroform 
extraction. The aqueous phase was subjected to PCR and southern 
analysis (Figure 7, lanes 3-7). The results of this analysis indicate that 
upwards of 50.tg of plasmid DNA should be used to facilitate the 
detection of transfected plasmid DNA. 
5.5.2 Electroporated plasmid DNA may enter the intracellular parasite. 
Since it was established that plasmid DNA can pass through the plasma 
membrane of uninfected erythrocytes a second series of electroporations - 
were used to establish whether the parasite contains plasmid DNA after 
electroporation. 
Three experiments were carried using both uninfected and infected 
erythrocytes. 0.5ml of erythrocytes at a 5% haematocrit were used in all 
experiments. An asynchronous culture at approximately 10% 
parasitaemia was used for the infected erythrocytes. After the experiment 
the erythrocytes were extracted with phenol-chloroform and the aqueous 
extract used for PCR and southern analysis (5.5.1). All results are shown 
in Figure 8. 
50tg of pGFP2 was added but not electroporated (lanes 1 and 4). 
no plasmid DNA was added but the erythrocytes were electroporated 
(lanes 2 and 5). 
50jig of pGFP2 was added and the erythrocytes were electroporated 
(lanes 3 and 6). 
Two samples of infected erythrocytes were subjected to conditions c. The 
parasites were subsequently isolated from one sample by saponin lysis 
(2.2.1.1). They were washed to ensure that plasmid DNA derived from the 
erythrocyte cytoplasm had been removed and an aqueous extract from a 
phenol-chloroform extraction was subjected to PCR and southern analysis 
(lanes 7). 
The results of this analysis show that only when plasmid DNA is added 
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Figure 7. 
Southern blot and PCR analysis of nucleic acids isolated from 
electroporated uninfected erythrocytes. DNA markers sizes are indicated 
in kb. 
PCR analysis results. 
Isolated nucleic acids were used in a PCR with oligonucleotides GFP/F and GFP/R 
(expected product of 760bp indicated by an arrow). The PCR products were separated by 
agarose gel electrophoresis, blotted, and the membrane hybridised to with an end-
labelled oligonucleotide GFP/I probe. 
a) Ethidium bromide stained agarose gel. 
b) Autoradiograph of the southern blot. 
M. x174 HaellI DNA markers 
20 p.g pGFP2 added but not electroporated. 
20 p.g pGFP2 added and electroporated, erythrocyte plasma 
membrane isolated. 
Ogg pGFP2 added and electroporated. 
lp.g pGFP2 added and electroporated. 
5p.g pGFP2 added and electroporated. 
209g pGFP2 added and electroporated. 
7.509g pGFP2 added and electroporated. 
Southern blotting analysis. 
The nucleic acids isolated were separated by agarose gel electrophoresis, blotted, and 
hybridised to with an end labelled oligonucleotide GFP/I probe. The position of the 2.02 
marker of ? HindIII/EcoRI is indicated by an arrow. 
c) Ethidium bromide stained agarose gel. 
d) Autoradiograph of the southern blot. 
M. ? Hindlil/EcoRl DNA markers. 
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PCR and southern blot analysis of the nucleic acids isolated from 
electroporated uninfected and infected erythrocytes. DNA marker sizes 
are indicated in kb. 
PCR analysis results. 
The isolated nucleic acid from each of the electroporations was used as a template 
in two PCRs (2.2.9.1). Oligonucleotides to the PfPCNA ORF; 533S (5' GGATTT 
AATTGTAACTCC 3') and 534S (5' GTCTATTGAATTGGACTC 3'), would give an 
expected product of 250bp (indicated by an arrow) which confirms the presence of 
P.falciparum gDNA. Oligonucleotides GFP/F and GFP/R (the expected PCR 
product of 760bp, indicated by an arrow) confirms the presence of pGFP2. The PCR 
products were separated by agarose gel electrophoresis, blotted and hybridised to 
an end-labelled oligonudeotide GFP/I probe. 
a) Ethidium bromide stained ãgarose gel of PfPCNA PCR. 
b) Ethidium bromide stained agarose gel of GFP PCR. 
c) Autoradiograph of the southern blot of GFP PCR. 
M. lOObp DNA markers. 
50.i.g pGFP2 added to uninfected erythrocytes but not 
electroporated. 
No pGFP2 added to uninfected erythrocytes and electroporated. 
50pg pGFP2 added to uninfected erythrocytes and electroporated. 
50jg pGFP2 added to infected erythrocytes but not electroporated. 
No pGFP2 added to infected erythrocytes and electroporated. 
50.tg pGFP2 added to infected erythrocytes and electroporated. 
50jig pGFP2 added to infected erythrocytes and electroporated, 
the parasites were subsequently isolated. 
Southern blotting analysis. 
The nucleic acids isolated were separated by agarose gel electrophoresis, blotted 
and hybridised to with an end-labelled oligonucleotide GFPII probe. The position 
of the 2.02kb marker of is ? Hindffl /EcoRJ indicated by an arrow. 
d) Ethidium bromide stained agarose gel. 
e) Autoradiograph of the southern blot. 
M. ? Hindffl /EcoRI DNA markers. 
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and electroporated can plasmid DNA be subsequently detected at least 
within the erythrocyte cytoplasm. The isolated parasite also contains 
plasmid DNA indicating that plasmid DNA must at least reach the 
surface of the parasite. 
5.5.3 Micrococcal nuclease treatment of isolated parasite nuclei indicates 
that plasmid DNA penetrates into the parasite. 
Micrococcal nuclease can enter intact nuclei and digest DNA not protected 
by its association with nucleosomes. Chromosomal DNA is wrapped 
around a succession of nucleosomes so that when digested incompletely 
by micrococcal nuclease a characteristic ladder pattern can be identified. 
Cary et al. (1994) showed that the chromosomal DNA of the asexual stage 
of P.falciparum is associated with nucleosomes using this method. Using 
micrococcal nuclease on nuclei isolated from electroporated parasites we 
asked whether the plasmid DNA was present in the nucleus, and if so, 
was it associated with nucleosomes? 
50xg of pGFP2 was electroporated in to 5 samples of 0.5m1 of infected 
erythrocytes (5% haematocrit) at approximately 10% parasitaemia. The 
cultures were incubated for 6 hours at 37°C to allow any nucleosomes to 
associate with the plasmid DNA (Mertz, 1982). The parasite nuclei were 
isolated and the nuclei treated with micrococcal nuclease (2.2.10) for 
either 0, 1, 2, 5 and 15 minutes. The isolated DNA was separated by 
agarose gel electrophoresis, blotted and probed using a random-labelled 
HindIII/EcoRl DNA fragment containing the GFP ORF (Figure 9). The 
ethidium bromide stained agarose gel shows a faint pattern characteristic 
of nucleosome bound chromosomal DNA. The southern blot analysis 
shows that, although the plasmid DNA must, at least, reach the surface of 
the parasite's nucleus after electroporation, there is no evidence that it 
enters to become associated with nucleosomes. 
5.6 Single pulse electroporation. 
During the course of this work a protocol describing the introduction of 
plasmid DNA into the asexual stages of P.falciparum was described by Wu 
et al. (1995). The introduction of a chioramphenicol acetyl transferase 
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Figure 9. 
Results of the micrococcal nuclease treatment of nuclei isolated from 
pGFP2 transfected infected erythrocytes. The isolated nuclei from infected 
erythrocytes electroporated with 50p.g of pGFP2 were treated with 
micrococcal nuclease for 0, 1, 2, 5 and 15 minutes. The isolated DNA was 
separated by agarose gel electrophoresis, blotted and hybridised to with a 
random-labelled EcoRl/Hindlil DNA fragment containing the GFP ORF. 
The position of the 2.02kb marker (A. Hindill/EcoRl) and the 1.35kb 
marker (x174 Haeffl) are indicated by arrows. 
Ethidium bromide stained agarose gel. 
Autoradiograph of the southern blot. 
M. A. Hindill/Ecoki DNA markers. 
0 minutes of micrococcal nuclease digestion. 
1 minute of micrococcal nuclease digestion. 
2 minutes of micrococcal nuclease digestion. 
5 minutes of micrococcal nuclease digestion. 
15 minutes of micrococcal nuclease digestion. 
m. x174 HaeIll DNA markers. 
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reporter gene was made using a single pulse electroporator. Using an 
adaptation of her original protocol (2.4.2) 60j.tg of pGFP2 was 
electroporated into approximately 2X10 8 parasites. The electroporated 
parasites were harvested at 24h and 48h after electroporation and 
examined for GFP fluorescence, no GFP fluorescence was observed. 
5.7 Discussion. 
The possibility that the failure to observe GFP fluorescence resulted from 
a failure of the plasmid DNA to penetrate the parasite has been examined. 
These experiments show that, after electrop oration, plasmid DNA 
penetrates at least to the parasite cytoplasm. Other work in this thesis and 
work carried out elsewhere (Wu et a!, 1995, 1996) cohfirms that the 
introduction of plasmid DNA into intraerythrocytic stage cultures can be 
reliably carried out and failure to detect GFP fluorescence here seems 
unlikely to be the consequence of failure of transfection. 
The functional integrity of the construct was tested by demonstrating that, 
even without an E.coli promoter, sufficient expression of GFP occurs in 
E.coli for activity to be detected. A similar observation has been made by 
T. Wellems (peTs comm.) using a construct with a CAT reporter gene. 
This expression could be due to "leaky" expression of T7 RNA 
polymerase in the BL21 (DE3) pLysS strain or a cryptic bacterial promoter 
in either the PfPCNA 5' flanking sequence or plasmid backbone. 
No attempt was made to ascertain whether the GFP polypeptide or 
transcript were being produced in the transfected parasites. Techniques to 
detect transcripts, such as northern analysis or RT-PCR, would be 
hampered by the small quantities of transfected culture, and the large 
quantities of plasmid DNA that would contaminate the RT-PCR. GFP has 
not been detected, using commercially available anti-GFP antibodies, 
from P.falciparum transfected with a GFP construct known to be capable 
of expressing a reporter gene (Goodyeri, I and Taraschi, T., pers comm.). 
The 5' flanking DNA from PfPCNA used in the construct has been shown 
elsewhere in this thesis to be sufficient for promoter activity. The level of 
activity of Plasmodium promoters in intraerythroctyic stage cultures 
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appears to be up to 1000 fold less than their activity in zygotes and 
ookinetes (Wirth, D., pers comm.). It is possible that the levels of GFP 
expressed are so low that they are undetectable using the fluorescence 
microscope. 
The regulation of expression of a protein may be brought about by 
variation in the stability, and therefore the turnover rates, of either the 
transcripts or polypeptides, or even both. To date neither issue appears to 
have been properly addressed for GFP. Since the PfPCNA 5' sequence 
flanking GFP has been subsequently successfully utilised to transiently 
express firefly luciferase (Chapter 6) it seems unlikely that a failure to 
detect GFP luminescence in transfected parasites is the result of transcript 
instability brought about by a signal in this region. It is possible, however, 
that there may be elements within either the GFP ORF or the PfPCNA 3' 
flanking sequence which are responsible for degradation. 
Codon usage bias have been proposed as a reason for the low levels of 
expression of Plasmodium genes in heterologous systems. The reverse 
may also be true; heterologous genes may be difficult to express in 
Plasmodium. A comparison of the codon usage in Plasmodium (Saul and 
Battistutta, 1988) to that of the OREs of firefly luciferase (X65325) and GFP 
(M62653) was made. This comparison revealed that there were regions in 
both ORFs where several rare codons are clustered close together. 
However, there appeared to be more of them in the luciferase ORF. 
Although a case for codon usage problem could not be made based on this 
quick visual comparison, it would only require a single "problem" codon 
in the GFP ORE to prevent expression. 
Molecular oxygen is required for the formation of the GFP chromophore 
(Hiem et al., 1994). The position regarding the oxygen tension in 
Plasmodium is the subject of debate as it is uncertain whether the parasite 
is a facultative anaeobe or a microaerophile. The asexual culture 
conditions originally described by Trager and Jensen (1979) establish a low 
02 concentration (3%) for optimal growth, with levels as low as 0.5% 
being tolerated. Parasites survive sequestration in sites of low oxygen 
tension (eg. post capillary venuoles) surrounded by large quantities of 
haemoglobin. Attempts to force up the molecular oxygen level, by 
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increasing the 02 concentration in culture, does not facilitate GFP 
luminescence (Goodyeri, I. and Tarasche, T., pers comm.). The possibility 
that low oxygen tension within the parasite is responsible for the lack of 
GFP luminescence remains, at present, unresolved. As it was, work with 






The intraerythrocytic stages of P.falcipa rum were transiently transfected 
with constructs containing a firefly luciferase reporter gene under the 
transcriptional control of variously modified elements of the PfPCNA 5' 
flanking sequence to test for transient promoter activity. This analysis 
identified an essential region for promoter activity which contains the 
physically mapped transcription start sites. In addition, a region between 
290bp-620bp upstream of the major transcription start site, containing a 
number of short GC-rich sequences, is required for efficient promoter 
activity. 
6.1 Introduction. 
The introduction of novel DNA into the genome facilitates an in depth 
analysis of gene function and expression. Over recent years several 
attempts to develop a transfection system for Plasmodium have failed. To 
ensure that enough flanking sequences are available to flank a reporter 
gene long tracts of AT-rich DNA have to be used which make the plasmid 
unstable in Escherichia coli. Extracellular Plasmodium parasites are not 
readily available in the large quantities required for transfecfion. The only 
stages of P.falciparum that can be cultured in reasonable volumes are 
protected by multiple membrane barriers within an erythrocyte. Attempts 
to introduce plasmid DNA into Plasmodium have included the use of the 
biolistic gun, lipofectin and the electroporator (Hyde, 1996, Roberts, 1994). 
The first successful report of the transfection of Plasmodium was made 
when a firefly luciferase reporter gene was introduced into the gametes 
and zygotes of P.gallinaceum by electroporation (Goonewardene et al., 
1993). The luciferase open reading frame was inserted into the sexual stage 
specific pgs28 gene flanked by 2.5kb of endogenous DNA. Ookinetes 
harvested 24 hours later contained readily detectable levels of luciferase. 
The introduction of plasmid DNA into P.falciparum was first described by 
Wu et al. (1995). Plasmid DNA, containing the chloramphenicol acetyl 
transferase (CAT) reporter gene, was introduced by electroporation into 
163 
the intraerythrocytic stages. In these experiments the expression of the 
CAT reporter gene was under the control of either a HRP3 or hsp86 5' 
flanking sequence and HRP2 3' flanking sequence. The firefly luciferase 
reporter gene has also been succesfully expressed in P.falciparum 
intrerythrocytic stages under the control of the HRP3 5' flanking sequence 
(Wu et al., 1995). 
Stable transfection of Plasmodium was achieved using a mutant 
dihydrofolate reductase-thymidylate synthase gene (dhfr-ts) which confers 
resistance to the drug, pyrimethamine (van Dijk et al., 1995, 1996, Wu et 
al., 1996, Crabb and Cowman, 1996). The first report of stable transfection 
of Plasmodium was made when a dhfr-ts gene under the control of 3.5kb 
of endogenous flanking DNA was electroporated into P.berghei 
merozoites (van Dijk et al, 1995). It was subsequently shown that 
resistance to pyrimethamine, in cloned intraerythrocytic stage parasites, 
was due to up to 15 copies of the episomally maintained plasmid. When 
2.2kb of a 2.3kb sub-telomeric repeat was added to the transfection 
construct the plasmid integrates within the sub-telomeric region and is 
stably maintained for at least 70 generations (van Dijk et al., 1996). 
Using mutant dhfr-ts genes from both P.falciparum and Toxoplasma 
gondii, under the control of 5' flanking sequences from both P.falciparum 
and P.chabaudi genes, stable transformations of P.falciparum 
intraerythrocytic stages have been made (Wu et al., 1996, Crabb and 
Cowman, 1996). Analysis indicates that the plasmids are initially 
maintained episomally, but after several months of drug selection the 
plasmid DNA integrates into the genome. Integration appears to be site 
specific and requires as little as 600bp of homologous sequence (Wu et al., 
1996). 
Analysis of gene expression in Plasmodium is already underway. Wu et 
al. (1995) demonstrated that the deletion of a 560bp region most proximal 
to the ORE of the HRP3 5' flanking sequence , decreased but did not abolish 
the promoter activity. Crabb and Cowman (1996) using a series of 
deletions have identified enhancer regions in the 5' flanking sequences of 
the P.falciparum dhfr-ts and calmodulin genes and the P.chabaudi dhfr-ts 
gene. Analysis of the 5' flanking sequences of the pgs28 gene of 
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P.gallinaceum has identified a region of approximately 250bp which is 
essential for promoter activity (Wirth, D. pers comm.). Deletion of 
sequences upstream of this essential region appears to disrupt the stage 
specific expression of the pgs28 gene. This data lends credence to the idea 
that Plasmodium promoters consist of a core promoter proximal to the 
transcription start site with stage- and sexual- specific elements further 
upstream (Wirth, 1995). 
Here we report the analysis of the PfPCNA 5' flanking sequence using the 
firefly luciferase reporter gene. Firefly (Photinus pyralis) luciferase is a 
61kDa monomeric protein that does not require any post-translational 
modification for enzymatic activity (de Wet et al., 1985, Wood et al., 1984). 
The relatively short half life of luciferase and the ease of detection of the 
protein's activity makes it a useful indicator of promoter activity. 
6.2 Construction of vectors used in transient transfection analysis. 
The firefly luciferase (luc) open reading frame was supplied in the 
construct, pHLH1 (Figure la), originally described by Wu et al. (1995). The 
reporter gene's expression is under the control of HRP3 5' flanking 
sequence and HRP2 3' flanking sequence. In the construction of the 
various vectors used for transient transfection analysis the luc gene and 
HRP2 3' flanking sequence were unmodified. 
All constructs were checked by restriction and southern analysis. A 
complete set of autoradiographs are presented for pPLH1. However, for 
the remaining constructs, except for the example of pPLH1B, the 
autoradiographs have been omitted with only the photograph of the 
restricted DNA presented. 
6.2.1 Replacement of pHLH1 HRP3 5' flanking sequence with PfPCNA 5' 
flanking sequence to give pPLH1. 
PCR with the primers 5'-CCCGGTACCGAATTCTTTATTTTTACAC-3' (L) 
and 5'-CCCCCATGCATTTTTTAATTAAGCTTTTTATG-3' (N7687, R) was 
used to amplify the 1.58kbp PfPCNA flanking sequence from the plasmid 
127-4 (Kilbey et al., 1993). The PCR product contained 2 further NsiI 
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restriction sites to that introduced by oligonucleotide N7687. The PCR 
product was initially restricted with KpnI for 1 hour in "l-phor-all" buffer 
(2.2.2) then restricted with NsiI for 1, 3 and 5 minutes. The products of the 
restriction were fractionated using agarose gel electrophoresis and 
products of approximately 1.58kb purified by electroelution (2.2.3.6). The 
KpnI-NsiI DNA fragment containing the HRP3 5' untranslated region 
from the plasmid pHLH1 was replaced with KpnI-NsiI restricted PCR 
product to give pPLH1 (Figure ib). The PfPCNA 5' flanking sequence was 
completely sequenced (2.2.8) to ensure no mutations had been introduced 
during amplification. The construction of pPLH1 was confirmed by 
restriction and southern analysis (Figures 2a & 3). The addition of the NsiI 
site at the PfPCNA 5' flanking-luc gene boundary introduces a histidine 
encoding codon immediately after the start codon, this has no effect on 
the enzymatic activity of luciferase (Wu et al., 1995). 
6.2.2 Partial NsiI restriction of pPLH1 to give the deletion constructs 
pPLHIAB, pPLH1AC and pPLH1EtBC. 
Restriction of the 5'PfPCNA 5' flanking sequence with NsiI was used to 
remove either, or both, of the restriction fragments delineated by these 
sites (Figure 2a & j). pPLH1 was restricted with NsiI under conditions 
which produced incomplete restriction. The length of restriction time, 
limitation of NsiI concentration and restriction at 25°C were all 
conditions used. The products of restriction were size fractionated by 
agarose gel electrophoresis and DNA fragments greater than 5kb in size 
purified by electroelution (2.2.3.6). The purified fragments were ligated 
(2.2.5) and transformed into E.coli (2.2.6). The DNA from transformants 
was restricted with NsiI to identify clones of interest. Clones lacking 
either, or both, the 800bp or 400bp NsiI restriction fragments were selected 
for a more complete restriction analysis (Figures 2 b-d, j Sr 4). The NsiI 
restriction site junctions were checked by sequencing (2.2.8). 
6.2.3 Inversion of the central 800bp NsiI restriction fragment. 
Inversion of the 800bp NsiI restriction fragment (B) was complicated by 
the presence of the NsiI site at the 3' end of the PfPCNA flanking sequence 
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Figure la. 

































Sizes are indicated in kb from an arbitrary point 0 on the 
pBluescript II SK+ vector (Stratagene). AmpR, ampicillin 
resistance gene; Luc, luciferase open reading frame. 
167 
(Figures 2a & j). HindIII restriction was therefore used to remove a 1.7kb 
DNA fragment containing luc to give an intermediate construct, pINT 
(Figure 2h), removing the NsiI site at the start of the luc gene. Complete 
NsiI restriction was used to remove an 800bp DNA fragment from the 
centre of the PfPCNA 5' flanking sequence to give pINThB (Figure 2i). 
The 800bp DNA fragment was reinserted into pINTAB and screened for 
the inverted orientation by PCR analysis (Figure 5) and checked by 
sequencing across the NsiI junctions. pINThB was restricted with Hindili 
and the 1.7kb HindIll DNA fragment, containing the luc gene, reinserted 
in the correct orientation. The PfPCNA 5' flanking sequence-luc boundary 
of pPLH1(R) was checked by restriction (Figures 2e, j & 4) and sequence 
analysis. - - - - -. 
6.2.4 Deletion from the extreme 5' end of the PfPCNA 5' flanking 
sequence. 
We wished to obtain a number of deletions, of increasing size, at the 5' 
end of the PfPCNA 5' flanking sequence. Initial attempts with a method 
using Ba131 (Sambrook et al., 1989) were unsuccessful as the digested 
products could not be recovered in the transfection vector. Attempts to 
engineer pPLH1 to facilitate Exolil deletions were also unsuccessful, only 
rearranged constructs were recovered after transformation of the ligations 
into E.coli. 
We decided to use PCR amplification of the PfPCNA 5' flanking sequences 
of interest. Oligonucleotides containing suitable restrictions sites for 
insertion into pINT (6.2.3) were used to overcome any potential problems 
in cloning regions containing multiple NsiI sites. PCR with the primers 
5'-CCCGGTACCGGGTGCITIIAAAAGAATGG-3' (L) or 5'-CCGGTACCG 
AATTACACATAAGTTATAC-3' (L) and N7687 (R) with the p127-4 
plasmid gave products of 1.25kb and 710bp, respectively. The KpnI-HindIII 
PfPCNA 5' flanking sequence from pINT was replaced with KpnI-Hin dill 
restricted PCR products. The 1.7kb DNA fragment containing the luc gene 
was reinserted, in the correct orientation, to give the constructs 
pPLH1z330 and pPLH1A870 (Figures 2 e-f & j). The PfPCNA 5' flanking 
IM 
Figure 2a-i. 
Schematics representing the pPLH1 series of transfection constructs and 
their derivatives used in their construction . All figures are drawn to scale 
and indicate the positions of restriction enzyme restriction sites used in 
either the construction of the plasmid or the confirmation of its 
construction. Oligonucleotide binding sites, used in southern analysis of 
constructs, are also indicated. 949T, 5' CTATACAGAGAGCCAAAT 3'; 
117V, 5' GAATTACACATAAGTTATAC 3'; 543T, 5' TGACAATTT 
TCTAATAGC 3'; P0901, 5' GCAGTTGCTCTCCAGCGG 3'; Uni, 5' 
TGAAAACGACGGCCATG 3'. 
a. pPLH1 	 b. pPLH1ABC 
c. pPLH1zB 	 d. pPLH1iC 
e. pPLH1 (R) 	 f. pPLH1i330 
g. pPLH1A870 	 h. pINT 
i. pINTh 
I 	I 500bp 
PfPCNA 5' flanking sequence 
[] Luciferase ORF 
HRP2 3' flanking sequence 
Figure 2j. 
Schematic indicating the modifications made to the PfPCNA 5' flanking 
regions. The positions of the endonuclease restriction sites discussed in 
the text are indicated. 
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Restriction and southern analysis of pPLH1. The restriction map 
indicating the positions of the oligonucleotide binding sites are indicated 
in figure 2a. The restriction fragments were size fractionated by agarose gel 
electrophoresis, blotted and hybridised to a range of end-labelled 
oligonucleotide probes. 
Restriction analysis. 
The 1.6kb marker of the 1kb marker (Gibco-BRL) range is indicated by an 
arrow. 
ethidium bromide stained agarose gel. The 1.6kb DNA fragment of the 
1kb marker range (Gibco-BRL) is indicated by an arrow. 
Southern analysis. 
The positions of the 1, 2 and 3kb DNA fragments are indicated. 
autoradiograph using the 949T end-labelled oligonucleotide probe. 
autoradiograph using the 117V end-labelled oligonucleotide probe. 
autoradiograph using the 543T end-labelled oligonucleotide probe. 
autoradiograph using the P0901 end-labelled oligonucleotide probe. 
autoradiograph using the Uni end-labelled oligonucleotide probe. 
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Restriction and southern analysis of the pPLH1 derivatives; pPLH1ABC, 
• pPLH1iB, pPLH1iC, pPLH1 (R), pPLH1330 and pPLH1i870. The 
restriction map indicating the positions of the oligonucleotide binding 
sites are indicated in figure 2b-g. For each construct the restriction 
fragments were sizw fractionated by agarose gel electrophoresis, blotted 
and hybridised to a range of end-labelled oligonucleotide probes. In this 
figure the data from the restriction analysis is presented with a 
representative set of autoradiographs from the southern analysis of the 
restricted construct pPLH1iB. 
Restriction analysis. 
All photographs have the position of the 1.6kb marker, from the 1kb 
marker range (Gibco-BRL), indicated. 
a) pPLH1zBC 	 b) pPLH1iB 
c) pPLH1iC 	 d) pPLH1 (R) 
e) pPLH1A330 	 f) pPLH1870 
Southern analysis of pPLH14BC. 
The position of the 1, 2 and 3kb markers are indicated. 
autoradiograph using the 117 end-labelled oligonucleotide probe. 
autoradiograph using the 949T end-labelled oligonucleotide probe. 
autoradiograph using the 543T end-labelled oligonucleotide probe. 
autoradiograph using the P0901 end-labelled oligonucleotide probe. 
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PCR analysis of the PfPCNA 5' flanking sequence to demonstrate the 
inversion of the central 800bp NsiI DNA restriction fragment (Figure 2e). 
Schematics indicating the positions of the oligonucleotides 949T, P0901 
and 828T (5'GTATAACTTATGTGTAATTC3') and their relative 
orientation in pPLH1 (A) and pPLH1(R) (B) are shown on the facing page. 
The sizes of the expected products are indicated in bp. 
C. An ethidium bromide stained agarose gel on which the results of a PCR 
between the oligonucleotides indicated below are size fractionated. The 
sizes of the principle products are indicated in bp. - - - 
M. lOObp markers. 
pPLH1, 949T and 828T. 
pPLH1, 828T and P0901. 
pPLH1 (R), 949T and 828T. 
pPLH1 (R), 828T and P0901. 
im 
pPLH1 
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sequence was completely sequenced to ensure no mutations were 
introduced during amplification, the constructs were analysed by 
restriction analysis (Figure 4) and the PfPCNA 5' flanking sequence-luc 
boundary checked by sequencing. 
6.3 Transfection of P.falciparum. 
6.3.1 Tests of the ability to detect luciferase expression from the pHLH1 
and pPLH1 constructs. 
On receiving the pHLH1 plasmid we demonstrated that, in our hands, 
luciferase was expressed in P.falciparum. An asynchronous culture was 
divided to give samples each containing approximately 2X10 8 parasites. 
Each sample was electroporated with 60ig of pHLH1 using a range of 
pulse intensities (2.5.2). After 48 hours the parasites were harvested and 
the luciferase activity measured in terms of the photons counts measured. 
The results of this analysis indicated that not only could we detect 
luciferase activity but that the levels of luciferase expressed varied with 
the pulse intensity used (Figure 6). The maximum activity was measured 
when approximately 50% of the parasites were killed. The same effect was 
noted with constructs containing the CAT reporter gene (Wu, Y., pers 
comm.). 
The HRP3 5' flanking sequence of pHLH1 was replaced with 1.58kb of 
PfPCNA 5' flanking sequence to give pPLH1 (6.2.1). Luciferase was 
expressed after electroporation of P.falciparum with 60p.g of this new 
construct (Figure 7a). Control experiments in which either no pPLH1 
(Figure 7j) was added or pPLH1 was added but not electroporated both 
gave no detectable levels of luciferase activity. 
6.3.2 pPLH1 recovered from the parasite 48 hours after electroporation is 
unrearranged. 
During preparation of the various constructs, rearrangement of the 
plasmids in E.coli was a considerable problem. To ensure that there were 





















X Photon counts 
Relative parasite survival 
The photon count from a luciferase assay where 60xg of 
pHLH1 was electroporated into 2x10 8 parasites at a range of 
pulse intensities. The parasite survival relative to a group of 
parasites to which 60pg of pHLH1 had been added but not 
electroporated is also indicated. 
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Figure 7. 
Colour representation of the image detected using the Argus-50 image 
processor (Hamamatsu Photonics K.K.). The image represents the 
photons detected over 10 minutes using the camera's most sensitive 
setting. Brighter regions of the image indicate a higher fequency of photon 
strikes. Extracts of parasites electroporated with 60pg of the following 
constructs were used in the assay; 
A. pPLH1 	 B. pPLH1ABC 
C. pPLH1AC 	 D. pPLH1AB 
E. pBluescriptllSK+ 	F. pPLH1 (R) 
C. pPLHIA870 	H. pPLH1A330 
I. pPLHI 	 J. no DNA 
K. pHLH1 L. assay buffer alone. 
of DNA replication which occurs during the 48 hours following 
electroporation, we rescued the plasmid for restriction analysis. 6iig  or 
60j.tg of pPLH1 was electroporated into ring synchronised cultures, each 
containing 2X10 8 parasites, and incubated for 48 hours. One further 
sample had 60jig of pPLH1 added but was not electroporated. The 
erythrocytes were harvested by centrifugation (3000g, 10 minutes, 4°C) 
and washed 4 times in 10 volumes of ice-cold PBS. These washes had 
previously been demonstrated to be sufficient to remove any DNA not 
inside the erythrocytes (5.5.1). The erythrocytes were lysed by saponin 
treatment (2.2.1.1.) and the washes repeated on the released parasites. The 
parasites were resuspended in imi of ice-cold hypotonic buffer (2.2.10) 
without the protease inhibitors, and broken open using a Potters 
homogeniser with a B-type pestle. 10.tl of each suspension recovered was 
used to transform 200pi of E.coli (2.2.6). Various volumes of transformed 
E.coli were plated on LB plates supplemented with 100p.gm1 1 ampicillin 
(2.2.6.2) and incubated overnight at 37°C. The results of the plating (Table 
1) indicate that the plasmid recovered originated from the protected 
environment of the parasite. 5 colonies were selected, at random, and 
along with a pPLH1 control restricted with EcoRE. This analysis showed 
that all the recovered plasmid appears to be the same as the original 
pPLH1 (data not shown), one recovered plasmid was restricted with a 
range of restriction enzymes and compared to pPLH1 (Figure 8). 
Table 1. Results of the transformation with plasmid isolated from 
transfected parasites. The numbers of cfu recovered on LB-Amp plates are 
indicated with the dilution of the parasite extract. 
Dilution 	60ig pPLH1 	6jtg pPLH1 	no DNA 
	
10-3 	 380 	 200 	 0 
10-4 60 	 29 0 
10-5 	 7 	 5 	 0 
10-6 1 	 0 	 0 
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Figure 8. 
Restriction analysis of pPLHI recovered from P.falciparum 48 hours after 
electroporation. pPLH1 was rescued by transformation of E.coli with the extract of 
transfected parasites. Sizes are indicated in bp. 
pPLI-11 that has not been electroporated into P.fa1ciparim. 
pPLHI rescued from transfected parasites. 
M. 1kb markers 
2. EcoRl 
4. EcoRl/ HindllI 
. kpul/NsiI 
S. !Ii,zdlll/Pstl 










The photon counts for each construct indicated were corrected for the 
parasitaemia measured when the parasites were harvested at the 
mononuclear ring stage 48 hours later. The mean average and the 
standard deviation are also presented for each construct. A. Represents 
data collected from experiments without the addition of proteinase 
inhibitors. B. Represents data collected from experiments where protease 
inhibitors have been added. 
pBSII SK+, pBluescriptll SK+; negative, 60p.g of pPLH1 added but not 
electroporated. 
Table 3. 	- 
The corrected photon counts within the transient transfection 
experiments were normalised relative to the value obtained for pPLH1. 
The mean average and the standard deviation for these relative activities 
of the promoter are presented. The constructs pBSII SK+ and pHLH1 are 
not displayed as these constructs are not part of the pPLH1 series of 
transfection constructs. 
pBSII SKi-, pBluescriptll SK+; negative, 60p.g of pPLH1 added but not 
electroporated. 
W. 
Table 2A: Photon counts/%parasitaemia from transient transfection assays 
(without protease inhibitors. 
Construct Experiment Mean Average Standard Deviation 
1 2 3 	4 5 6 
pPLH1 345 338 410 	289 241 347 328 57.5 
pPLH1ABC 28.7 22.1 14.2 21.7 7.26 
pPLH1iB 45.2 20.4 36.8 12.8 16.3 26.3 14.0 
pPLH1C 223 320 	237 183 281 249 53.0 
00 	 pPLH1 (R) 
10 
16.6 12.9 14.8 266 
pPLH1 A330 
pPLH1 A870 
pBSII SK+ 31.6 19.8 15.6 	175 21.1 7.20 
negative 22.9 14.9 6.35 6.07 9.86 12.0 7.05 
pHLH1 433 616 	376 286 409 424 53.0 
Table 2B: Photon counts/%parasitaemia from transient transfection assays (with protease inhibitors). 
Construct Experiment Mean Average Standard Deviation 
1 2 	3 
pPLH1 726 786 	983 831 134 
pPLH1ABC 145 14.5 
pPLH1B 8.70 8.70 
pPLH1C 782 782 
pPLH1 (R) 22.6 22.6 
pPLH1 M30 260 269 	344 291 46.1 
pPLH1870 38.7 39.4 	24.1 34.1 8.64 
pBSII SK+ 40 40 
negative 28.2 12.3 	24.0 21.5 8.24 
pHLH1 1059 989 	1323 1123 176 
Table 3: Relative photon counts/%parasitaemia of transient transfection assays. 
Construct 	 Experiment 	 Mean Av. 	Standard Dev. 
1 2 3 4 5 6 7 8 9 
pPLH1 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
pPLH1BC 0.08 0.07 0.06 0.01 0.06 0.03 
pPLH1iB 0.13 0.06 0.09 0.05 0.05 0.01 0.07 0.04 
pPLH1iC 0.66 0.78 0.82 0.76 0.81 0.80 0.77 0.06 
pPLH1 (R) 0.07 0.04 0.02 0.04 0.03 
pPLH1 A330 0.36 0.34 0.35 0.35 0.01 
pPLH1 i870 0.05 0.05 0.02 0.04 0.02 
pBSII SK+ 







Graphical representation of the relative promoter activities of the 





flanking sequence was deleted (Figure 2j and Table 3). Deletion of 870bp to 
give pPLH1A870, effectively abolished promoter activity (relative 
promoter activity of 0.04+/-0.02) indicating that a region of 470bp at the 5' 
end of segment B contains elements essential for the activity of the 
PfPCNA promoter. It is this region which contains the putative 
transcription start sites described earlier (Chapter 4). 
6.5 A region of 330bp (between 1250-1580bp upstream of the translational 
start site) in the PfPCNA 5' flanking sequence is required for efficient 
promoter activity. 
The deletion of 330bp from the extreme 5' end of the PfPCNA 5'flanking 
sequence, in pPLH1330, has a substantially reduced promoter activity 
(relative promoter activity of 0.35+/-0.01). This region lies between 290 
and 620bp upstream of the putative major transcription start sites and 
contains the "GC patches" referred to earlier (Chapter 4). At present we do 
not know if these have any functional significance. 
6.6 A region of 380bp (between 1-380bp upstream of the translational start 
site) in the PfPCNA 5' flanking sequence can be removed without 
abolishing promoter activity. 
The deletion of sequences proximal to the translational start site in the 
PfPCNA 5' flanking sequence appears to decrease, but not to abolish 
promoter activity. The deletion of NsiI DNA fragment C, in pPLH1AC 
(Figure 3), gives a relatively high promoter activity compared to the full 
length 5' UTR (relative promoter activity of 0.77+1-0.06). This region lies 
between 580bp and 960bp downstream of the transcription start sites. The 
approximately 20% reduction in promoter activity may be the result of 
moving the transcription start sites relative to the translational start 
rather than the removal of sequences important to the activity of the 
promoter. 
6.7 Protease inhibitors increase the efficiency of the luciferase assay. 
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Lysis of the parasite during the assay procedure (2.5.2) releases a range of 
proteases from organelles within the parasite such as the food vacuole. To 
help preserve the luciferase during the subsequent assay the lysis buffer in 
experiments 7-9 (Table 2b) was supplemented by the addition of a protease 
inhibitor cocktail. The data from pPLH1 and pHLH1 suggest that the 
sensitivity of the luciferase assay was increased 2-3 fold (taking the mean 
values before and after addition of the proteases in Table 2). 
6.7 Discussion. 
Firefly luciferase expression in Plasmodium had previously been 
demonstrated in both the intraerythrocytic and ookinete stages of 
development (Goonewardene et al., 1993, Wu et al., 1995). The ease of 
detection of the activity of this protein makes it a useful marker of the 
promoter activity. In these experiments we were assaying the cumulative 
expression of this protein over the first 48 hours following introduction 
of the constructs. We tried to eliminate inaccuracies in measuring the 
promoter activities by determining the photon counts of the samples 
immediately after extraction and calculating an activity related to the 
percentage parasitaemia. In spite of these precautions precise reproduction 
of the assays is difficult and differences are found between the absolute 
photon counts from experiment to experiment. These we assume to be 
attributable to minor differences in culture conditions and other 
experimental variables which will be constant for the samples in a given 
experiment but will probably vary across the different experiments carried 
out. When the data are expressed relative to the activity of the full length 
construct, a common control for every experiment, a striking consistency 
is found (Table 3). This was maintained even when the experimental 
conditions were knowingly changed, as was demonstrated by the addition 
of protease inhibitors (experiments 7-9). 
The analysis of the promoter activity of a number of constructs identified 
a region of PfPCNA 5' flanking sequence approximately 710-1180bp 
upstream of the translational start which is essential for promoter activity 
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(Figure 2j). This region contains the putative transcriptional start sites 
identified by physical mapping methods (Chapter 4). A second region, 
between 1250-1580bp upstream of the translational start site, has also been 
shown to be required for efficient promoter activity. However whether 
this region can be described as an enhancer has not been settled since we 
have not yet tested the effect of inverting it on promoter activity. 
Enhancers have recently been identified from the 5' flanking sequences of 
P. falciparum calmodulin and dhfr-ts and P.chabaudi dhfr-ts encoding 
genes (Crabb and Cowman, 1996). These enhancers share neither sequence 
similarity to each other nor with the region required for PfPCNA 
promoter efficiency. 
The apparent lack of a significant effect on the level of the promoter 
activity due to the deletion of sequences proximal to the open reading 
frame prompts us to question the role of such extensive 5'UTRs so 
frequently found for genes of Plasmodium. Suggestions of probable 
functions have included the targeting of the transcript, control of 
transcript stability or perhaps the presence of elements which determine 
stage specific translation. At present we do not know which, if any, of 
these suggestions, apply. The substitution of these sequences, rather than 
their deletion, may give a clearer indication of whether these sequences 
are required for promoter activity. 
As far as we are aware this is the first time that transient transfection in 
P.falciparum has been used to confirm the essential nature of a region 
which contains putative transcription start sites. At present the analysis is 
limited and future studies will be directed towards a more detailed study 
of the PfPCNA promoter region including a mutational analysis of the 
various sequences identified in this work; the transcription start site(s), 
TATA boxes, OCT1 binding sites and the "GC patches". It is also possible 
that other regions which influence PfPCNA promoter expression lie 




This study has provided a start to a more complete analysis of the 
regulation of the expression of DNA replication proteins of P.falciparum. 
The pattern of accumulation of PfPCNA and PfPolö mRNA and 
polypeptide levels were the same. However, the promoter activities of 
these genes were different dismissing the possibility that their expression 
is through a unitary control. PfPCNA appears to be regulated at the post- 
transcriptional level whereas PfPolö apperars to be regulated at the level 
of transcript initiation. PfPCNA and PfPol6 mRNA and polypeptide 
levels increase in trophozoites yet only the polypeptide persists in 
schizonts, the mRNA presumably degrades. These results suggest that 
enough polypeptide is translated in trophozoites to complete DNA 
synthesis. Although we now have some ideas regarding the regulation of - 
expression of PfPCNA and PfPol6 at the onset of DNA replication, the 
regulation of the activity of these proteins during the subsequent rounds 
of DNA replication is unknown, although this is presumably through 
some posttranslational mechanism. The activity of both DNA polymerase 
a and 6 in proliferating human cells appears to be regulated by 
phosphorylation (Nasheuer et al., 1991, Zeng et al., 1994), PCNA does not 
appear to be phosphorylated at any point in the cell cycle (Zeng et al., 
1994). To date, no studies have been made regarding such 
posttranslational mechanisms in the regulation of the activity of DNA 
polymerase 6 and PCNA in Plasmodium. The P.falciparum DNA 
polymerase a major subunit, however, does not appear to be 
phosphorylated at any point during intraerythrocytic schizogony (Choi 
and Mikkelson, 1991). 
Initial attempts to compare the 5' flanking sequences from PfPCNA and 
PfPol6 were thwarted when we were unable to isolate an overlapping 
genomic clone containing PfPol6 5' flanking sequence. In mapping the 
PfPCNA transcription start sites we employed a strategy which involved 
the use of 4 methods. The transcription start sites were first mapped 
approximately to identify a region that we could concentrate on. This 
region was then analysed more closely using both primer extension 
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analysis and RNase protection assays. Two transcription start sites at 
960bp and 1000bp upstream of the translational start site were identified. 
Associated with these sites were good consensus-matching TATA boxes 
between 30-35bp upstream of both transcription start sites and two 
oppositely orientated OCT1 boxes placed between 235-275bp upstream of 
the major transcription start site. We also identified a number of "GC 
patches", short regions of DNA unusually rich in guanosine and cytosine 
nucleosides. 
Northern analysis indicates that there are two PfPCNA transcripts; a 
predominant 1.85kb transcript and a minor 2.2kb transcript. We found no 
evidence for additional transcription start sites apart from the two sites 
already mapped. Analysis of the 3' flanking sequence identified a good 
consensus transcription stop site at the extreme 3' end of a cDNA clone. 
The distance between the mapped transcription start and the putative 
stop site, 250bp downstream of the PfPCNA ORE, would correspond to the 
2.2kb transcript. Repeated screening of the cDNA library indicated that no 
other PfPCNA cDNA clones were present even though there is a weak 
consensus transcription stop site 120bp downstream of the PfPCNA ORE. 
Evidence from RT-PCR experiments across the 5' flanking sequence did 
not suggest that there were deletions present in the 5'UTR of the 
transcripts. The 5'UTR sequence available from the cDNA clone was 
colinear with the genomic sequence. Both observations would suggest 
that any differences in transcript size would be a result of different sized 
3'UTRs. Northern analysis using a probe from the extreme 3' of the cDNA 
clone indicated that the 1.85kb transcript may lack sequences from this 
region. To date we have no explanation for the presence of two PfPCNA 
transcripts, we hope that a combination of RNase protection and transient 
transfection assays may provide some clues. That two different transcripts 
arise from a gene that is regulated at the post-transcriptional level is 
intriguing. 
We were disappointed with the lack of expression of the GFP reporter 
gene. The use of GFP as either a reporter of expression or a tag for a 
protein of interest has flourished since the first report of heterologous 
expression by Chalfie et al. (1994). However, it now seems apparant that 
expression of "reasonable" quantities of the protein is required to 
visualise the fluorescence. The expression of firefly luciferase in the 
intraerythrocytic stages of parasites is approximately 1000 fold less than in 
the sexual stages (Wirth, D., pers comm.). Given the apparantly greater 
efficiency of the sexual stages to express heterologous proteins we would 
suggest that an attempt to express GFP in these stages be tried. 
Transient transfection analysis identified 3 regions of interest in the 5' 
flanking sequence of PfPCNA. (1) An essential region, containing the 
putative transcription start sites, was characterised when deletion or 
inversion of a region between 810bp-1180bp upstream of the translation 
start abolished promoter activity. (2) A region essential for the efficiency 
of the promoter was characterised between 295bp-625bp upstream of the 
major transcription start site. (3) The deletion of sequences proximal to 
the ORF did not appear to significantly lower the activity of the promoter. 
Unfortunately these studies did not help in identifying a role for the 
extremely long 5'UTRs. 
This preliminary analysis of the 5' flanking sequence identified gross 
regions of interest. A new range of constructs will enable a more accurate 
mapping of the regions already identified as well as hopefully finding 
new regions to study more closely. More specifically; the transcription 
start sites, TATA boxes, and OCT1 boxes should be replaced or deleted to 
assess their effect on the promoter activity. The region required for 
promoter efficiency will be replaced in the opposite orientation to 
determine whether this is an enhancer region. Sequences proximal to the 
reporter gene will be replaced with other sequences and the effect on both 
the level and periodicity of promoter activity monitored. 
The ability to transfect Plasmodium has, in recent years especially, been 
regarded as the next step towards the successful development of rationally 
designed drugs. With the system now available within our laboratory we 
should be able to start to address questions regarding the biology of the 
parasite in general and of DNA replication in particular. 
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